0001140361-23-024396.txt : 20230512 0001140361-23-024396.hdr.sgml : 20230512 20230512163120 ACCESSION NUMBER: 0001140361-23-024396 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 51 CONFORMED PERIOD OF REPORT: 20230331 FILED AS OF DATE: 20230512 DATE AS OF CHANGE: 20230512 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ARYA Sciences Acquisition Corp V CENTRAL INDEX KEY: 0001852432 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-40595 FILM NUMBER: 23916354 BUSINESS ADDRESS: STREET 1: 51 ASTOR PLACE, 10TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10003 BUSINESS PHONE: 212-284-2300 MAIL ADDRESS: STREET 1: 51 ASTOR PLACE, 10TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10003 10-Q 1 brhc20052681_10q.htm 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2023

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to________________

ARYA SCIENCES ACQUISITION CORP V

(Exact name of registrant as specified in its charter)

Cayman Islands	001-40595	98-1590338
(State or other jurisdiction of incorporation or organization)	(Commission File Number)	(IRS Employer Identification No.)

51 Astor Place, 10th Floor New York, NY		10003
(Address Of Principal Executive Offices)		(Zip Code)

(212) 284-2300

Registrant’s telephone number, including area code

Not Applicable

(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Class A Ordinary Share, $0.0001 par value	ARYE	The Nasdaq Capital Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐

As of May 12, 2023, 15,449,000 Class A ordinary shares, par value $0.0001 per share, and 3,737,500 Class B ordinary shares, par value $0.0001 per share, were issued and outstanding.

ARYA SCIENCES ACQUISITION CORP V

Form 10-Q

For the Quarter Ended March 31, 2023

Table of Contents

		Page
PART I. FINANCIAL INFORMATION
Item 1.	Condensed Financial Statements	1
	Condensed Balance Sheets as of March 31, 2023 (unaudited) and December 31, 2022	1
	Unaudited Condensed Statements of Operations for the Three Months ended March 31, 2023 and 2022	2
	Unaudited Condensed Statements of Changes in Shareholders’ Deficit for the Three Months ended March 31, 2023 and 2022	3
	Unaudited Condensed Statements of Cash Flows for the Three Months ended March 31, 2023 and 2022	4
	Notes to Unaudited Condensed Financial Statements	5
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	16
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	21
Item 4.	Controls and Procedures	21
PART II. OTHER INFORMATION
Item 1.	Legal Proceedings	22
Item 1A.	Risk Factors	22
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds from Registered Securities	23
Item 3.	Defaults Upon Senior Securities	23
Item 4.	Mine Safety Disclosures	23
Item 5.	Other Information	23
Item 6.	Exhibits	24
Signature		25

Table of Contents

PART I. FINANCIAL INFORMATION

Item 1.

Condensed Financial Statements

ARYA SCIENCES ACQUISITION CORP V

CONDENSED BALANCE SHEETS

	March 31,			December 31,
	2023			2022
	(unaudited)
Assets
Current assets:
Cash	$	295,974		$	385,187
Prepaid expenses		130,000			157,000
Total current assets		425,974			542,187
Investments held in Trust Account		153,294,256			151,601,721
Total Assets	$	153,720,230		$	152,143,908

Liabilities and Shareholders’ Deficit
Current liabilities:
Accounts payable	$	12,974		$	11,466
Accrued expenses		2,830,329			2,776,182
Due to related party		120,000			90,000
Total current liabilities		2,963,303			2,877,648
Deferred underwriting commissions		2,616,250			2,616,250
Total Liabilities		5,579,553			5,493,898

Commitments and Contingencies
Class A ordinary shares subject to possible redemption; 14,950,000 shares at redemption value of approximately $10.25 and $10.13 per share at March 31, 2023 and December 31, 2022, respectively		153,194,256			151,501,721

Shareholders’ Deficit:
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding at March 31, 2023 and December 31, 2022		-			-
Class A ordinary shares, $0.0001 par value; 479,000,000 shares authorized; 499,000 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively		50			50
Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 3,737,500 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively		374			374
Additional paid-in capital		-			-
Accumulated deficit		(5,054,003	)		(4,852,135	)
Total shareholders’ deficit		(5,053,579	)		(4,851,711	)
Total Liabilities and Shareholders’ Deficit	$	153,720,230		$	152,143,908

The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

ARYA SCIENCES ACQUISITION CORP V

UNAUDITED CONDENSED STATEMENTS OF OPERATIONS

	For the Three Months Ended March 31,
	2023			2022
General and administrative expenses	$	201,868		$	228,530
Loss from operations		(201,868	)		(228,530	)
Other income (expense)
Unrealized gain (loss) on investments held in Trust Account		1,692,535			(49,628	)
Total other income (expense)		1,692,535			(49,628	)
Net income (loss)	$	1,490,667		$	(278,158	)

Basic and diluted weighted average shares outstanding of Class A ordinary shares		15,449,000			15,449,000
Basic and diluted net income (loss) per share, Class A ordinary share	$	0.08		$	(0.01	)
Basic and diluted weighted average shares outstanding of Class B ordinary shares		3,737,500			3,737,500
Basic and diluted net income (loss) per share, Class B ordinary share	$	0.08		$	(0.01	)

The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

ARYA SCIENCES ACQUISITION CORP V

UNAUDITED CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS’ DEFICIT

FOR THE THREE MONTHS ENDED MARCH 31, 2023

	Ordinary Shares																	Total
	Class A					Class B					Additional Paid-in			Accumulated				Shareholders’
	Shares		Amount			Shares		Amount			Capital			Deficit				Deficit
Balance - December 31, 2022		499,000		$	50		3,737,500		$	374		$	-		$	(4,852,135	)		$	(4,851,711	)
Increase in redemption value of Class A ordinary shares subject to possible redemption		-			-		-			-			-			(1,692,535	)			(1,692,535	)
Net income		-			-		-			-			-			1,490,667				1,490,667
Balance - March 31, 2023 (unaudited)		499,000		$	50		3,737,500		$	374		$	-		$	(5,054,003	)		$	(5,053,579	)

FOR THE THREE MONTHS ENDED MARCH 31, 2022

	Ordinary Shares																	Total
	Class A					Class B					Additional Paid-in			Accumulated				Shareholders’
	Shares		Amount			Shares		Amount			Capital			Deficit				Deficit
Balance - December 31, 2021		499,000		$	50		3,737,500		$	374		$	-		$	(6,681,846	)		$	(6,681,422	)
Net loss		-			-		-			-			-			(278,158	)			(278,158	)
Balance - March 31, 2022 (unaudited)		499,000		$	50		3,737,500		$	374		$	-		$	(6,960,004	)			(6,959,580	)

The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

ARYA SCIENCES ACQUISITION CORP V

UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS

	For the Three Months Ended March 31,
	2023			2022
Cash Flows from Operating Activities:
Net income (loss)	$	1,490,667		$	(278,158	)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Unrealized (gain) loss on investments held in Trust Account		(1,692,535	)		49,628
Changes in operating assets and liabilities:
Prepaid expenses		27,000			36,402
Accounts payable		1,508			42,603
Accrued expenses		54,147			47,361
Due to related party		30,000			30,000
Net cash used in operating activities		(89,213	)		(72,164	)

Net change in cash		(89,213	)		(72,164	)

Cash - beginning of the period		385,187			775,885
Cash - end of the period	$	295,974		$	703,721

The accompanying notes are an integral part of these unaudited condensed financial statements.

Table of Contents

ARYA SCIENCES ACQUISITION CORP V

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

Note 1 - Description of Organization and Business Operations

ARYA Sciences Acquisition Corp V (the “Company”) was incorporated as a Cayman Islands exempted company on February 22, 2021. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies.

All activity for the period from February 22, 2021 (inception) through March 31, 2023 was related to the Company’s formation and the initial public offering (the “Initial Public Offering”) described below, and since the Initial Public Offering, the search for a prospective initial Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end.

The Company’s sponsor is ARYA Sciences Holdings V, a Cayman Islands exempted limited company (the “Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on July 12, 2021. On July 15, 2021, the Company consummated its Initial Public Offering of 14,950,000 Class A ordinary shares (the “Public Shares”), including the 1,950,000 Public Shares as a result of the underwriters’ full exercise of their over-allotment option, at an offering price of $10.00 per Public Share, generating gross proceeds of $149.5 million, and incurring offering costs of approximately $8.7 million, inclusive of approximately $5.2 million in deferred underwriting commissions (see Note 5). On August 8, 2022, the Company received a waiver from one of the underwriters of its Initial Public Offering pursuant to which such underwriter waived all rights to its 50% share of the deferred underwriting commissions payable upon completion of an initial Business Combination. In connection with this waiver, the underwriter also agreed that (i) this waiver is not intended to allocate its 50% portion of the deferred underwriting commissions to the other underwriter that has not waived its right to receive its share of the deferred underwriting commissions and (ii) the waived portion of the deferred underwriting commissions can, at the discretion of the Company, be paid to one or more parties or otherwise be used in connection with an initial Business Combination.

Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 499,000 Class A ordinary shares (the “Private Placement Shares”), at a price of $10.00 per Private Placement Share to the Sponsor, generating gross proceeds of approximately $5.0 million (see Note 4).

Upon the closing of the Initial Public Offering and the Private Placement, $149.5 million ($10.00 per Public Share) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement were placed in a trust account (the “Trust Account”), located in the United States, with Continental Stock Transfer & Trust Company acting as trustee, and are invested only in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, until the earlier of (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Shares, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the net assets held in the Trust Account (excluding the amount of deferred underwriting commissions and taxes payable on the interest earned on the Trust Account) at the time of the signing of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act.

Table of Contents

ARYA SCIENCES ACQUISITION CORP V

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

The Company will provide the holders of Public Shares (the “Public Shareholders”), with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay income taxes). The per-share amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 5).

These Public Shares were classified as temporary equity in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity” (“ASC 480”). In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, only if a majority of the ordinary shares, represented in person or by proxy and entitled to vote thereon, voted at a shareholder meeting are voted in favor of the Business Combination. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to the amended and restated memorandum and articles of association which the Company will adopt upon the consummation of the Initial Public Offering (the “Amended and Restated Memorandum and Articles of Association”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transactions is required by law, or the Company decides to obtain shareholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction or vote at all. If the Company seeks shareholder approval in connection with a Business Combination, the initial shareholders (as defined below) agreed to vote their Founder Shares (as defined below in Note 4) and any Public Shares they hold in favor of a Business Combination. Subsequent to the consummation of the Initial Public Offering, the Company will adopt an insider trading policy which will require insiders to: (i) refrain from purchasing shares during certain blackout periods and when they are in possession of any material non-public information and (ii) to clear all trades with the Company’s legal counsel prior to execution. In addition, the initial shareholders agreed to waive their redemption rights with respect to their Founder Shares, Private Placement Shares and Public Shares in connection with the completion of a Business Combination.

Notwithstanding the foregoing, if the Company seeks shareholder approval of its Business Combination and does not conduct redemptions in connection with its Business Combination pursuant to the tender offer rules, the Amended and Restated Memorandum and Articles of Association provide that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Class A ordinary shares sold in the Initial Public Offering, without the prior consent of the Company.

The Company’s Sponsor, officers and directors (the “initial shareholders”) agreed not to propose an amendment to the Amended and Restated Memorandum and Articles of Association (a) that would modify the substance or timing of the Company’s obligation to provide holders of its Public Shares the right to have their shares redeemed in connection with a Business Combination or to redeem 100% of the Public Shares if the Company does not complete its Business Combination within 24 months from the closing of the Initial Public Offering, or July 15, 2023, (the “Combination Period”), or (b) with respect to any other provision relating to the rights of Public Shareholders, unless the Company provides the Public Shareholders with the opportunity to redeem their Class A ordinary shares in conjunction with any such amendment.

If the Company has not completed a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its income taxes, if any (less up to $100,000 of interest to pay dissolution expenses), divided by the number of the then-outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii) to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.

Table of Contents

ARYA SCIENCES ACQUISITION CORP V

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

The initial shareholders agreed to waive their liquidation rights with respect to the Founder Shares and Private Placement Shares held by them if the Company fails to complete a Business Combination within the Combination Period. However, if the initial shareholders acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters agreed to waive their rights to their deferred underwriting commission (see Note 5) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution (including Trust Account assets) will be only $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor agreed to be liable to the Company if and to the extent any claims by a third party (excluding the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account if less than $10.00 per Public Share due to reductions in the value of the assets in the Trust Account, in each case net of the interest that may be withdrawn to pay for the Company’s tax obligations. This liability will not apply with respect to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”).

Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (excluding the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. The Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and the Company believes that the Sponsor’s only assets are securities of the Company. The Sponsor may not be able to satisfy those obligations. None of the Company’s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses.

Going Concern

As of March 31, 2023, the Company had approximately $296,000 in its operating bank account, and working capital deficit of approximately $2.6 million.

The Company’s liquidity needs to date have been satisfied through a contribution of $25,000 from the Sponsor to cover for certain expenses in exchange for the issuance of the Founder Shares, the loan of approximately $151,000 from the Sponsor pursuant to the Note (as defined in Note 4) and advances from the Sponsor, and $2 million in proceeds from the consummation of the Private Placement not held in the Trust Account. The Company fully repaid the Note on July 15, 2021. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (as defined in Note 4). As of March 31, 2023 and December 31, 2022, there were no amounts outstanding under any Working Capital Loan.

Table of Contents

ARYA SCIENCES ACQUISITION CORP V

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

The Company cannot provide any assurance that new financing along the lines detailed above will be available to it on commercially acceptable terms, if at all. Further, the Company has until July 15, 2023 to consummate a Business Combination, but the Company cannot provide assurance that it will be able to consummate a Business Combination by that date. If a Business Combination is not consummated by the required date, there will be a mandatory liquidation and subsequent dissolution. In connection with the Company’s assessment of going concern considerations in accordance with FASB ASC Topic 205-40, “Basis of Presentation - Going Concern,” management has determined that the working capital deficit and liquidity conditions raise substantial doubt about the Company’s ability to continue as a going concern until the earlier of the consummation of the Business Combination or the date the Company is required to liquidate, July 15, 2023. The unaudited condensed financial statements do not include any adjustment that might be necessary if the Company is unable to continue as a going concern. The Company intends to complete its initial Business Combination before the mandatory liquidation date; however, there can be no assurance that the Company will be able to consummate any Business Combination by July 15, 2023. No adjustments have been made to the carrying amounts of assets and liabilities should the Company be required to liquidate after July 15, 2023, nor do these unaudited condensed financial statements include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.

Risks and Uncertainties

Results of operations and the Company’s ability to complete a Business Combination may be adversely affected by various factors that could cause economic uncertainty and volatility in the financial markets, many of which are beyond its control. The Company’s business of pursuing and consummating an initial Business Combination could be impacted by, among other things, downturns in the financial markets or in economic conditions, export controls, tariffs, trade wars, inflation, increases in interest rates, supply chain disruptions, declines in consumer confidence and spending, the ongoing effects of the COVID-19 pandemic, including resurgences and the emergence of new variants, and geopolitical instability, such as the military conflict in the Ukraine. The Company cannot at this time fully predict the likelihood of one or more of the above events, their duration or magnitude or the extent to which they may materially impact the Company’s business and its ability to complete an initial Business Combination.

Note 2 - Summary of Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. Accordingly, certain disclosures included in the annual financial statements have been condensed or omitted from these unaudited condensed financial statements as they are not required for unaudited interim condensed financial statements. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the three months ended March 31, 2023 are not necessarily indicative of the results that may be expected through December 31, 2023 or any future periods.

The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form 10-K for the year ended December 31, 2022 and filed by the Company with the SEC on April 12, 2023.

Emerging Growth Company

The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s unaudited condensed financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Table of Contents

ARYA SCIENCES ACQUISITION CORP V

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

Concentration of Cash Balances

The Company has significant cash balances at financial institutions which throughout the year regularly exceed the federally insured limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of March 31, 2023 and December 31, 2022, aside from the cash maintained in the Trust Account (see Note 8).

Use of Estimates

The preparation of unaudited condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets liabilities and expenses and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements. Actual results could differ from those estimates.

Investments Held in Trust Account

The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities are included in interest income and unrealized gain on investments held in Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.

Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC Topic 820, “Fair Value Measurements and Disclosures,” equals or approximates the carrying amounts represented in the condensed balance sheets.

Fair Value Measurements

Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:

•	Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

•	Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

•	Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

Table of Contents

ARYA SCIENCES ACQUISITION CORP V

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.

As of March 31, 2023 and December 31, 2022, the carrying values of cash, accounts payable, accrued expenses and due to related party approximate their fair values due to the short-term nature of the instruments. The Company’s investments held in Trust Account are comprised of investments in U.S. Treasury securities with an original maturity of 185 days or less and are recognized at fair value. The fair value of investments held in Trust Account is determined using quoted prices in active markets.

Offering Costs Associated with the Initial Public Offering

Offering costs consisted of legal, accounting, underwriting and other costs incurred that were directly related to the Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with the Class A ordinary shares issued were charged against the carrying value of the Class A ordinary shares subject to possible redemption upon the completion of the Initial Public Offering. The Company classifies deferred underwriting commissions as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.

Class A Ordinary Shares Subject to Possible Redemption

The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ deficit. The Public Shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of March 31, 2023 and December 31, 2022, 14,950,000 Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s condensed balance sheets.

The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the Class A ordinary shares subject to possible redemption to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit.

Income Taxes

FASB ASC Topic 740, “Income Taxes,” prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of March 31, 2023 and December 31, 2022. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of March 31, 2023 and December 31, 2022, there were no unrecognized tax benefits and no amounts were accrued for the payment of interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.

There is currently no taxation imposed on income by the government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s unaudited condensed financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.

Table of Contents

ARYA SCIENCES ACQUISITION CORP V

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

Net Income (Loss) per Ordinary Share

The Company has two classes of shares: Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per ordinary share is computed by dividing net income (loss) by the weighted-average number of ordinary shares outstanding during the periods. Accretion associated with the Class A ordinary shares subject to possible redemption is excluded from earnings per ordinary share as the redemption value approximates fair value.

	For the Three Months Ended March 31,
	2023				2022
	Class A		Class B		Class A			Class B
Basic and diluted net income (loss) per ordinary share:
Numerator:
Allocation of net income (loss)	$	1,200,287	$	290,380	$	(223,973	)	$	(54,185	)
Denominator:
Basic and diluted weighted average ordinary shares outstanding		15,449,000		3,737,500		15,449,000			3,737,500
Basic and diluted net income (loss) per ordinary share	$	0.08	$	0.08	$	(0.01	)	$	(0.01	)

Recent Accounting Pronouncements

The Company’s management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying unaudited condensed financial statements.

Note 3 - Initial Public Offering

On July 15, 2021, the Company consummated its Initial Public Offering of 14,950,000 Public Shares, including the 1,950,000 Public Shares as a result of the underwriters’ full exercise of their over-allotment option, at an offering price of $10.00 per Public Share, generating gross proceeds of $149.5 million, and incurring offering costs of approximately $8.7 million, inclusive of approximately $5.2 million in deferred underwriting commissions. On August 8, 2022, the Company received a waiver from one of the underwriters of its Initial Public Offering pursuant to which such underwriter waived all rights to its 50% share of the deferred underwriting commissions payable upon completion of an initial Business Combination (see Note 1).

Table of Contents

ARYA SCIENCES ACQUISITION CORP V

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

Note 4 - Related Party Transactions

Founder Shares

On March 18, 2021, the Sponsor paid $25,000 to cover certain of the Company’s expenses in exchange for the issuance of 3,737,500 Class B ordinary shares, par value $0.0001 (the “Founder Shares”). In June 2021, the Sponsor transferred an aggregate of 120,000 Founder Shares to the Company’s independent directors. The Sponsor agreed to forfeit up to 487,500 Founder Shares to the extent that the over-allotment option was not exercised in full by the underwriters, so that the Founder Shares would represent 20.0% of the Company’s issued and outstanding ordinary shares (excluding the Private Placement Shares) after the Initial Public Offering. On July 15, 2021, the underwriters fully exercised the over-allotment option to purchase additional 1,950,000 Public Shares. As a result, the 487,500 Class B ordinary shares were no longer subject to forfeiture.

The initial shareholders agreed, subject to limited exceptions, not to transfer, assign or sell any of their Founder Shares until the earlier to occur of: (A) one year after the completion of the initial Business Combination and (B) subsequent to the initial Business Combination, (x) if the closing price of Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the Public Shareholders having the right to exchange their ordinary shares for cash, securities or other property.

Private Placement Shares

Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement of 499,000 Private Placement Shares, at a price of $10.00 per Private Placement Share to the Sponsor, generating gross proceeds of approximately $5.0 million. Certain proceeds from the Private Placement Shares were added to the proceeds from the Initial Public Offering held in the Trust Account.

The Private Placement Shares are not transferable or salable until 30 days after the completion of the initial Business Combination. Certain proceeds from the Private Placement Shares have been added to the proceeds from the Initial Public Offering held in the Trust Account. The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Shares until 30 days after the completion of the initial Business Combination.

Related Party Loans

On March 31, 2021, a related party advanced approximately $1,400 to cover for certain expenses on behalf of the Company. The Company fully repaid the advance from related party of approximately $1,400 on April 5, 2021.

On March 18, 2021, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover for expenses related to the Initial Public Offering pursuant to a promissory note (the “Note”). This loan was non-interest bearing and payable upon the completion of the Initial Public Offering. The Company borrowed $150,000 under the Note and fully repaid the Note amount on July 15, 2021. Subsequent to the repayment, the loan facility was no longer available to the Company.

In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company may repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans may be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of the proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon the consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into shares of the post Business Combination entity at a price of $10.00 per share. The shares would be identical to the Private Placement Shares. As of March 31, 2023 and December 31, 2022, the Company had no outstanding borrowings under the Working Capital Loans.

Table of Contents

ARYA SCIENCES ACQUISITION CORP V

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

Administrative Support Agreement

Commencing on the date that the Company’s registration statement relating to its Initial Public Offering was declared effective through the earlier of consummation of the initial Business Combination and the Company’s liquidation, the Company agreed to reimburse the Sponsor for office space, secretarial and administrative services provided to the Company in the amount of $10,000 per month. For the three months ended March 31, 2023 and 2022, the Company incurred expenses of approximately $30,000 (unaudited) and $30,000 (unaudited), respectively, under this agreement. As of March 31, 2023 and December 31, 2022, the Company had $120,000 (unaudited) and $90,000, respectively, in due to related party on the balance sheets.

Note 5 - Commitments and Contingencies

Registration Rights

The holders of Founder Shares, Private Placement Shares, as well as the Private Placement Shares that may be issued upon conversion of Working Capital Loans, are entitled to registration rights pursuant to a registration and shareholder rights agreement signed upon the consummation of the Initial Public Offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the Company’s completion of its Business Combination. However, the registration and shareholder rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lock-up period, which occurs (i) in the case of the Founder Shares, in accordance with the letter agreement the Company’s initial shareholders entered into and (ii) in the case of the Private Placement Shares, 30 days after the completion of the Company’s Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

The Company granted the underwriters a 45-day option from the final prospectus relating to the Initial Public Offering to purchase up to 1,950,000 additional Public Shares to cover over-allotments at the Initial Public Offering price less the underwriting discounts and commissions. On July 15, 2021, the underwriters fully exercised the over-allotment option.

On August 8, 2022, the Company received a waiver from one of the underwriters of its Initial Public Offering pursuant to which such underwriter waived all rights to its 50% share of the deferred underwriting commissions payable upon completion of an initial Business Combination. In connection with this waiver, the underwriter also agreed that (i) this waiver is not intended to allocate its 50% portion of the deferred underwriting commissions to the other underwriter that has not waived its right to receive its share of the deferred underwriting commissions and (ii) the waived portion of the deferred underwriting commissions can, at the discretion of the Company, be paid to one or more parties or otherwise be used in connection with an initial Business Combination. During the year ended December 31, 2022, the Company derecognized approximately $2.6 million of the deferred underwriting commissions and recorded an adjustment to the carrying value of the shares of Class A ordinary shares subject to possible redemption.

Table of Contents

ARYA SCIENCES ACQUISITION CORP V

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

Note 6 - Class A Ordinary Shares Subject to Possible Redemption

The Public Shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of future events. As of March 31, 2023 and December 31, 2022, there were 14,950,000 Class A ordinary shares subject to possible redemption.

The Public Shares issued in the Initial Public Offering and in connection with the exercise by the underwriters of the over-allotment option were recognized in Class A ordinary shares subject to possible redemption as follows:

Gross proceeds	$	149,500,000
Less:
Offering costs allocated to Class A ordinary shares subject to possible redemption		(8,709,154	)
Plus:
Waiver of deferred underwriting commission		2,616,250
Accretion on Class A ordinary shares subject to possible redemption amount		8,094,625
Class A ordinary shares subject to possible redemption at December 31, 2022		151,501,721
Plus:
Accretion on Class A ordinary shares subject to possible redemption amount		1,692,535
Class A ordinary shares subject to possible redemption at March 31, 2023	$	153,194,256

Note 7 - Shareholders’ Deficit

Preference Shares - The Company is authorized to issue 1,000,000 preference shares with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of March 31, 2023 and December 31, 2022, there were no preference shares issued or outstanding.

Class A Ordinary Shares - The Company is authorized to issue 479,000,000 Class A ordinary shares with a par value of $0.0001 per share. Holders of the Company’s Class A ordinary shares are entitled to one vote for each share. As of March 31, 2023 and December 31, 2022, there were 15,449,000 Class A ordinary shares issued and outstanding, of which 14,950,000 shares were subject to possible redemption and classified in temporary equity, respectively (see Note 6).

Class B Ordinary Shares - The Company is authorized to issue 20,000,000 Class B ordinary shares with a par value of $0.0001 per share. As of March 31, 2023 and December 31, 2022, there were 3,737,500 Class B ordinary shares issued and outstanding (see Note 4).

Ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders. Holders of Class A ordinary shares and holders of Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the shareholders except as required by law.

The Class B ordinary shares will automatically convert into Class A ordinary shares on the first business day following the consummation of the initial Business Combination at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, 20% of the sum of (i) the total number of ordinary shares issued and outstanding (excluding the Private Placement Shares) upon the consummation of the Initial Public Offering, plus (ii) the sum of the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Shares issued to the Sponsor, members of the Company’s management team or any of their affiliates upon conversion of Working Capital Loans. In no event will the Class B ordinary shares convert into Class A ordinary shares at a rate of less than one-to-one.

Table of Contents

ARYA SCIENCES ACQUISITION CORP V

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

Note 8 - Fair Value Measurements

The following tables present information about the Company’s assets that are measured at fair value on a recurring basis as of March 31, 2023 and December 31, 2022 and indicate the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value.

March 31, 2023

Description	Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Other Unobservable Inputs (Level 3)
Investments held in Trust Account
U.S. Treasury Securities	$	153,293,384	$	—	$	—
Cash equivalents - money market funds		872		—		—
	$	153,294,256	$	—	$	—

December 31, 2022

Description	Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Other Unobservable Inputs (Level 3)
Investments held in Trust Account
U.S. Treasury Securities	$	151,592,810	$	—	$	—
Cash equivalents - money market funds		8,911		—		—
	$	151,601,721	$	—	$	—

Transfers to/from Levels 1, 2, and 3 are recognized at the end of the reporting period. There were no transfers between levels of the hierarchy for the three months ended March 31, 2023 and the year ended December 31, 2022. Level 1 instruments include investments U.S. Treasury securities with an original maturity of 185 days or less.

Note 9 - Subsequent Events

The Company evaluated subsequent events and transactions that occurred up to the date the unaudited condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.

Table of Contents

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations.

References to the “Company,” “ARYA Sciences Acquisition Corp V,” “ARYA,” “our,” “us” or “we” refer to ARYA Sciences Acquisition Corp V. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited interim condensed financial statements and the notes thereto contained elsewhere in this Quarterly Report on Form 10-Q (this “Report”). Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Cautionary Note Regarding Forward-Looking Statements

Some of the statements contained in this Report may constitute “forward-looking statements” for purposes of the federal securities laws. Our forward-looking statements include, but are not limited to, statements regarding our or our management team’s expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking.

The forward-looking statements contained in this Report are based on our current expectations and beliefs concerning future developments and their potential effects on us. There can be no assurance that future developments affecting us will be those that we have anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond our control) or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to, the following risks, uncertainties (some of which are beyond our control) or other factors:

•	we have no operating history and no revenues, and you have no basis on which to evaluate our ability to achieve our business objective;

•	our ability to select an appropriate target business or businesses;

•	our ability to complete a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”);

•	our expectations around the performance of a prospective target business or businesses;

•	our success in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial Business Combination;

•	our officers and directors allocating their time to other businesses and potentially having conflicts of interest with our business or in approving our initial Business Combination;

•	our potential ability to obtain additional financing to complete our initial Business Combination or reimburse any loans ARYA Sciences Holdings V (the “Sponsor”) may loan to the Company (the “Working Capital Loans”);

•	our pool of prospective target businesses;

•

our ability to consummate an initial Business Combination due to the uncertainty resulting from general economic and political conditions such as recessions, interest rates, international currency fluctuations and health epidemics and pandemics (including the ongoing COVID-19 pandemic), inflation, changes in diplomatic and trade relationships and acts of war or terrorism (such as the military conflict between Ukraine, the Russian Federation and Belarus that started in February 2022);

•	the ability of our officers and directors to generate a number of potential Business Combination opportunities;

•	our ability to obtain additional financing to complete a Business Combination;

•	our public securities’ potential liquidity and trading;

•	the use of proceeds not held in the trust account (“Trust Account”) or available to us from interest income on the Trust Account balance;

•	our ability to continue as a going concern

•	the Trust Account not being subject to claims of third parties;

•	our financial performance following our initial public offering (the “Initial Public Offering”);

•	the amount of redemptions by our public shareholders in connection with a proposed Business Combination; and

•	the other risks and uncertainties discussed herein and in our filings with the SEC, including in our Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on April 12, 2023.

Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.

Table of Contents

Overview

We are a blank check company incorporated as a Cayman Islands exempted company on February 22, 2021. We were formed for the purpose of effecting a Business Combination that we have not yet identified. Our Sponsor is ARYA Sciences Holdings V, a Cayman Islands exempted limited company.

Our registration statement for our Initial Public Offering was declared effective on July 12, 2021. On July 15, 2021, we consummated its Initial Public Offering of 14,950,000 Class A ordinary shares (the “Public Shares”), including the 1,950,000 Public Shares as a result of the underwriters’ full exercise of their over-allotment option, at an offering price of $10.00 per Public Share, generating gross proceeds of $149.5 million, and incurring offering costs of approximately $8.7 million, inclusive of approximately $5.2 million in deferred underwriting commissions. On August 8, 2022, the Company received a waiver from one of the underwriters of its Initial Public Offering pursuant to which such underwriter waived all rights to its 50% share of the deferred underwriting commissions payable upon completion of an initial Business Combination (the “Waiver”). In connection with this Waiver, the underwriter also agreed that (i) this Waiver is not intended to allocate its 50% portion of the deferred underwriting commissions to the other underwriter that has not waived its right to receive its share of the deferred underwriting commissions and (ii) the waived portion of the deferred underwriting commissions can, at the discretion of the Company, be paid to one or more parties or otherwise be used in connection with an initial Business Combination.

Simultaneously with the closing of the Initial Public Offering, we consummated the private placement (“Private Placement”) of 499,000 Class A ordinary shares (the “Private Placement Shares”), at a price of $10.00 per Private Placement Share to the Sponsor, generating gross proceeds of approximately $5.0 million.

Upon the closing of the Initial Public Offering and the Private Placement, $149.5 million ($10.00 per Public Share) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement were placed in the Trust Account, located in the United States, with Continental Stock Transfer & Trust Company acting as trustee, and are invested only in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.

Our management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Shares, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination.

If we have not completed a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to us to pay our income taxes, if any (less up to $100,000 of interest to pay dissolution expenses), divided by the number of the then-outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining shareholders and our board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii) to our obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.

Table of Contents

We intend to effectuate our initial Business Combination using cash from the proceeds of our Initial Public Offering and the sale of the Private Placement Shares, our shares, debt or a combination of cash, equity and debt.

The issuance of additional shares in a Business Combination:

•

may significantly dilute the equity interest of investors in our Initial Public Offering, which dilution would increase if the anti-dilution provisions in the Class B ordinary shares resulted in the issuance of Class A ordinary shares on a greater than one-to-one basis upon conversion of the Class B ordinary shares;

•

may subordinate the rights of holders of Class A ordinary shares if preference shares are issued with rights senior to those afforded our Class A ordinary shares;

•

could cause a change in control if a substantial number of our Class A ordinary shares are issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and directors;

•

may have the effect of delaying or preventing a change of control of us by diluting the share ownership or voting rights of a person seeking to obtain control of us; and

•

may adversely affect prevailing market prices for our Class A ordinary shares.

Similarly, if we issue debt or otherwise incur significant debt, it could result in:

•

default and foreclosure on our assets if our operating revenues after an initial Business Combination are insufficient to repay our debt obligations;

•

acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant;

•

our immediate payment of all principal and accrued interest, if any, if the debt is payable on demand;

•

our inability to obtain necessary additional financing if the debt contains covenants restricting our ability to obtain such financing while the debt is outstanding;

•

our inability to pay dividends on our Class A ordinary shares;

•

using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on our Class A ordinary shares if declared, expenses, capital expenditures, acquisitions and other general corporate purposes;

•

limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate;

•

increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; and

•

limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, execution of our strategy and other purposes and other disadvantages compared to our competitors who have less debt.

Results of Operations

Our entire activity since inception up to March 31, 2023 was in preparation for our formation and the Initial Public Offering, and since the Initial Public Offering, the search for a prospective initial Business Combination. We will not be generating any operating revenues until the closing and completion of our initial Business Combination.

For the three months ended March 31, 2023, we had net income of approximately $1.5 million, which consisted of approximately $1.7 million in unrealized gains on marketable securities, dividends and interest held in Trust Account, which were partially offset by approximately $202,000 general and administrative expenses.

For the three months ended March 31, 2022, we had net loss of approximately $278,000, which consisted of general and administrative expenses of $228,000 and an unrealized loss on investments of approximately $50,000.

Table of Contents

Going Concern

As of March 31, 2023, we had approximately $296,000 in our operating bank account and working capital deficit of approximately $2.6 million.

Our liquidity needs to date have been satisfied through a contribution of $25,000 from the Sponsor to cover for certain expenses in exchange for the issuance of the Founder Shares, the loan of approximately $151,000 from the Sponsor pursuant to the $300,000 unsecured, non-interest bearing promissory note (the “Note”) that the Sponsor agreed to advance to the Company, and $2 million in proceeds from the consummation of the Private Placement not held in the Trust Account. We fully repaid the Note on July 15, 2021. Subsequent to the repayment, the loan facility was no longer available to us. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of our officers and directors may, but are not obligated to, provide the Company Working Capital Loans. As of March 31, 2023 and December 31, 2022, there were no amounts outstanding under any Working Capital Loan.

We cannot provide any assurance that new financing along the lines detailed above will be available to us on commercially acceptable terms, if at all. Further, we have until July 15, 2023 to consummate a Business Combination, but we cannot provide assurance that we will be able to consummate a Business Combination by that date. If a Business Combination is not consummated by the required date, there will be a mandatory liquidation and subsequent dissolution. In connection with our assessment of going concern considerations in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 205-40, “Basis of Presentation - Going Concern,” we have determined that the working capital deficit and mandatory liquidation and subsequent dissolution raises substantial doubt about our ability to continue as a going concern until the earlier of the consummation of the Business Combination or the date we are required to liquidate. The unaudited condensed financial statements do not include any adjustment that might be necessary if the Company is unable to continue as a going concern. We intend to complete our initial Business Combination before the mandatory liquidation date; however, there can be no assurance that we will be able to consummate any Business Combination by July 15, 2023. No adjustments have been made to the carrying amounts of assets and liabilities should we be required to liquidate after July 15, 2023, nor do these unaudited condensed financial statements include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should we be unable to continue as a going concern.

Risks and Uncertainties

Contractual Obligations

Administrative Support Agreement

Commencing on the effective date of the registration statement on Form S-1 related to the Initial Public Offering through the earlier of consummation of the initial Business Combination and our liquidation, we reimburse the Sponsor for office space, secretarial and administrative services provided to us in the amount of $10,000 per month.

We incurred approximately $30,000 and $30,000 in general and administrative expenses in the accompanying unaudited condensed statements of operations for the three months ended March 31, 2023 and 2022, respectively. As of March 31, 2023 and December 31, 2022, the Company had $120,000 (unaudited) and $90,000, respectively, included in due to related party on the balance sheets.

Table of Contents

Registration Rights

The holders of Founder Shares, Private Placement Shares, including Private Placement Shares that may be issued upon conversion of Working Capital Loans, are entitled to registration rights pursuant to a registration and shareholder rights agreement signed upon the consummation of the Initial Public Offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that we register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to our completion of a Business Combination. However, the registration and shareholder rights agreement provides that we will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lock-up period, which occurs (i) in the case of the Founder Shares, in accordance with the letter agreement that our initial shareholders entered into and (ii) in the case of the Private Placement Shares, 30 days after the completion of our Business Combination. We will bear the expenses incurred in connection with the filing of any such registration statements.

Underwriting Agreement

We granted the underwriters a 45-day option from the date of the final prospectus relating to the Initial Public Offering to purchase up to 1,950,000 additional Public Shares to cover over-allotments at the Initial Public Offering price less the underwriting discounts and commissions. On July 15, 2021, the underwriters fully exercised the over-allotment option.

The underwriters were paid an underwriting discount of $0.20 per Public Share, or approximately $3.0 million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.35 per Public Share, or approximately $5.2 million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that we complete a Business Combination, subject to the terms of the underwriting agreement. On August 8, 2022, the Company received a waiver from one of the underwriters of its Initial Public Offering pursuant to which such underwriter waived all rights to its 50% share of the deferred underwriting commissions payable upon completion of an initial Business Combination. In connection with the Waiver, the underwriter also agreed that (i) this Waiver is not intended to allocate its 50% portion of the deferred underwriting commissions to the other underwriter that has not waived its right to receive its share of the deferred underwriting commissions and (ii) the waived portion of the deferred underwriting commissions can, at the discretion of the Company, be paid to one or more parties or otherwise be used in connection with an initial Business Combination.

Critical Accounting Estimates

The preparation of financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of income and expenses during the period reported. Actual results could materially differ from those estimates. The Company has not identified any critical accounting estimates.

Critical Accounting Policies

Class A ordinary shares subject to possible redemption

We account for our Class A ordinary shares subject to possible redemption in accordance with the guidance in FASB ASC Topic 480, “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within our control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ deficit. Our Class A ordinary shares feature certain redemption rights that are considered to be outside of our control and subject to the occurrence of uncertain future events. Accordingly, as of March 31, 2023 and December 31, 2022, 14,950,000 Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit section of our condensed balance sheets.

Table of Contents

Off-Balance Sheet Arrangements

As of March 31, 2023, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K.

JOBS Act

The Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We qualify as an “emerging growth company” and under the JOBS Act are allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. As a result, the unaudited condensed financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.

Additionally, we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an “emerging growth company,” we choose to rely on such exemptions we may not be required to, among other things, (i) provide an auditor’s attestation report on our system of internal control over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act of 2002, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (auditor discussion and analysis) and (iv) disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the executive compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of our Initial Public Offering or until we are no longer an “emerging growth company,” whichever is earlier.

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.

Item 4.

Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in Company reports filed or submitted under the Exchange Act is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

Table of Contents

As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of March 31, 2023 (the “Evaluation Date”). Based upon their evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of the Evaluation Date, our disclosure controls and procedures (as defined in Rules 13a-15 (e) and 15d-15 (e) under the Exchange Act) were not effective because we identified a material weakness in our internal control over financial reporting in connection with the preparation of our Annual Report on Form 10-K for the year ended December 31, 2022. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis. Specifically, the Company’s management has concluded that our control around the interpretation and accounting for extinguishment of a significant contingent obligation in connection with the Waiver was not effectively designed or maintained. Historically, the Company had recognized a liability upon closing of its Initial Public Offering in July 2021 for a portion of the deferred underwriting commissions which was contingently payable upon closing of a future business combination, with the offsetting entry resulting in an initial discount to the securities sold in the Initial Public Offering. In its previously issued unaudited condensed financial statements as of and for the period ended September 30, 2022, the Company recognized the Waiver as an extinguishment, with a resulting non-operating gain recognized in its statement of operations. Upon subsequent review and analysis, management concluded that the Company should have recognized the extinguishment of the contingent liability as a credit to shareholders’ deficit.

In light of this material weakness, the Company performed additional analysis as deemed necessary to ensure that our financial statements were prepared in accordance with GAAP. Accordingly, management believes that the financial statements included in this Report present fairly in all material respects our financial position, results of operations and cash flows for the period presented.

We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we detected all of our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. Based on the evaluation we conducted, our management has concluded that no such changes have occurred.

PART II. OTHER INFORMATION

Item 1.

Legal Proceedings

None.

Item 1A.

Risk Factors

As of the date of this Report, there have been no material changes to the risk factors disclosed in our Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on April 12, 2023. We may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC.

Table of Contents

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds from Registered Securities.

Private Placements and Initial Public Offering Proceeds

On March 18, 2021, we issued 3,737,500 of our Class B ordinary shares to our sponsor, in exchange for a capital contribution of $25,000, or approximately $0.007 per share. Such securities were issued in connection with our organization pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.

Simultaneously with the consummation of the Initial Public Offering and the exercise of the over-allotment option by the underwriters in full, our sponsor purchased 499,000 Private Placement Shares, at a price of $10.00 per Private Placement Share to the Sponsor, generating gross proceeds of approximately $5.0 million. A portion of the proceeds from the Private Placement Shares was added to the proceeds from the Initial Public Offering held in the Trust Account. The Private Placement Shares were issued pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.

No underwriting discounts or commissions were paid with respect to the sales of the Class B ordinary shares or the private placement shares.

In connection with the Initial Public Offering, our sponsor had agreed to loan us an aggregate of up to $300,000 pursuant to the Note. This loan is non-interest bearing and payable on the consummation of the Initial Public Offering. The Company borrowed $150,000 under the Note and fully repaid the Note amount on July 15, 2021.

Use of Proceeds

Of the gross proceeds received from the Initial Public Offering and the full exercise of the option to purchase additional Shares, $149,500,000 was placed in the Trust Account. The net proceeds of the Initial Public Offering and certain proceeds from the Private Placement are invested in U.S. government treasury bills with a maturity of 180 days or less and in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations.

We paid a total of approximately $3.0 million in underwriting discounts and commissions related to the Initial Public Offering. In addition, the underwriters agreed to defer $5.2 million in underwriting discounts and commissions. On August 8, 2022, the Company received a waiver from one of its underwriters pursuant to which such underwriter waived all rights to its 50% share of the deferred underwriting commissions payable upon completion of an initial Business Combination. In connection with this waiver, the underwriter also agreed that (i) this waiver is not intended to allocate its 50% portion of the deferred underwriting commissions to the other underwriter that has not waived its right to receive its share of the deferred underwriting commissions and (ii) the waived portion of the deferred underwriting commissions can, at the discretion of the Company, be paid to one or more parties or otherwise be used in connection with an initial Business Combination. There has been no material change in the planned use of the proceeds from the Initial Public Offering and private placement as is described in the Company’s final prospectus relating to the Initial Public Offering.

Item 3.

Defaults upon Senior Securities

None.

Item 4.

Mine Safety Disclosures.

Not applicable.

Item 5.

Other Information.

None.

Table of Contents

Item 6.

Exhibits.

The following exhibits are filed or furnished as a part of, or incorporated by reference into, this Report.

Exhibit Number		Description
3.1		Amended and Restated Memorandum and Articles of Association.(1)
4.1		Specimen Ordinary Share Certificate.(2)
10.1		Private Placement Shares Purchase Agreement between the Company and the Sponsor.(1)
10.2		Investment Management Trust Agreement between Continental Stock Transfer & Trust Company and the Company.(1)
10.3		Registration and Shareholder Rights Agreement among the Company, the Sponsor and certain other equityholders named therein.(1)
10.4		Letter Agreement among the Company, the Sponsor and the Company’s officers and directors.(1)
10.5		Administrative Services Agreement between the Company and the Sponsor.(1)
10.6		Form of Indemnity Agreement.(2)
31.1		Certification of Chief Executive Officer (Principal Executive Officer) Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
31.2		Certification of Chief Financial Officer (Principal Financial and Accounting Officer) Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*
32.1		Certification of Chief Executive Officer (Principal Executive Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**
32.2		Certification of Chief Financial Officer (Principal Financial and Accounting Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.**
101.INS		Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).*
101.SCH		Inline XBRL Taxonomy Extension Schema Document.*
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document.*
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document.*
101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document.*
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document.*
104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).*

*	Filed herewith.

**	Furnished herewith.

(1)	Incorporated by reference to the registrant’s Current Report on Form 8-K, filed with the SEC on July 15, 2021.

(2)	Incorporated by reference to the registrant’s Registration Statement on Form S-1, filed with the SEC on June 24, 2021.

Table of Contents

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: May 12, 2023	ARYA SCIENCES ACQUISITION CORP V

	By:	/s/ Michael Altman
	Name:	Michael Altman
	Title:	Chief Financial Officer

EX-31.1 2 brhc20052681_ex31-1.htm EXHIBIT 31.1

EXHIBIT 31.1

CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Adam Stone, certify that:

1.	I have reviewed the Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 of ARYA Sciences Acquisition Corp V;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.	The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

Date: May 12, 2023	By:	/s/ Adam Stone
		Adam Stone
		Chief Executive Officer and Director
		(Principal Executive Officer)

EX-31.2 3 brhc20052681_ex31-2.htm EXHIBIT 31.2

EXHIBIT 31.2

CERTIFICATION PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Michael Altman, certify that:

1.	I have reviewed the Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 of ARYA Sciences Acquisition Corp V;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.	The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

5.	The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

Date: May 12, 2023	By:	/s/ Michael Altman
		Michael Altman
		Chief Financial Officer and Director
		(Principal Financial and Accounting Officer)

EX-32.1 4 brhc20052681_ex32-1.htm EXHIBIT 32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of ARYA Sciences Acquisition Corp V (the “Company”) on Form 10-Q for the quarter ended March 31, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Adam Stone, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1)	the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 12, 2023
	/s/ Adam Stone
	Name:	Adam Stone
	Title:	Chief Executive Officer and Director
		(Principal Executive Officer)

EX-32.2 5 brhc20052681_ex32-2.htm EXHIBIT 32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of ARYA Sciences Acquisition Corp V (the “Company”) on Form 10-Q for the quarter ended March 31, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Michael Altman, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1)	the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 12, 2023
	/s/ Michael Altman
	Name:	Michael Altman
	Title:	Chief Financial Officer and Director
		(Principal Financial and Accounting Officer)

EX-101.SCH 6 arye-20230331.xsd XBRL TAXONOMY EXTENSION SCHEMA 000100 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 010000 - Statement - CONDENSED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 010100 - Statement - CONDENSED BALANCE SHEETS (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 020000 - Statement - UNAUDITED CONDENSED STATEMENTS OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 030000 - Statement - UNAUDITED CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT link:presentationLink link:calculationLink link:definitionLink 040000 - Statement - UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 060100 - Disclosure - Description of Organization and Business Operations link:presentationLink link:calculationLink link:definitionLink 060200 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 060300 - Disclosure - Initial Public Offering link:presentationLink link:calculationLink link:definitionLink 060400 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 060500 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 060600 - Disclosure - Class A Ordinary Shares Subject to Possible Redemption link:presentationLink link:calculationLink link:definitionLink 060700 - Disclosure - Shareholders' Deficit link:presentationLink link:calculationLink link:definitionLink 060800 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 060900 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 070200 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 080200 - Disclosure - Summary of Significant Accounting Policies (Tables) link:presentationLink link:calculationLink link:definitionLink 080600 - Disclosure - Class A Ordinary Shares Subject to Possible Redemption (Tables) link:presentationLink link:calculationLink link:definitionLink 080800 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 090100 - Disclosure - Description of Organization and Business Operations, Summary (Details) link:presentationLink link:calculationLink link:definitionLink 090102 - Disclosure - Description of Organization and Business Operations, Going Concern (Details) link:presentationLink link:calculationLink link:definitionLink 090200 - Disclosure - Summary of Significant Accounting Policies, Cash and Cash Equivalents (Details) link:presentationLink link:calculationLink link:definitionLink 090202 - Disclosure - Summary of Significant Accounting Policies, Class A Ordinary Shares Subject to Possible Redemption (Details) link:presentationLink link:calculationLink link:definitionLink 090204 - Disclosure - Summary of Significant Accounting Policies, Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 090206 - Disclosure - Summary of Significant Accounting Policies, Net Income (Loss) Per Ordinary Shares (Details) link:presentationLink link:calculationLink link:definitionLink 090300 - Disclosure - Initial Public Offering (Details) link:presentationLink link:calculationLink link:definitionLink 090400 - Disclosure - Related Party Transactions, Founder Shares (Details) link:presentationLink link:calculationLink link:definitionLink 090402 - Disclosure - Related Party Transactions, Founder Shares, Private Placement Shares (Details) link:presentationLink link:calculationLink link:definitionLink 090404 - Disclosure - Related Party Transactions, Related Party Loans and Administrative Support Agreement (Details) link:presentationLink link:calculationLink link:definitionLink 090500 - Disclosure - Commitments and Contingencies, Registration Rights (Details) link:presentationLink link:calculationLink link:definitionLink 090502 - Disclosure - Commitments and Contingencies, Underwriting Agreement (Details) link:presentationLink link:calculationLink link:definitionLink 090600 - Disclosure - Class A Ordinary Shares Subject to Possible Redemption (Details) link:presentationLink link:calculationLink link:definitionLink 090700 - Disclosure - Shareholders' Deficit (Details) link:presentationLink link:calculationLink link:definitionLink 090800 - Disclosure - Fair Value Measurements (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 arye-20230331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 arye-20230331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 arye-20230331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Summary of Significant Accounting Policies [Abstract] Accounts payable Accrued expenses Accrued Liabilities, Current Additional paid-in capital Additional Paid-in Capital [Member] Adjustments to reconcile net income (loss) to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Assets Assets [Abstract] Total Assets Assets Investments held in Trust Account Total current assets Assets, Current Current assets: Summary of Significant Accounting Policies Basis of Presentation Cash and Cash Equivalents [Abstract] Cash - end of the period Cash - beginning of the period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Net change in cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Cash Cash at bank Cash equivalents Cash Equivalents, at Carrying Value Cash and Cash Equivalents Class of Warrant or Right [Axis] Class of Stock [Line Items] Class of Stock [Domain] Class of Warrant or Right [Domain] Commitments and Contingencies [Abstract] Commitments and Contingencies Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Ordinary Shares [Member] Class A Ordinary Shares [Member] Class A [Member] Class B Ordinary Shares [Member] Class B [Member] Ordinary shares, par value (in dollars per share) Common stock Common Stock, Value, Issued Ordinary shares, shares issued (in shares) Ordinary shares, shares authorized (in shares) Ordinary shares, shares outstanding (in shares) Concentration of Cash Balances Conversion value Investment maturity period Conversion price (in dollars per share) Offering Costs Associated with the Initial Public Offering Deferred Charges, Policy [Policy Text Block] Offering costs allocated to Class A ordinary shares subject to possible redemption Deferred offering costs associated with initial public offering Due to related party Due to Related Parties, Current Net Income (Loss) per Ordinary Share Basic net income (loss) per ordinary share (in dollars per share) Earnings Per Share, Basic Diluted net income (loss) per ordinary share (in dollars per share) Earnings Per Share, Diluted Basic and Diluted Net Income (Loss) Per Common Share [Abstract] Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items] Shareholders' Deficit [Abstract] Equity Component [Domain] Fair Value Measurements Fair Value Measurement, Policy [Policy Text Block] Measurement Frequency [Axis] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Asset Class [Domain] Fair Value Measurements [Abstract] Asset Class [Axis] Fair Value, Recurring and Nonrecurring [Table] Fair Value Hierarchy and NAV [Axis] Transfers in into Level 3 Recurring [Member] Measurement Frequency [Domain] Fair Value Hierarchy and NAV [Domain] Transfers out of Level 3 Fair Value Measurements Financial Instruments Assets Measured on Recurring Basis Quoted Prices in Active Markets (Level 1) [Member] Significant Other Observable Inputs (Level 2) [Member] Significant Other Unobservable Inputs (Level 3) [Member] Unrealized (gain) loss on investments held in Trust Account Unrealized gain (loss) on investments held in Trust Account General and administrative expenses Related party expense Income Taxes [Abstract] Income Tax Disclosure [Abstract] UNAUDITED CONDENSED STATEMENTS OF OPERATIONS [Abstract] Income Taxes Income Tax, Policy [Policy Text Block] Prepaid expenses Increase (Decrease) in Prepaid Expenses, Other Due to related party Accounts payable Increase (Decrease) in Accounts Payable, Trade Accrued expenses Changes in operating assets and liabilities: Increase (Decrease) in Stockholders' Equity [Roll Forward] Investments Held in Trust Account Investment, Policy [Policy Text Block] Investments held in Trust Account [Abstract] Investments, Fair Value Disclosure [Abstract] Investments held in Trust Account Investments, Fair Value Disclosure Sponsor [Member] Sponsor [Member] Initial Public Offering [Member] IPO [Member] Liabilities and Shareholders' Deficit Liabilities and Equity [Abstract] Total Liabilities and Shareholders' Deficit Liabilities and Equity Total Liabilities Liabilities Total current liabilities Liabilities, Current Current liabilities: Cash Equivalents - Money Market Funds [Member] Money Market Funds [Member] Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Cash Flows from Operating Activities: Numerator: [Abstract] Net income (loss) Net income (loss) Net Income (Loss) Attributable to Parent Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Total other income (expense) Nonoperating Income (Expense) Other income (expense) Nonoperating Income (Expense) [Abstract] Borrowings outstanding Working capital loan outstanding amount Over-Allotment Option [Member] Loss from operations Operating Income (Loss) Description of Organization and Business Operations Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Description of Organization and Business Operations [Abstract] Common stock subject to possible redemption [Abstract] Other Liabilities and Financial Instruments Subject to Mandatory Redemption [Abstract] Net proceeds from Initial Public Offering and Private Placement deposited in Trust Account Payments to Acquire Marketable Securities Preference shares, shares issued (in shares) Preference shares, par value (in dollars per share) Preference shares, shares authorized (in shares) Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding at March 31, 2023 and December 31, 2022 Preference shares, shares outstanding (in shares) Prepaid expenses Proceeds from issuance of common stock Gross proceeds from private placement Proceeds from Issuance of Private Placement Gross proceeds Gross proceeds from initial public offering Initial Public Offering and Private Placement [Abstract] Proceeds from Issuance or Sale of Equity [Abstract] Loan proceeds Related Party Transactions [Abstract] Related Party Transaction [Line Items] Related party transaction Related Party Loans [Abstract] Related Party Transactions Related Party Transaction [Domain] Related Party [Domain] Related Party Transaction [Axis] Related Party [Axis] Repayment to related party Accumulated deficit Accumulated Deficit [Member] Sale of Stock [Domain] Basic and Diluted Net Income (Loss) Per Common Share Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table] Schedule of Related Party Transactions, by Related Party [Table] Schedule of Stock by Class [Table] Share price (in dollars per share) Ending balance (in shares) Beginning balance (in shares) Number of shares no longer subject to forfeiture (in shares) Share price (in dollars per share) Shares Issued, Price Per Share CONDENSED BALANCE SHEETS [Abstract] Class of Stock [Axis] Equity Components [Axis] Statement [Line Items] UNAUDITED STATEMENTS OF CASH FLOWS [Abstract] Statement [Table] UNAUDITED CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT [Abstract] Shares issued (in shares) Stock Issued During Period, Shares, New Issues Shares issued (in shares) Stock Issued During Period, Shares, Issued for Services Total shareholders' deficit Beginning balance Ending balance Stockholders' Equity Attributable to Parent Shareholders' Deficit Shareholders' Deficit: Stockholders' Deficit [Abstract] Subsequent Events Subsequent Events [Text Block] Subsequent Events [Abstract] Sale of Stock [Axis] Subsidiary, Sale of Stock [Line Items] Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Class A ordinary shares subject to possible redemption Class A ordinary shares subject to possible redemption; 14,950,000 shares at redemption value of approximately $10.25 and $10.13 per share at March 31, 2023 and December 31, 2022, respectively Class A Ordinary Shares Subject to Possible Redemption [Abstract] Temporary Equity [Line Items] Accretion on Class A ordinary shares subject to possible redemption amount Ordinary shares, par value (in dollars per share) Temporary Equity, Par or Stated Value Per Share Class A Ordinary Shares Subject to Possible Redemption Ordinary shares subject to possible redemption (in shares) Ordinary shares subject to possible redemption (in shares) Temporary Equity, Shares Outstanding EX-101.PRE 10 arye-20230331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 11 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	3 Months Ended
Document and Entity Information - shares	Mar. 31, 2023	May 12, 2023
Entity Listings [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2023
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q1
Document Transition Report	false
Entity File Number	001-40595
Entity Registrant Name	ARYA SCIENCES ACQUISITION CORP V
Entity Central Index Key	0001852432
Entity Incorporation, State or Country Code	E9
Entity Tax Identification Number	98-1590338
Entity Address, Address Line One	51 Astor Place, 10th Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10003
City Area Code	212
Local Phone Number	284-2300
Title of 12(b) Security	Class A Ordinary Share, $0.0001 par value
Trading Symbol	ARYE
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Class A Ordinary Shares [Member]
Entity Listings [Line Items]
Entity Common Stock, Shares Outstanding		15,449,000
Class B Ordinary Shares [Member]
Entity Listings [Line Items]
Entity Common Stock, Shares Outstanding		3,737,500

XML 12 R2.htm IDEA: XBRL DOCUMENT

CONDENSED BALANCE SHEETS - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Current assets:
Cash	$ 295,974	$ 385,187
Prepaid expenses	130,000	157,000
Total current assets	425,974	542,187
Investments held in Trust Account	153,294,256	151,601,721
Total Assets	153,720,230	152,143,908
Current liabilities:
Accounts payable	12,974	11,466
Accrued expenses	2,830,329	2,776,182
Due to related party	120,000	90,000
Total current liabilities	2,963,303	2,877,648
Deferred underwriting commissions	2,616,250	2,616,250
Total Liabilities	5,579,553	5,493,898
Commitments and Contingencies
Class A ordinary shares subject to possible redemption; 14,950,000 shares at redemption value of approximately $10.25 and $10.13 per share at March 31, 2023 and December 31, 2022, respectively	153,194,256	151,501,721
Shareholders' Deficit:
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding at March 31, 2023 and December 31, 2022	0	0
Additional paid-in capital	0	0
Accumulated deficit	(5,054,003)	(4,852,135)
Total shareholders' deficit	(5,053,579)	(4,851,711)
Total Liabilities and Shareholders' Deficit	153,720,230	152,143,908
Class A Ordinary Shares [Member]
Shareholders' Deficit:
Common stock	50	50
Class B Ordinary Shares [Member]
Shareholders' Deficit:
Common stock	$ 374	$ 374

XML 13 R3.htm IDEA: XBRL DOCUMENT

CONDENSED BALANCE SHEETS (Parenthetical) - $ / shares	Mar. 31, 2023	Dec. 31, 2022
Shareholders' Deficit:
Preference shares, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preference shares, shares authorized (in shares)	1,000,000	1,000,000
Preference shares, shares issued (in shares)	0	0
Preference shares, shares outstanding (in shares)	0	0
Class A Ordinary Shares [Member]
Liabilities and Shareholders' Deficit
Ordinary shares, par value (in dollars per share)	$ 10.25	$ 10.13
Ordinary shares subject to possible redemption (in shares)	14,950,000	14,950,000
Shareholders' Deficit:
Ordinary shares, par value (in dollars per share)	$ 0.0001	$ 0.0001
Ordinary shares, shares authorized (in shares)	479,000,000	479,000,000
Ordinary shares, shares issued (in shares)	499,000	499,000
Ordinary shares, shares outstanding (in shares)	499,000	499,000
Class B Ordinary Shares [Member]
Shareholders' Deficit:
Ordinary shares, par value (in dollars per share)	$ 0.0001	$ 0.0001
Ordinary shares, shares authorized (in shares)	20,000,000	20,000,000
Ordinary shares, shares issued (in shares)	3,737,500	3,737,500
Ordinary shares, shares outstanding (in shares)	3,737,500	3,737,500

XML 14 R4.htm IDEA: XBRL DOCUMENT

UNAUDITED CONDENSED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended
UNAUDITED CONDENSED STATEMENTS OF OPERATIONS - USD ($)	Mar. 31, 2023	Mar. 31, 2022
General and administrative expenses	$ 201,868	$ 228,530
Loss from operations	(201,868)	(228,530)
Other income (expense)
Unrealized gain (loss) on investments held in Trust Account	1,692,535	(49,628)
Total other income (expense)	1,692,535	(49,628)
Net income (loss)	$ 1,490,667	$ (278,158)
Class A Ordinary Shares [Member]
Other income (expense)
Weighted average ordinary shares outstanding, basic (in shares)	15,449,000	15,449,000
Weighted average ordinary shares outstanding, diluted (in shares)	15,449,000	15,449,000
Basic net income (loss) per ordinary share (in dollars per share)	$ 0.08	$ (0.01)
Diluted net income (loss) per ordinary share (in dollars per share)	$ 0.08	$ (0.01)
Class B Ordinary Shares [Member]
Other income (expense)
Weighted average ordinary shares outstanding, basic (in shares)	3,737,500	3,737,500
Weighted average ordinary shares outstanding, diluted (in shares)	3,737,500	3,737,500
Basic net income (loss) per ordinary share (in dollars per share)	$ 0.08	$ (0.01)
Diluted net income (loss) per ordinary share (in dollars per share)	$ 0.08	$ (0.01)

XML 15 R5.htm IDEA: XBRL DOCUMENT

UNAUDITED CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT - USD ($)	Ordinary Shares [Member] Class A [Member]	Ordinary Shares [Member] Class B [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Total
Beginning balance at Dec. 31, 2021	$ 50	$ 374	$ 0	$ (6,681,846)	$ (6,681,422)
Beginning balance (in shares) at Dec. 31, 2021	499,000	3,737,500
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	$ 0	$ 0	0	(278,158)	(278,158)
Ending balance at Mar. 31, 2022	$ 50	$ 374	0	(6,960,004)	(6,959,580)
Ending balance (in shares) at Mar. 31, 2022	499,000	3,737,500
Beginning balance at Dec. 31, 2022	$ 50	$ 374	0	(4,852,135)	(4,851,711)
Beginning balance (in shares) at Dec. 31, 2022	499,000	3,737,500
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Increase in redemption value of Class A ordinary shares subject to possible redemption	$ 0	$ 0	0	(1,692,535)	(1,692,535)
Net income (loss)	0	0	0	1,490,667	1,490,667
Ending balance at Mar. 31, 2023	$ 50	$ 374	$ 0	$ (5,054,003)	$ (5,053,579)
Ending balance (in shares) at Mar. 31, 2023	499,000	3,737,500

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 50
-Paragraph 6
-URI https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580

Reference 25: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

+ Details

- Definition

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-Section 55
-Paragraph 10
-URI https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

+ Details

XML 16 R6.htm IDEA: XBRL DOCUMENT

UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended
UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS - USD ($)	Mar. 31, 2023	Mar. 31, 2022
Cash Flows from Operating Activities:
Net income (loss)	$ 1,490,667	$ (278,158)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Unrealized (gain) loss on investments held in Trust Account	(1,692,535)	49,628
Changes in operating assets and liabilities:
Prepaid expenses	27,000	36,402
Accounts payable	1,508	42,603
Accrued expenses	54,147	47,361
Due to related party	30,000	30,000
Net cash used in operating activities	(89,213)	(72,164)
Net change in cash	(89,213)	(72,164)
Cash - beginning of the period	385,187	775,885
Cash - end of the period	$ 295,974	$ 703,721

XML 17 R7.htm IDEA: XBRL DOCUMENT

Description of Organization and Business Operations	3 Months Ended
Description of Organization and Business Operations	Mar. 31, 2023
Description of Organization and Business Operations [Abstract]
Description of Organization and Business Operations	Note 1 - Description of Organization and Business Operations ARYA Sciences Acquisition Corp V (the “Company”) was incorporated as a Cayman Islands exempted company on February 22, 2021. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies. All activity for the period from February 22, 2021 (inception) through March 31, 2023 was related to the Company’s formation and the initial public offering (the “Initial Public Offering”) described below, and since the Initial Public Offering, the search for a prospective initial Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end. The Company’s sponsor is ARYA Sciences Holdings V, a Cayman Islands exempted limited company (the “Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on July 12, 2021. On July 15, 2021, the Company consummated its Initial Public Offering of 14,950,000 Class A ordinary shares (the “Public Shares”), including the 1,950,000 Public Shares as a result of the underwriters’ full exercise of their over-allotment option, at an offering price of $10.00 per Public Share, generating gross proceeds of $149.5 million, and incurring offering costs of approximately $8.7 million, inclusive of approximately $5.2 million in deferred underwriting commissions (see Note 5). On August 8, 2022, the Company received a waiver from one of the underwriters of its Initial Public Offering pursuant to which such underwriter waived all rights to its 50% share of the deferred underwriting commissions payable upon completion of an initial Business Combination. In connection with this waiver, the underwriter also agreed that (i) this waiver is not intended to allocate its 50% portion of the deferred underwriting commissions to the other underwriter that has not waived its right to receive its share of the deferred underwriting commissions and (ii) the waived portion of the deferred underwriting commissions can, at the discretion of the Company, be paid to one or more parties or otherwise be used in connection with an initial Business Combination. Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 499,000 Class A ordinary shares (the “Private Placement Shares”), at a price of $10.00 per Private Placement Share to the Sponsor, generating gross proceeds of approximately $5.0 million (see Note 4). Upon the closing of the Initial Public Offering and the Private Placement, $149.5 million ($10.00 per Public Share) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement were placed in a trust account (the “Trust Account”), located in the United States, with Continental Stock Transfer & Trust Company acting as trustee, and are invested only in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, until the earlier of (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Shares, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the net assets held in the Trust Account (excluding the amount of deferred underwriting commissions and taxes payable on the interest earned on the Trust Account) at the time of the signing of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. The Company will provide the holders of Public Shares (the “Public Shareholders”), with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay income taxes). The per-share amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 5). These Public Shares were classified as temporary equity in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity” (“ASC 480”). In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, only if a majority of the ordinary shares, represented in person or by proxy and entitled to vote thereon, voted at a shareholder meeting are voted in favor of the Business Combination. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to the amended and restated memorandum and articles of association which the Company will adopt upon the consummation of the Initial Public Offering (the “Amended and Restated Memorandum and Articles of Association”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transactions is required by law, or the Company decides to obtain shareholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction or vote at all. If the Company seeks shareholder approval in connection with a Business Combination, the initial shareholders (as defined below) agreed to vote their Founder Shares (as defined below in Note 4) and any Public Shares they hold in favor of a Business Combination. Subsequent to the consummation of the Initial Public Offering, the Company will adopt an insider trading policy which will require insiders to: (i) refrain from purchasing shares during certain blackout periods and when they are in possession of any material non-public information and (ii) to clear all trades with the Company’s legal counsel prior to execution. In addition, the initial shareholders agreed to waive their redemption rights with respect to their Founder Shares, Private Placement Shares and Public Shares in connection with the completion of a Business Combination. Notwithstanding the foregoing, if the Company seeks shareholder approval of its Business Combination and does not conduct redemptions in connection with its Business Combination pursuant to the tender offer rules, the Amended and Restated Memorandum and Articles of Association provide that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Class A ordinary shares sold in the Initial Public Offering, without the prior consent of the Company. The Company’s Sponsor, officers and directors (the “initial shareholders”) agreed not to propose an amendment to the Amended and Restated Memorandum and Articles of Association (a) that would modify the substance or timing of the Company’s obligation to provide holders of its Public Shares the right to have their shares redeemed in connection with a Business Combination or to redeem 100% of the Public Shares if the Company does not complete its Business Combination within 24 months from the closing of the Initial Public Offering, or July 15, 2023, (the “Combination Period”), or (b) with respect to any other provision relating to the rights of Public Shareholders, unless the Company provides the Public Shareholders with the opportunity to redeem their Class A ordinary shares in conjunction with any such amendment. If the Company has not completed a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its income taxes, if any (less up to $100,000 of interest to pay dissolution expenses), divided by the number of the then-outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii) to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. The initial shareholders agreed to waive their liquidation rights with respect to the Founder Shares and Private Placement Shares held by them if the Company fails to complete a Business Combination within the Combination Period. However, if the initial shareholders acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters agreed to waive their rights to their deferred underwriting commission (see Note 5) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution (including Trust Account assets) will be only $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor agreed to be liable to the Company if and to the extent any claims by a third party (excluding the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account if less than $10.00 per Public Share due to reductions in the value of the assets in the Trust Account, in each case net of the interest that may be withdrawn to pay for the Company’s tax obligations. This liability will not apply with respect to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (excluding the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. The Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and the Company believes that the Sponsor’s only assets are securities of the Company. The Sponsor may not be able to satisfy those obligations. None of the Company’s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses. Going Concern As of March 31, 2023, the Company had approximately $296,000 in its operating bank account, and working capital deficit of approximately $2.6 million. The Company’s liquidity needs to date have been satisfied through a contribution of $25,000 from the Sponsor to cover for certain expenses in exchange for the issuance of the Founder Shares, the loan of approximately $151,000 from the Sponsor pursuant to the Note (as defined in Note 4) and advances from the Sponsor, and $2 million in proceeds from the consummation of the Private Placement not held in the Trust Account. The Company fully repaid the Note on July 15, 2021. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (as defined in Note 4). As of March 31, 2023 and December 31, 2022, there were no amounts outstanding under any Working Capital Loan. The Company cannot provide any assurance that new financing along the lines detailed above will be available to it on commercially acceptable terms, if at all. Further, the Company has until July 15, 2023 to consummate a Business Combination, but the Company cannot provide assurance that it will be able to consummate a Business Combination by that date. If a Business Combination is not consummated by the required date, there will be a mandatory liquidation and subsequent dissolution. In connection with the Company’s assessment of going concern considerations in accordance with FASB ASC Topic 205-40, “Basis of Presentation - Going Concern,” management has determined that the working capital deficit and liquidity conditions raise substantial doubt about the Company’s ability to continue as a going concern until the earlier of the consummation of the Business Combination or the date the Company is required to liquidate, July 15, 2023. The unaudited condensed financial statements do not include any adjustment that might be necessary if the Company is unable to continue as a going concern. The Company intends to complete its initial Business Combination before the mandatory liquidation date; however, there can be no assurance that the Company will be able to consummate any Business Combination by July 15, 2023. No adjustments have been made to the carrying amounts of assets and liabilities should the Company be required to liquidate after July 15, 2023, nor do these unaudited condensed financial statements include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern. Risks and Uncertainties Results of operations and the Company’s ability to complete a Business Combination may be adversely affected by various factors that could cause economic uncertainty and volatility in the financial markets, many of which are beyond its control. The Company’s business of pursuing and consummating an initial Business Combination could be impacted by, among other things, downturns in the financial markets or in economic conditions, export controls, tariffs, trade wars, inflation, increases in interest rates, supply chain disruptions, declines in consumer confidence and spending, the ongoing effects of the COVID-19 pandemic, including resurgences and the emergence of new variants, and geopolitical instability, such as the military conflict in the Ukraine. The Company cannot at this time fully predict the likelihood of one or more of the above events, their duration or magnitude or the extent to which they may materially impact the Company’s business and its ability to complete an initial Business Combination.

XML 18 R8.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies

3 Months Ended

Mar. 31, 2023

Summary of Significant Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Note 2 - Summary of Significant Accounting Policies

Basis of Presentation

Emerging Growth Company

Concentration of Cash Balances

Cash and Cash Equivalents

Use of Estimates

Investments Held in Trust Account

Financial Instruments

Fair Value Measurements

•	Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

•	Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

•	Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

Offering Costs Associated with the Initial Public Offering

Class A Ordinary Shares Subject to Possible Redemption

Income Taxes

Net Income (Loss) per Ordinary Share

	For the Three Months Ended March 31,
	2023				2022
	Class A		Class B		Class A			Class B
Basic and diluted net income (loss) per ordinary share:
Numerator:
Allocation of net income (loss)	$	1,200,287	$	290,380	$	(223,973	)	$	(54,185	)
Denominator:
Basic and diluted weighted average ordinary shares outstanding		15,449,000		3,737,500		15,449,000			3,737,500
Basic and diluted net income (loss) per ordinary share	$	0.08	$	0.08	$	(0.01	)	$	(0.01	)

Recent Accounting Pronouncements

XML 19 R9.htm IDEA: XBRL DOCUMENT

Initial Public Offering	3 Months Ended
Initial Public Offering	Mar. 31, 2023
Initial Public Offering [Abstract]
Initial Public Offering	Note 3 - Initial Public Offering On July 15, 2021, the Company consummated its Initial Public Offering of 14,950,000 Public Shares, including the 1,950,000 Public Shares as a result of the underwriters’ full exercise of their over-allotment option, at an offering price of $10.00 per Public Share, generating gross proceeds of $149.5 million, and incurring offering costs of approximately $8.7 million, inclusive of approximately $5.2 million in deferred underwriting commissions. On August 8, 2022, the Company received a waiver from one of the underwriters of its Initial Public Offering pursuant to which such underwriter waived all rights to its 50% share of the deferred underwriting commissions payable upon completion of an initial Business Combination (see Note 1).

XML 20 R10.htm IDEA: XBRL DOCUMENT

Related Party Transactions	3 Months Ended
Related Party Transactions	Mar. 31, 2023
Related Party Transactions [Abstract]
Related Party Transactions	Note 4 - Related Party Transactions Founder Shares On March 18, 2021, the Sponsor paid $25,000 to cover certain of the Company’s expenses in exchange for the issuance of 3,737,500 Class B ordinary shares, par value $0.0001 (the “Founder Shares”). In June 2021, the Sponsor transferred an aggregate of 120,000 Founder Shares to the Company’s independent directors. The Sponsor agreed to forfeit up to 487,500 Founder Shares to the extent that the over-allotment option was not exercised in full by the underwriters, so that the Founder Shares would represent 20.0% of the Company’s issued and outstanding ordinary shares (excluding the Private Placement Shares) after the Initial Public Offering. On July 15, 2021, the underwriters fully exercised the over-allotment option to purchase additional 1,950,000 Public Shares. As a result, the 487,500 Class B ordinary shares were no longer subject to forfeiture. The initial shareholders agreed, subject to limited exceptions, not to transfer, assign or sell any of their Founder Shares until the earlier to occur of: (A) one year after the completion of the initial Business Combination and (B) subsequent to the initial Business Combination, (x) if the closing price of Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the Public Shareholders having the right to exchange their ordinary shares for cash, securities or other property. Private Placement Shares Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement of 499,000 Private Placement Shares, at a price of $10.00 per Private Placement Share to the Sponsor, generating gross proceeds of approximately $5.0 million. Certain proceeds from the Private Placement Shares were added to the proceeds from the Initial Public Offering held in the Trust Account. The Private Placement Shares are not transferable or salable until 30 days after the completion of the initial Business Combination. Certain proceeds from the Private Placement Shares have been added to the proceeds from the Initial Public Offering held in the Trust Account. The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Shares until 30 days after the completion of the initial Business Combination. Related Party Loans On March 31, 2021, a related party advanced approximately $1,400 to cover for certain expenses on behalf of the Company. The Company fully repaid the advance from related party of approximately $1,400 on April 5, 2021. On March 18, 2021, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover for expenses related to the Initial Public Offering pursuant to a promissory note (the “Note”). This loan was non-interest bearing and payable upon the completion of the Initial Public Offering. The Company borrowed $150,000 under the Note and fully repaid the Note amount on July 15, 2021. Subsequent to the repayment, the loan facility was no longer available to the Company. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company may repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans may be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of the proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon the consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into shares of the post Business Combination entity at a price of $10.00 per share. The shares would be identical to the Private Placement Shares. As of March 31, 2023 and December 31, 2022, the Company had no outstanding borrowings under the Working Capital Loans. Administrative Support Agreement Commencing on the date that the Company’s registration statement relating to its Initial Public Offering was declared effective through the earlier of consummation of the initial Business Combination and the Company’s liquidation, the Company agreed to reimburse the Sponsor for office space, secretarial and administrative services provided to the Company in the amount of $10,000 per month. For the three months ended March 31, 2023 and 2022, the Company incurred expenses of approximately $30,000 (unaudited) and $30,000 (unaudited), respectively, under this agreement. As of March 31, 2023 and December 31, 2022, the Company had $120,000 (unaudited) and $90,000, respectively, in due to related party on the balance sheets.

XML 21 R11.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies	3 Months Ended
Commitments and Contingencies	Mar. 31, 2023
Commitments and Contingencies [Abstract]
Commitments and Contingencies	Note 5 - Commitments and Contingencies Registration Rights The holders of Founder Shares, Private Placement Shares, as well as the Private Placement Shares that may be issued upon conversion of Working Capital Loans, are entitled to registration rights pursuant to a registration and shareholder rights agreement signed upon the consummation of the Initial Public Offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the Company’s completion of its Business Combination. However, the registration and shareholder rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lock-up period, which occurs (i) in the case of the Founder Shares, in accordance with the letter agreement the Company’s initial shareholders entered into and (ii) in the case of the Private Placement Shares, 30 days after the completion of the Company’s Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company granted the underwriters a 45-day option from the final prospectus relating to the Initial Public Offering to purchase up to 1,950,000 additional Public Shares to cover over-allotments at the Initial Public Offering price less the underwriting discounts and commissions. On July 15, 2021, the underwriters fully exercised the over-allotment option. The underwriters were paid an underwriting discount of $0.20 per Public Share, or approximately $3.0 million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.35 per Public Share, or approximately $5.2 million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. On August 8, 2022, the Company received a waiver from one of the underwriters of its Initial Public Offering pursuant to which such underwriter waived all rights to its 50% share of the deferred underwriting commissions payable upon completion of an initial Business Combination. In connection with this waiver, the underwriter also agreed that (i) this waiver is not intended to allocate its 50% portion of the deferred underwriting commissions to the other underwriter that has not waived its right to receive its share of the deferred underwriting commissions and (ii) the waived portion of the deferred underwriting commissions can, at the discretion of the Company, be paid to one or more parties or otherwise be used in connection with an initial Business Combination. During the year ended December 31, 2022, the Company derecognized approximately $2.6 million of the deferred underwriting commissions and recorded an adjustment to the carrying value of the shares of Class A ordinary shares subject to possible redemption.

XML 22 R12.htm IDEA: XBRL DOCUMENT

Class A Ordinary Shares Subject to Possible Redemption

3 Months Ended

Mar. 31, 2023

Class A Ordinary Shares Subject to Possible Redemption [Abstract]

Class A Ordinary Shares Subject to Possible Redemption

Note 6 - Class A Ordinary Shares Subject to Possible Redemption

Gross proceeds	$	149,500,000
Less:
Offering costs allocated to Class A ordinary shares subject to possible redemption		(8,709,154	)
Plus:
Waiver of deferred underwriting commission		2,616,250
Accretion on Class A ordinary shares subject to possible redemption amount		8,094,625
Class A ordinary shares subject to possible redemption at December 31, 2022		151,501,721
Plus:
Accretion on Class A ordinary shares subject to possible redemption amount		1,692,535
Class A ordinary shares subject to possible redemption at March 31, 2023	$	153,194,256

XML 23 R13.htm IDEA: XBRL DOCUMENT

Shareholders' Deficit	3 Months Ended
Shareholders' Deficit	Mar. 31, 2023
Shareholders' Deficit [Abstract]
Shareholders' Deficit	Note 7 - Shareholders’ Deficit Preference Shares - The Company is authorized to issue 1,000,000 preference shares with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of March 31, 2023 and December 31, 2022, there were no preference shares issued or outstanding. Class A Ordinary Shares - The Company is authorized to issue 479,000,000 Class A ordinary shares with a par value of $0.0001 per share. Holders of the Company’s Class A ordinary shares are entitled to one vote for each share. As of March 31, 2023 and December 31, 2022, there were 15,449,000 Class A ordinary shares issued and outstanding, of which 14,950,000 shares were subject to possible redemption and classified in temporary equity, respectively (see Note 6). Class B Ordinary Shares - The Company is authorized to issue 20,000,000 Class B ordinary shares with a par value of $0.0001 per share. As of March 31, 2023 and December 31, 2022, there were 3,737,500 Class B ordinary shares issued and outstanding (see Note 4). Ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders. Holders of Class A ordinary shares and holders of Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the shareholders except as required by law. The Class B ordinary shares will automatically convert into Class A ordinary shares on the first business day following the consummation of the initial Business Combination at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, 20% of the sum of (i) the total number of ordinary shares issued and outstanding (excluding the Private Placement Shares) upon the consummation of the Initial Public Offering, plus (ii) the sum of the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Shares issued to the Sponsor, members of the Company’s management team or any of their affiliates upon conversion of Working Capital Loans. In no event will the Class B ordinary shares convert into Class A ordinary shares at a rate of less than one-to-one.

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-URI https://asc.fasb.org/topic&trid=2208762

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (g)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (h)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 16
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (i)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e)(1))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 50
-Paragraph 6
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008

+ Details

XML 24 R14.htm IDEA: XBRL DOCUMENT

Fair Value Measurements

3 Months Ended

Mar. 31, 2023

Fair Value Measurements [Abstract]

Fair Value Measurements

Note 8 - Fair Value Measurements

March 31, 2023

Description	Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Other Unobservable Inputs (Level 3)
Investments held in Trust Account
U.S. Treasury Securities	$	153,293,384	$	—	$	—
Cash equivalents - money market funds		872		—		—
	$	153,294,256	$	—	$	—

December 31, 2022

Description	Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Other Unobservable Inputs (Level 3)
Investments held in Trust Account
U.S. Treasury Securities	$	151,592,810	$	—	$	—
Cash equivalents - money market funds		8,911		—		—
	$	151,601,721	$	—	$	—

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

XML 25 R15.htm IDEA: XBRL DOCUMENT

Subsequent Events	3 Months Ended
Subsequent Events	Mar. 31, 2023
Subsequent Events [Abstract]
Subsequent Events	Note 9 - Subsequent Events The Company evaluated subsequent events and transactions that occurred up to the date the unaudited condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.

XML 26 R16.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Policies)

3 Months Ended

Mar. 31, 2023

Summary of Significant Accounting Policies [Abstract]

Basis of Presentation

Concentration of Cash Balances

Cash and Cash Equivalents

Use of Estimates

Investments Held in Trust Account

Financial Instruments

Fair Value Measurements

•	Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;

•	Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and

•	Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.

Offering Costs Associated with the Initial Public Offering

Class A Ordinary Shares Subject to Possible Redemption

Income Taxes

Net Income (Loss) per Ordinary Share

	For the Three Months Ended March 31,
	2023				2022
	Class A		Class B		Class A			Class B
Basic and diluted net income (loss) per ordinary share:
Numerator:
Allocation of net income (loss)	$	1,200,287	$	290,380	$	(223,973	)	$	(54,185	)
Denominator:
Basic and diluted weighted average ordinary shares outstanding		15,449,000		3,737,500		15,449,000			3,737,500
Basic and diluted net income (loss) per ordinary share	$	0.08	$	0.08	$	(0.01	)	$	(0.01	)

Recent Accounting Pronouncements

XML 27 R17.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2023

Summary of Significant Accounting Policies [Abstract]

Basic and Diluted Net Income (Loss) Per Common Share

	For the Three Months Ended March 31,
	2023				2022
	Class A		Class B		Class A			Class B
Basic and diluted net income (loss) per ordinary share:
Numerator:
Allocation of net income (loss)	$	1,200,287	$	290,380	$	(223,973	)	$	(54,185	)
Denominator:
Basic and diluted weighted average ordinary shares outstanding		15,449,000		3,737,500		15,449,000			3,737,500
Basic and diluted net income (loss) per ordinary share	$	0.08	$	0.08	$	(0.01	)	$	(0.01	)

XML 28 R18.htm IDEA: XBRL DOCUMENT

Class A Ordinary Shares Subject to Possible Redemption (Tables)

3 Months Ended

Mar. 31, 2023

Class A Ordinary Shares Subject to Possible Redemption [Abstract]

Class A Ordinary Shares Subject to Possible Redemption

Gross proceeds	$	149,500,000
Less:
Offering costs allocated to Class A ordinary shares subject to possible redemption		(8,709,154	)
Plus:
Waiver of deferred underwriting commission		2,616,250
Accretion on Class A ordinary shares subject to possible redemption amount		8,094,625
Class A ordinary shares subject to possible redemption at December 31, 2022		151,501,721
Plus:
Accretion on Class A ordinary shares subject to possible redemption amount		1,692,535
Class A ordinary shares subject to possible redemption at March 31, 2023	$	153,194,256

XML 29 R19.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Tables)

3 Months Ended

Mar. 31, 2023

Fair Value Measurements [Abstract]

Assets Measured on Recurring Basis

March 31, 2023

Description	Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Other Unobservable Inputs (Level 3)
Investments held in Trust Account
U.S. Treasury Securities	$	153,293,384	$	—	$	—
Cash equivalents - money market funds		872		—		—
	$	153,294,256	$	—	$	—

December 31, 2022

Description	Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Other Unobservable Inputs (Level 3)
Investments held in Trust Account
U.S. Treasury Securities	$	151,592,810	$	—	$	—
Cash equivalents - money market funds		8,911		—		—
	$	151,601,721	$	—	$	—

XML 30 R20.htm IDEA: XBRL DOCUMENT

Description of Organization and Business Operations, Summary (Details)		3 Months Ended	12 Months Ended
	Jul. 15, 2021 USD ($) $ / shares shares	Mar. 31, 2023 USD ($) Business	Dec. 31, 2022 USD ($)	Aug. 08, 2022
Initial Public Offering and Private Placement [Abstract]
Deferred offering costs associated with initial public offering	$ 8,700,000
Deferred underwriting commissions	5,200,000
Percentage of deferred underwriting commissions payable included in initial business combination				50.00%
Net proceeds from Initial Public Offering and Private Placement deposited in Trust Account	$ 149,500,000
Unit price, Initial Public Offering and Private Placement (in dollars per unit) \| $ / shares	$ 10
Percentage of Public Shares that would not be redeemed if Business Combination is not completed within Initial Combination Period		100.00%
Minimum [Member]
Initial Public Offering and Private Placement [Abstract]
Number of operating businesses included in initial Business Combination \| Business		1
Fair market value as percentage of net assets held in Trust Account included in initial Business Combination		80.00%
Post-transaction ownership percentage of the target business		50.00%
Net tangible asset threshold for redeeming Public Shares		$ 5,000,001
Percentage of Public Shares that can be redeemed without prior consent		15.00%
Maximum [Member]
Initial Public Offering and Private Placement [Abstract]
Period to redeem Public Shares if Business Combination is not completed within Initial Combination Period		24 months
Period to cease operations if Business Combination is not completed within Combination Period		10 days
Interest from Trust Account that can be held to pay dissolution expenses		$ 100,000
Private Placement Shares [Member]
Initial Public Offering and Private Placement [Abstract]
Shares issued (in shares) \| shares	499,000
Share price (in dollars per share) \| $ / shares	$ 10
Gross proceeds from private placement	$ 5,000,000
Initial Public Offering [Member]
Initial Public Offering and Private Placement [Abstract]
Gross proceeds from initial public offering			$ 149,500,000
Initial Public Offering [Member] \| Public Shares [Member]
Initial Public Offering and Private Placement [Abstract]
Shares issued (in shares) \| shares	14,950,000
Share price (in dollars per share) \| $ / shares	$ 10
Gross proceeds from initial public offering	$ 149,500,000
Over-Allotment Option [Member] \| Public Shares [Member]
Initial Public Offering and Private Placement [Abstract]
Shares issued (in shares) \| shares	1,950,000
Share price (in dollars per share) \| $ / shares	$ 10

XML 31 R21.htm IDEA: XBRL DOCUMENT

Description of Organization and Business Operations, Going Concern (Details) - USD ($)			3 Months Ended
	Jul. 15, 2021	Mar. 18, 2021	Mar. 31, 2023	Dec. 31, 2022
Going Concern [Abstract]
Cash at bank			$ 295,974	$ 385,187
Working capital			(2,600,000)
Private Placement Shares [Member]
Going Concern [Abstract]
Proceeds from private placement not held in Trust Account	$ 2,000,000
Sponsor [Member]
Going Concern [Abstract]
Offering costs paid by sponsor in exchange for issuance of founder shares			25,000
Sponsor [Member] \| Promissory Note [Member]
Going Concern [Abstract]
Loan proceeds		$ 150,000	151,000
Working capital loan outstanding amount			$ 0	$ 0

XML 32 R22.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies, Cash and Cash Equivalents (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Cash and Cash Equivalents [Abstract]
Cash equivalents	$ 0	$ 0

XML 33 R23.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies, Class A Ordinary Shares Subject to Possible Redemption (Details) - shares	Mar. 31, 2023	Dec. 31, 2022
Class A Ordinary Shares [Member]
Common stock subject to possible redemption [Abstract]
Ordinary shares subject to possible redemption (in shares)	14,950,000	14,950,000

XML 34 R24.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies, Income Taxes (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Income Taxes [Abstract]
Unrecognized tax benefits	$ 0	$ 0
Accrued interest and penalties	$ 0	$ 0

XML 35 R25.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies, Net Income (Loss) Per Ordinary Shares (Details) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Class A Ordinary Shares [Member]
Numerator: [Abstract]
Allocation of net income (loss)	$ 1,200,287	$ (223,973)
Denominator: [Abstract]
Basic weighted average ordinary shares outstanding (in shares)	15,449,000	15,449,000
Diluted weighted average ordinary shares outstanding (in shares)	15,449,000	15,449,000
Basic net income (loss) per ordinary share (in dollars per share)	$ 0.08	$ (0.01)
Diluted net income (loss) per ordinary share (in dollars per share)	$ 0.08	$ (0.01)
Class B Ordinary Shares [Member]
Numerator: [Abstract]
Allocation of net income (loss)	$ 290,380	$ (54,185)
Denominator: [Abstract]
Basic weighted average ordinary shares outstanding (in shares)	3,737,500	3,737,500
Diluted weighted average ordinary shares outstanding (in shares)	3,737,500	3,737,500
Basic net income (loss) per ordinary share (in dollars per share)	$ 0.08	$ (0.01)
Diluted net income (loss) per ordinary share (in dollars per share)	$ 0.08	$ (0.01)

- Definition

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (e)(4)
-URI https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 10
-URI https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(23))
-URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 15
-URI https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 7
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(25))
-URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(27))
-URI https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

+ Details

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 7
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 15
-URI https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(27))
-URI https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(23))
-URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (e)(4)
-URI https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(25))
-URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227

+ Details

XML 36 R26.htm IDEA: XBRL DOCUMENT

Initial Public Offering (Details) - USD ($)		12 Months Ended
Initial Public Offering (Details) - USD ($)	Jul. 15, 2021	Dec. 31, 2022	Aug. 08, 2022
Initial Public Offering [Abstract]
Deferred offering costs associated with initial public offering	$ 8,700,000
Deferred underwriting commissions	$ 5,200,000
Percentage of deferred underwriting commissions payable included in initial business combination			50.00%
Initial Public Offering [Member]
Initial Public Offering [Abstract]
Gross proceeds from initial public offering		$ 149,500,000
Initial Public Offering [Member] \| Public Shares [Member]
Initial Public Offering [Abstract]
Shares issued (in shares)	14,950,000
Share price (in dollars per share)	$ 10
Gross proceeds from initial public offering	$ 149,500,000
Over-Allotment Option [Member] \| Public Shares [Member]
Initial Public Offering [Abstract]
Shares issued (in shares)	1,950,000
Share price (in dollars per share)	$ 10

XML 37 R27.htm IDEA: XBRL DOCUMENT

Related Party Transactions, Founder Shares (Details) - USD ($)			1 Months Ended	3 Months Ended
	Jul. 15, 2021	Mar. 18, 2021	Jun. 30, 2021	Mar. 31, 2023	Dec. 31, 2022
Founder Shares [Abstract]
Founder shares as a percentage of issued and outstanding shares after initial public offering				20.00%
Over-Allotment Option [Member] \| Public Shares [Member]
Founder Shares [Abstract]
Shares issued (in shares)	1,950,000
Class A Ordinary Shares [Member]
Founder Shares [Abstract]
Ordinary shares, par value (in dollars per share)				$ 0.0001	$ 0.0001
Class B Ordinary Shares [Member]
Founder Shares [Abstract]
Ordinary shares, par value (in dollars per share)		$ 0.0001		$ 0.0001	$ 0.0001
Sponsor [Member] \| Class A Ordinary Shares [Member]
Founder Shares [Abstract]
Number of trading days				20 days
Trading day threshold period				30 days
Sponsor [Member] \| Class A Ordinary Shares [Member] \| Minimum [Member]
Founder Shares [Abstract]
Share price (in dollars per share)				$ 12
Threshold period after initial Business Combination				150 days
Sponsor [Member] \| Class B Ordinary Shares [Member]
Founder Shares [Abstract]
Proceeds from issuance of common stock		$ 25,000
Shares issued (in shares)		3,737,500
Founder shares as a percentage of issued and outstanding shares after initial public offering		20.00%
Number of shares no longer subject to forfeiture (in shares)	487,500
Period to not transfer, assign or sell Founder Shares				1 year
Sponsor [Member] \| Class B Ordinary Shares [Member] \| Maximum [Member]
Founder Shares [Abstract]
Shares subject to forfeiture (in shares)		487,500
Independent Director Nominees [Member]
Founder Shares [Abstract]
Shares issued (in shares)			120,000

XML 38 R28.htm IDEA: XBRL DOCUMENT

Related Party Transactions, Founder Shares, Private Placement Shares (Details) - Private Placement Shares [Member] - USD ($) $ / shares in Units, $ in Millions		3 Months Ended
	Jul. 15, 2021	Mar. 31, 2023
Private Placement [Abstract]
Shares issued (in shares)	499,000
Share price (in dollars per share)	$ 10
Gross proceeds from private placement	$ 5.0
Number of days shares are transferrable after completion of initial business combination		30 days
Sponsor [Member]
Private Placement [Abstract]
Shares issued (in shares)	499,000
Share price (in dollars per share)	$ 10
Gross proceeds from private placement	$ 5.0

XML 39 R29.htm IDEA: XBRL DOCUMENT

Related Party Transactions, Related Party Loans and Administrative Support Agreement (Details) - USD ($)					3 Months Ended
	Jul. 15, 2021	Apr. 05, 2021	Mar. 31, 2021	Mar. 18, 2021	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Related Party Loans [Abstract]
Repayment to related party					$ 0
Administrative Support Agreement [Abstract]
Related party expense					201,868	$ 228,530
Due to related party					120,000		$ 90,000
Administrative Support Agreement [Member]
Administrative Support Agreement [Abstract]
Due to related party					120,000		90,000
Sponsor [Member] \| Promissory Note [Member]
Related Party Loans [Abstract]
Related party transaction				$ 300,000
Repayment to related party	$ 150,000
Loan proceeds				$ 150,000	151,000
Sponsor [Member] \| Administrative Support Agreement [Member]
Administrative Support Agreement [Abstract]
Monthly fee					10,000
Related party expense					30,000	$ 30,000
Sponsor [Member] \| Advance [Member]
Related Party Loans [Abstract]
Related party transaction			$ 1,400
Repayment to related party		$ 1,400
Sponsor Affiliate of Sponsor or Certain Company Officers and Directors [Member] \| Working Capital Loans [Member]
Related Party Loans [Abstract]
Conversion value					$ 1,500,000
Conversion price (in dollars per share)					$ 10
Borrowings outstanding					$ 0		$ 0

XML 40 R30.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies, Registration Rights (Details)	Jul. 15, 2021 Demand
Registration Rights [Abstract]
Number of demands eligible security holder can make	3

XML 41 R31.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies, Underwriting Agreement (Details) - USD ($) $ / shares in Units, $ in Millions	Aug. 08, 2022	Jul. 15, 2021
Underwriting Agreement [Abstract]
Term of option for underwriters to purchase additional Units to cover over-allotments		45 days
Additional shares that can be purchased to cover over-allotments (in shares)		1,950,000
Underwriting discount (in dollars per share)		$ 0.2
Underwriting discount		$ 3.0
Deferred underwriting commissions (in dollars per share)		$ 0.35
Deferred underwriting commissions		$ 5.2
Percentage of deferred underwriting commissions payable included in initial business combination	50.00%
Gain from settlement of deferred underwriting commissions	$ 2.6

XML 42 R32.htm IDEA: XBRL DOCUMENT

Class A Ordinary Shares Subject to Possible Redemption (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022	Jul. 15, 2021
Common Stock Subject To Possible Redemption [Abstract]
Offering costs allocated to Class A ordinary shares subject to possible redemption			$ (8,700,000)
Accretion on Class A ordinary shares subject to possible redemption amount	$ (1,692,535)
Class A ordinary shares subject to possible redemption	$ 153,194,256	$ 151,501,721
Class A Ordinary Shares [Member]
Common Stock Subject To Possible Redemption [Abstract]
Ordinary shares subject to possible redemption (in shares)	14,950,000	14,950,000
Initial Public Offering [Member]
Common Stock Subject To Possible Redemption [Abstract]
Gross proceeds		$ 149,500,000
Initial Public Offering [Member] \| Class A Ordinary Shares [Member]
Common Stock Subject To Possible Redemption [Abstract]
Ordinary shares subject to possible redemption (in shares)	14,950,000	14,950,000
Offering costs allocated to Class A ordinary shares subject to possible redemption		$ (8,709,154)
Waiver of deferred underwriting commission		2,616,250
Accretion on Class A ordinary shares subject to possible redemption amount		8,094,625
Accretion on Class A ordinary shares subject to possible redemption amount	$ 1,692,535
Class A ordinary shares subject to possible redemption	$ 153,194,256	$ 151,501,721

XML 43 R33.htm IDEA: XBRL DOCUMENT

Shareholders' Deficit (Details)	3 Months Ended
Shareholders' Deficit (Details)	Mar. 31, 2023 Vote $ / shares shares	Dec. 31, 2022 $ / shares shares	Mar. 18, 2021 $ / shares
Stockholders' Deficit [Abstract]
Preference shares, shares authorized (in shares)	1,000,000	1,000,000
Preference shares, shares issued (in shares)	0	0
Preference shares, shares outstanding (in shares)	0	0
Voting rights per share \| Vote	1
Founder shares as a percentage of issued and outstanding shares after initial public offering	20.00%
Stock conversion basis at time of business combination	1
Class A Ordinary Shares [Member]
Stockholders' Deficit [Abstract]
Ordinary shares, shares authorized (in shares)	479,000,000	479,000,000
Ordinary shares, par value (in dollars per share) \| $ / shares	$ 0.0001	$ 0.0001
Voting rights per share \| Vote	1
Ordinary shares, shares issued (in shares)	15,449,000	15,449,000
Ordinary shares, shares outstanding (in shares)	15,449,000	15,449,000
Ordinary shares, shares issued (in shares)	499,000	499,000
Ordinary shares, shares outstanding (in shares)	499,000	499,000
Ordinary shares subject to possible redemption (in shares)	14,950,000	14,950,000
Class B Ordinary Shares [Member]
Stockholders' Deficit [Abstract]
Ordinary shares, shares authorized (in shares)	20,000,000	20,000,000
Ordinary shares, par value (in dollars per share) \| $ / shares	$ 0.0001	$ 0.0001	$ 0.0001
Ordinary shares, shares issued (in shares)	3,737,500	3,737,500
Ordinary shares, shares outstanding (in shares)	3,737,500	3,737,500

XML 44 R34.htm IDEA: XBRL DOCUMENT

Fair Value Measurements (Details) - USD ($)	3 Months Ended	12 Months Ended
Fair Value Measurements (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Investments held in Trust Account [Abstract]
Transfers in into Level 3	$ 0	$ 0
Transfers out of Level 3	$ 0	0
Maximum [Member]
Investments held in Trust Account [Abstract]
Investment maturity period	185 days
Recurring [Member] \| Quoted Prices in Active Markets (Level 1) [Member]
Investments held in Trust Account [Abstract]
Investments held in Trust Account	$ 153,294,256	151,601,721
Recurring [Member] \| Quoted Prices in Active Markets (Level 1) [Member] \| US Treasury Securities [Member]
Investments held in Trust Account [Abstract]
Investments held in Trust Account	153,293,384	151,592,810
Recurring [Member] \| Quoted Prices in Active Markets (Level 1) [Member] \| Cash Equivalents - Money Market Funds [Member]
Investments held in Trust Account [Abstract]
Investments held in Trust Account	872	8,911
Recurring [Member] \| Significant Other Observable Inputs (Level 2) [Member]
Investments held in Trust Account [Abstract]
Investments held in Trust Account	0	0
Recurring [Member] \| Significant Other Observable Inputs (Level 2) [Member] \| US Treasury Securities [Member]
Investments held in Trust Account [Abstract]
Investments held in Trust Account	0	0
Recurring [Member] \| Significant Other Observable Inputs (Level 2) [Member] \| Cash Equivalents - Money Market Funds [Member]
Investments held in Trust Account [Abstract]
Investments held in Trust Account	0	0
Recurring [Member] \| Significant Other Unobservable Inputs (Level 3) [Member]
Investments held in Trust Account [Abstract]
Investments held in Trust Account	0	0
Recurring [Member] \| Significant Other Unobservable Inputs (Level 3) [Member] \| US Treasury Securities [Member]
Investments held in Trust Account [Abstract]
Investments held in Trust Account	0	0
Recurring [Member] \| Significant Other Unobservable Inputs (Level 3) [Member] \| Cash Equivalents - Money Market Funds [Member]
Investments held in Trust Account [Abstract]
Investments held in Trust Account	$ 0	$ 0

XML 45 brhc20052681_10q_htm.xml IDEA: XBRL DOCUMENT 0001852432 2023-01-01 2023-03-31 0001852432 us-gaap:CommonClassBMember 2023-05-12 0001852432 us-gaap:CommonClassAMember 2023-05-12 0001852432 2023-03-31 0001852432 2022-12-31 0001852432 us-gaap:CommonClassAMember 2023-03-31 0001852432 us-gaap:CommonClassAMember 2022-12-31 0001852432 us-gaap:CommonClassBMember 2022-12-31 0001852432 us-gaap:CommonClassBMember 2023-03-31 0001852432 2022-01-01 2022-03-31 0001852432 us-gaap:CommonClassAMember 2023-01-01 2023-03-31 0001852432 us-gaap:CommonClassBMember 2023-01-01 2023-03-31 0001852432 us-gaap:CommonClassBMember 2022-01-01 2022-03-31 0001852432 us-gaap:CommonClassAMember 2022-01-01 2022-03-31 0001852432 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-12-31 0001852432 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-12-31 0001852432 us-gaap:RetainedEarningsMember 2022-12-31 0001852432 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001852432 us-gaap:RetainedEarningsMember 2021-12-31 0001852432 2021-12-31 0001852432 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-12-31 0001852432 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-12-31 0001852432 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001852432 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001852432 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001852432 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001852432 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001852432 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001852432 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001852432 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001852432 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001852432 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2023-03-31 0001852432 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2023-03-31 0001852432 us-gaap:RetainedEarningsMember 2023-03-31 0001852432 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001852432 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-03-31 0001852432 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001852432 us-gaap:RetainedEarningsMember 2022-03-31 0001852432 2022-03-31 0001852432 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2022-03-31 0001852432 arye:PublicSharesMember us-gaap:IPOMember 2021-07-15 2021-07-15 0001852432 arye:PublicSharesMember us-gaap:OverAllotmentOptionMember 2021-07-15 2021-07-15 0001852432 arye:PrivatePlacementSharesMember 2021-07-15 2021-07-15 0001852432 arye:PublicSharesMember us-gaap:OverAllotmentOptionMember 2021-07-15 0001852432 arye:PublicSharesMember us-gaap:IPOMember 2021-07-15 0001852432 arye:PrivatePlacementSharesMember 2021-07-15 0001852432 2021-07-15 0001852432 2022-08-08 0001852432 2021-07-15 2021-07-15 0001852432 srt:MinimumMember 2023-01-01 2023-03-31 0001852432 srt:MinimumMember 2023-03-31 0001852432 srt:MaximumMember 2023-01-01 2023-03-31 0001852432 srt:MaximumMember 2023-03-31 0001852432 us-gaap:InvestorMember 2023-01-01 2023-03-31 0001852432 arye:PromissoryNoteToCoverExpensesRelatedToInitialPublicOfferingMember us-gaap:InvestorMember 2023-01-01 2023-03-31 0001852432 arye:PromissoryNoteToCoverExpensesRelatedToInitialPublicOfferingMember us-gaap:InvestorMember 2023-03-31 0001852432 arye:PromissoryNoteToCoverExpensesRelatedToInitialPublicOfferingMember us-gaap:InvestorMember 2022-12-31 0001852432 us-gaap:InvestorMember us-gaap:CommonClassBMember 2021-03-18 2021-03-18 0001852432 arye:IndependentDirectorNomineesMember 2021-06-01 2021-06-30 0001852432 us-gaap:CommonClassBMember 2021-03-18 0001852432 srt:MaximumMember us-gaap:InvestorMember us-gaap:CommonClassBMember 2021-03-18 0001852432 us-gaap:InvestorMember us-gaap:CommonClassBMember 2021-03-18 0001852432 us-gaap:InvestorMember us-gaap:CommonClassBMember 2021-07-15 0001852432 us-gaap:InvestorMember us-gaap:CommonClassBMember 2023-01-01 2023-03-31 0001852432 srt:MinimumMember us-gaap:InvestorMember us-gaap:CommonClassAMember 2023-03-31 0001852432 us-gaap:InvestorMember us-gaap:CommonClassAMember 2023-01-01 2023-03-31 0001852432 srt:MinimumMember us-gaap:InvestorMember us-gaap:CommonClassAMember 2023-01-01 2023-03-31 0001852432 arye:PrivatePlacementSharesMember us-gaap:InvestorMember 2021-07-15 2021-07-15 0001852432 arye:PrivatePlacementSharesMember us-gaap:InvestorMember 2021-07-15 0001852432 arye:PrivatePlacementSharesMember 2023-01-01 2023-03-31 0001852432 arye:AdvanceMember us-gaap:InvestorMember 2021-03-31 2021-03-31 0001852432 arye:PromissoryNoteToCoverExpensesRelatedToInitialPublicOfferingMember us-gaap:InvestorMember 2021-03-18 2021-03-18 0001852432 arye:PromissoryNoteToCoverExpensesRelatedToInitialPublicOfferingMember us-gaap:InvestorMember 2021-07-15 2021-07-15 0001852432 arye:AdvanceMember us-gaap:InvestorMember 2021-04-05 2021-04-05 0001852432 arye:WorkingCapitalLoansMember arye:SponsorAffiliateOfSponsorOrCertainCompanyOfficersAndDirectorsMember 2023-01-01 2023-03-31 0001852432 arye:WorkingCapitalLoansMember arye:SponsorAffiliateOfSponsorOrCertainCompanyOfficersAndDirectorsMember 2023-03-31 0001852432 arye:WorkingCapitalLoansMember arye:SponsorAffiliateOfSponsorOrCertainCompanyOfficersAndDirectorsMember 2022-12-31 0001852432 arye:AdministrativeSupportAgreementMember us-gaap:InvestorMember 2023-01-01 2023-03-31 0001852432 arye:AdministrativeSupportAgreementMember us-gaap:InvestorMember 2022-01-01 2022-03-31 0001852432 arye:AdministrativeSupportAgreementMember 2023-03-31 0001852432 arye:AdministrativeSupportAgreementMember 2022-12-31 0001852432 2022-08-08 2022-08-08 0001852432 us-gaap:CommonClassAMember us-gaap:IPOMember 2022-12-31 0001852432 us-gaap:CommonClassAMember us-gaap:IPOMember 2023-03-31 0001852432 us-gaap:IPOMember 2022-01-01 2022-12-31 0001852432 us-gaap:CommonClassAMember us-gaap:IPOMember 2022-01-01 2022-12-31 0001852432 us-gaap:CommonClassAMember us-gaap:IPOMember 2023-01-01 2023-03-31 0001852432 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001852432 us-gaap:USTreasurySecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001852432 us-gaap:USTreasurySecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001852432 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001852432 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001852432 us-gaap:USTreasurySecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001852432 us-gaap:USTreasurySecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001852432 us-gaap:USTreasurySecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001852432 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001852432 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001852432 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001852432 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001852432 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001852432 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001852432 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001852432 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001852432 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-03-31 0001852432 us-gaap:USTreasurySecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001852432 2022-01-01 2022-12-31 shares iso4217:USD iso4217:USD shares pure arye:Business arye:Demand arye:Vote false --12-31 2023 Q1 0001852432 P10D NASDAQ

10-Q true 2023-03-31 false ARYA SCIENCES ACQUISITION CORP V E9 001-40595 98-1590338 51 Astor Place, 10th Floor New York NY 10003 212 284-2300 Class A Ordinary Share, $0.0001 par value ARYE Yes Yes Non-accelerated Filer true true false true 15449000 3737500

295974

385187

130000

157000

425974

542187

153294256

151601721

153720230

152143908

12974

11466

2830329

2776182

120000

90000

2963303

2877648

2616250 2616250

5579553

5493898

14950000

10.25

10.13

153194256

151501721

0.0001

1000000

0.0001

479000000

499000

0.0001

20000000

3737500

374

-5054003

-4852135

-5053579

-4851711

153720230

152143908

201868

228530

-201868

-228530

1692535

-49628

1692535

-49628

1490667

-278158

15449000

0.08

-0.01

3737500

0.08

-0.01

499000

3737500

374

-4852135

-4851711

0 0 0 -1692535 -1692535

1490667

499000

3737500

374

-5054003

-5053579

499000

3737500

374

-6681846

-6681422

-278158

499000

3737500

374

-6960004

-6959580

1490667

-278158

1692535

-49628

-27000

-36402

1508

42603

54147

47361

30000

-89213

-72164

-89213

-72164

385187

775885

295974

703721

<div style="font-family: 'Times New Roman'; font-weight: bold; font-size: 10pt;">Note 1 - Description of Organization and Business Operations</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">ARYA Sciences Acquisition Corp V (the “Company”) was incorporated as a Cayman Islands exempted company on February 22, 2021. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies.</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">All activity for the period from February 22, 2021 (inception) through <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">March 31, 2023</span> was related to the Company’s formation and the initial public offering (the “Initial Public Offering”) described below, and since the Initial Public Offering, the search for a prospective initial Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">The Company has selected December 31 as its fiscal year end.</span> </div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div style="text-align: justify;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company’s sponsor is ARYA Sciences Holdings V, a Cayman Islands exempted limited company (the “Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on July 12, 2021. On July 15, 2021, the Company consummated its Initial Public Offering of 14,950,000 Class A ordinary shares (the “Public Shares”), including the 1,950,000 Public Shares as a result of the underwriters’ full exercise of their over-allotment option, at an offering price of $10.00 per Public Share, generating gross proceeds of $149.5 million, and incurring offering costs of approximately $8.7 million, inclusive of approximately $5.2 million in deferred underwriting commissions (see Note 5). On August 8, 2022, the Company received a waiver from <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">one of the underwriters of its Initial Public Offering pursuant to which such underwriter waived</span> all rights to its 50% share of the deferred underwriting commissions payable upon completion of an initial Business Combination. In connection with this waiver, the underwriter also agreed that (i) this waiver is not intended to allocate its 50% portion of the deferred underwriting commissions to the other underwriter that has not waived its right to receive its share of the deferred underwriting commissions and (ii) the waived portion of the deferred underwriting commissions can, at the discretion of the Company, be paid to one or more parties or otherwise be used in connection with an initial Business Combination. </span> </div> <div> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 499,000 Class A ordinary shares (the “Private Placement Shares”), at a price of $10.00 per Private Placement Share to the Sponsor, generating gross proceeds of approximately $5.0 million (see Note 4).</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Upon the closing of the Initial Public Offering and the Private Placement, $149.5 million ($10.00 per Public Share) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement were placed in a trust account (the “Trust Account”), located in the United States, with Continental Stock Transfer & Trust Company acting as trustee, and are invested only in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, until the earlier of (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below.</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Shares, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the net assets held in the Trust Account (excluding the amount of deferred underwriting commissions and taxes payable on the interest earned on the Trust Account) at the time of the signing of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act.</div> <div><br/></div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company will provide the holders of Public Shares (the “Public Shareholders”), with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (<span style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">initially anticipated to be</span> $10.00 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay income taxes). The per-share amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 5).</div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">These Public Shares were classified as temporary equity in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity” (“ASC 480”). In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, only if a majority of the ordinary shares, represented in person or by proxy and entitled to vote thereon, voted at a shareholder meeting are voted in favor of the Business Combination. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to the amended and restated memorandum and articles of association which the Company will adopt upon the consummation of the Initial Public Offering (the “Amended and Restated Memorandum and Articles of Association”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transactions is required by law, or the Company decides to obtain shareholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction or vote at all. If the Company seeks shareholder approval in connection with a Business Combination, the initial shareholders (as defined below) agreed to vote their Founder Shares (as defined below in Note 4) <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">and any Public Shares they hold in favor of a Business Combination.</span> Subsequent to the consummation of the Initial Public Offering, the Company will adopt an insider trading policy which will require insiders to: (i) refrain from purchasing shares during certain blackout periods and when they are in possession of any material non-public information and (ii) to clear all trades with the Company’s legal counsel prior to execution. In addition, the initial shareholders agreed to waive their redemption rights with respect to their Founder Shares, Private Placement Shares and Public Shares in connection with the completion of a Business Combination.</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Notwithstanding the foregoing, if the Company seeks shareholder approval of its Business Combination and does not conduct redemptions in connection with its Business Combination pursuant to the tender offer rules, the Amended and Restated Memorandum and Articles of Association provide that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Class A ordinary shares sold in the Initial Public Offering, without the prior consent of the Company.</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company’s Sponsor, officers and directors (the “initial shareholders”) agreed not to propose an amendment to the Amended and Restated Memorandum and Articles of Association (a) that would modify the substance or timing of the Company’s obligation to provide holders of its Public Shares the right to have their shares redeemed in connection with a Business Combination or to redeem 100% of the Public Shares if the Company does not complete its Business Combination within 24 months from the closing of the Initial Public Offering, or July 15, 2023, (the “Combination Period”), or (b) with respect to any other provision relating to the rights of Public Shareholders, unless the Company provides the Public Shareholders with the opportunity to redeem their Class A ordinary shares in conjunction with any such amendment.</div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">If the Company has not completed a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than <span style="-sec-ix-hidden:Fact_63d07ecce9b74f38ab48900335314075">ten</span> business days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its income taxes, if any (less up to $100,000 of interest to pay dissolution expenses), divided by the number of the then-outstanding Public Shares, which redemption will completely extinguish Public Shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining shareholders and the board of directors, liquidate and dissolve, subject in the case of clauses (ii) and (iii) to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.</div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <span style="font-family: 'Times New Roman'; font-size: 10pt;"> The initial shareholders agreed to waive their liquidation rights with respect to the Founder Shares and Private Placement Shares held by them if the Company fails to complete a Business Combination within the Combination Period. However, if the initial shareholders acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters agreed to waive their rights to their deferred underwriting commission (see Note 5) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution (including Trust Account assets) will be only $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor agreed to be liable to the Company if and to the extent any claims by a third party (excluding the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account if less than $10.00 per Public Share due to reductions in the value of the assets in the Trust Account, in each case net of the interest that may be withdrawn to pay for the Company’s tax obligations. This liability will not apply with respect to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”).</span></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div style="text-align: justify; font-family: 'Times New Roman';"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (excluding the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account</span><span style="font-family: 'Times New Roman'; font-size: 10pt;">. The Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and the Company believes that the Sponsor’s only assets are securities of the Company. The Sponsor may not be able to satisfy those obligations. None of the Company’s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses.</span></div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div style="text-align: justify; font-family: 'Times New Roman'; font-style: italic; font-size: 10pt;">Going Concern<br/> </div> <div style="font-family: 'Times New Roman'; font-size: 10pt;"><br/> </div> <div style="text-align: justify; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">As of March 31, 2023, the Company had approximately</span> $296,000 in its operating bank account, and working capital deficit of approximately $2.6 million.</div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">The Company’s liquidity needs to date have been satisfied through a contribution of $25,000 from the Sponsor to cover for certain <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">expenses in exchange</span> for the issuance of the Founder Shares, the loan of approximately $151,000 from the Sponsor pursuant to the Note (as defined in Note 4) and advances from the Sponsor, and $2 million in proceeds from the consummation of the Private Placement not held in the Trust Account. The Company fully repaid the Note on July 15, 2021. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (as defined in Note 4). <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">As of March 31, 2023 and December 31, 2022,</span> there were no amounts outstanding under any Working Capital Loan.</div> <div><br/></div> <div><span style="font-family: 'Times New Roman';"> </span></div> <div><span style="font-family: 'Times New Roman';"> </span></div> <div><span style="font-family: 'Times New Roman';"> </span></div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">The Company cannot provide any assurance that new financing along the lines detailed above will be available to it on commercially acceptable terms, if at all. Further, the Company has until July 15, 2023 to consummate a Business Combination, but the Company cannot provide assurance that it will be able to consummate a Business Combination by that date. If a Business Combination is not consummated by the required date, there will be a mandatory liquidation and subsequent dissolution. In connection with the Company’s assessment of going concern considerations in accordance with FASB ASC Topic 205-40, “Basis of Presentation - Going Concern,” management has determined that the working capital deficit and liquidity conditions raise substantial doubt about the Company’s ability to continue as a going concern until the earlier of the consummation of the Business Combination or the date the Company is required to liquidate, July 15, 2023. <span style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">The unaudited condensed financial statements do not include any adjustment that might be necessary if the Company is unable to continue as a going concern. The Company intends to complete its initial Business Combination before the mandatory liquidation date; however, there can be no assurance that the Company will be able to consummate any Business Combination by July 15, 2023. No adjustments have been made to the carrying amounts of assets and liabilities should the Company be required to liquidate after July 15, 2023, nor do these unaudited condensed financial statements include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.</span></div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;"> <br/> </span></div> <div style="display:none;"><br/></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; text-align: justify; font-style: italic; font-weight: bold;">Risks and Uncertainties</div> <div style="display:none;"><br/></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"><br/> </div> <div style="display:none;"><br/></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; text-align: justify;">Results of operations and the Company’s ability to complete a Business Combination may be adversely affected by various factors that could cause economic uncertainty and volatility in the financial markets, many of which are beyond its control. The Company’s business of pursuing and consummating an initial Business Combination could be impacted by, among other things, downturns in the financial markets or in economic conditions, export controls, tariffs, trade wars, inflation, increases in interest rates, supply chain disruptions, declines in consumer confidence and spending, the ongoing effects of the COVID-19 pandemic, including resurgences and the emergence of new variants, and geopolitical instability, such as the military conflict in the Ukraine. The Company cannot at this time fully predict the likelihood of one or more of the above events, their duration or magnitude or the extent to which they may materially impact the Company’s business and its ability to complete an initial Business Combination.</div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;"> </span></div>

14950000

1950000

149500000

8700000

5200000 0.50 0.50

499000

5000000

149500000

10 1 0.80 0.50 10 5000001 0.15 1 P24M 100000 10 10 10

296000

-2600000 25000

151000

2000000

<div><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal;"><span style="font-weight: bold;">Note 2 - Summary of Significant Accounting Policies</span></span></span> </div> <div style="font-style: normal; font-variant: normal; text-transform: none;"><span style="font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-weight: normal;"><span style="font-weight: bold;"> <br/> </span></span></span></div> <div style="text-align: justify; font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">Basis of Presentation</div> <div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div style="display:none;"><br/></div> <div style="font-family: 'Times New Roman',Times,serif; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify;">The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. Accordingly, certain disclosures included in the annual financial statements have been condensed or omitted from these unaudited condensed financial statements as they are not required for unaudited interim condensed financial statements. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the three months ended March 31, 2023 are not necessarily indicative of the results that may be expected through December 31, 2023 or any future periods.</div> <div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div style="display:none;"><br/></div> <div style="font-family: 'Times New Roman',Times,serif; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify;">The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form 10-K for the year ended December 31, 2022 and filed by the Company with the SEC on April 12, 2023.</div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"> <span style="font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div><span style="font-style: italic;"> <span style="font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">Emerging Growth Company</span></span></div> <div style="font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt;"> <br/> </span></div> <div style="text-align: justify; margin-bottom: 12pt; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt;"> The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.</span></div> <div style="text-align: justify;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; font-style: normal; font-weight: normal;">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s unaudited condensed financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.</span> </div> <div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div style="text-align: justify; font-style: italic; font-weight: bold; font-family: 'Times New Roman',Times,serif; font-size: 13.3333px; font-variant: normal; text-transform: none;"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; text-indent: 0px; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Concentration of Cash Balances</span></div> <div style="display:none;"><br/></div> <div style="text-align: justify; text-indent: 24.5pt;"><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/> </span> </div> <div style="text-align: justify; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company has significant cash balances at financial institutions which throughout the year regularly exceed the federally insured limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.</div> <div style="text-align: justify; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt;"> <br/> </span></div> <div style="text-align: justify; font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">Cash and Cash Equivalents</div> <div><span style="font-style: normal; font-variant: normal; text-transform: none;"> <span style="font-family: 'Times New Roman'; font-size: 10pt;"> </span> </span></div> <div style="text-align: justify; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no<span style="font-family: 'Times New Roman',Times,serif; font-size: 13.3333px; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: 0px; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;"> cash equivalents as of March 31, 2023 and December 31, 2022, aside from the cash maintained in the Trust Account (see Note 8).</span> </div> <div style="text-align: justify;"> <span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div style="text-align: justify; font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">Use of Estimates</div> <div><span style="font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; font-style: normal;"> </span></div> <div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> <span style="font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; font-style: normal;"><br/> </span> </div> <div><span style="font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; font-style: normal;"> </span></div> <div style="text-align: justify; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <span style="display: inline; float: none; letter-spacing: normal; white-space: normal; word-spacing: 0px; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: normal; text-indent: 0px; text-transform: none; font-variant: normal;">The preparation of <span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt;">unaudited </span></span><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets liabilities and expenses and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements. Actual results could differ from those estimates.</span></div> <div><span style="font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; font-variant: normal; text-transform: none;">Investments Held in Trust Account</div> <div><span style="font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities are included <span style="font-family: 'Times New Roman',Times,serif; font-size: 13.3333px; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: 0px; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">in interest income and unrealized gain on investments held in Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.</span></div> <div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div style="text-align: justify; font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">Financial Instruments</div> <div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div style="text-align: justify; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC Topic 820, “Fair Value Measurements and Disclosures,” equals or approximates the carrying amounts represented in the condensed balance sheets.</div> <div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div style="text-align: justify; font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">Fair Value Measurements</div> <div><span style="font-style: normal; font-variant: normal; text-transform: none;"> <span style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"> </span> </span></div> <div style="text-align: justify; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:</div> <div><span style="font-style: normal; font-variant: normal; text-transform: none;"> <span style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"> </span> </span></div> <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"> <tr> <td style="width: 18pt; vertical-align: top; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">•</td> <td style="width: auto; vertical-align: top;"> <div style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify;">Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;</div> </td> </tr> </table> <div><br/></div> <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"> <tr> <td style="width: 18pt; vertical-align: top; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">•</td> <td style="width: auto; vertical-align: top;"> <div style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify;">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and</div> </td> </tr> </table> <div><br/></div> <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"> <tr> <td style="width: 18pt; vertical-align: top; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">•</td> <td style="width: auto; vertical-align: top;"> <div style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify;">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</div> </td> </tr> </table> <div><span style="font-style: normal; font-variant: normal; text-transform: none;"> <span style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"> </span></span></div> <div><span style="font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="text-align: justify; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.</div> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <span style="font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-family: 'Times New Roman',Times,serif; font-size: 13.3333px; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: 0px; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">As of March 31, 2023 and December 31, 2022, the carrying values of cash, accounts payable, accrued expenses and due to related party approximate their fair values due to the short-term nature of the instruments. The Company’s investments held in Trust Account are comprised of investments in U.S. Treasury securities with an original maturity of 185 days or less and are recognized at fair value. The fair value of investments held in Trust Account is determined using quoted prices in active markets.</span></div> <div><span style="font-style: normal; font-variant: normal; text-transform: none;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"> </span> <span style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"> </span> </span></div> <div style="text-align: justify; font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">Offering Costs Associated with the Initial Public Offering</div> <div style="display:none;"><br/></div> <div style="text-align: justify; text-indent: 23.55pt;"><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/> </span> </div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">Offering costs consisted of legal, accounting, underwriting and other costs incurred that were directly related to the Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with the Class A ordinary shares issue</span><span style="font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">d were charged against the carrying value of the Class A ordinary shares subject to possible redemption upon<span style="font-size: 10pt;"> the completion of the Initial Public Offering. The Company classifies deferred underwriting commissions as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.</span></span></div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-family: 'Times New Roman';"><span style="font-size: 10pt;"> <br/> </span></span></div> <div><span style="font-family: 'Times New Roman'; font-style: italic; font-weight: bold; font-size: 10pt; font-variant: normal; text-transform: none;">Class A Ordinary Shares Subject to Possible Redemption</span> </div> <div style="font-family: 'Times New Roman';"><span style="font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-style: normal; font-variant: normal; text-transform: none;">The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholder<span style="font-family: 'Times New Roman',Times,serif; font-size: 13.3333px; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: 0px; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">s’ deficit. The Public Shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of March 31, 2023 and December 31, 2022,</span> 14,950,000 Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s condensed balance sheets.<br class="Apple-interchange-newline"/> </span> </div> <div style="font-family: 'Times New Roman';"><span style="font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the Class A ordinary shares subject to possible redemption to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit.</div> <div><span style="font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="text-align: justify; font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">Income Taxes</div> <div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> <span style="font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">FASB ASC Topic 740, “Income Taxes,” prescribes<span style="font-weight: normal; font-size: 10pt;"> a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits <span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; text-indent: 0px; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">as of March 31, 2023 and December 31, 2022.</span> The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. <span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; text-indent: 0px; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">As of March 31, 2023 and December 31, 2022,</span> there were no unrecognized tax benefits and no amounts were accrued for the payment of interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. </span></div> <div><span style="font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none;"> <span style="font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div><span style="font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">There is currently no taxation imposed on income by the government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s unaudited condensed financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.</div> <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none;"> <span style="font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"><span style="font-weight: bold; font-style: italic; font-variant: normal; text-transform: none;">Net Income (Loss) per Ordinary Share</span><span style="font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: bold;"> <br/> </span></div> <div style="display:none;"><br/></div> <div style="font-family: 'Times New Roman',Times,serif; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify;">The Company has two classes of shares: Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per ordinary share is computed by dividing net income (loss) by the weighted-average number of ordinary shares outstanding during the periods. Accretion associated with the Class A ordinary shares subject to possible redemption is excluded from earnings per ordinary share as the redemption value approximates fair value.</div> <div style="display:none;"><br/></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"><span style="font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman', Times, serif; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"> <tr> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> <div style="margin-right: 0.8pt; font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;"> </div> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="14" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; font-weight: bold; font-style: normal; font-variant: normal; text-transform: none;">For the Three Months Ended</div> <div style="text-align: center; font-weight: bold; font-style: normal; font-variant: normal; text-transform: none;">March 31,</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; font-size: 10pt; font-weight: bold; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;"> 2023</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; font-size: 10pt; font-weight: bold; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">2022</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> <div style="margin-right: 0.8pt; font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;"> </div> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; font-size: 10pt; font-weight: bold; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">Class A</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; font-size: 10pt; font-weight: bold; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">Class B</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; font-size: 10pt; font-weight: bold; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">Class A</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; font-size: 10pt; font-weight: bold; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">Class B</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom;" valign="bottom"> <div style="margin-right: 0.8pt; font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">Basic and diluted net income (loss) per ordinary share:</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom;" valign="bottom"> <div style="margin-right: 0.8pt; font-size: 10pt; font-style: normal; font-family: 'Times New Roman'; font-variant: normal; text-transform: none;">Numerator:</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 52%; background-color: #CCEEFF;" valign="bottom"> <div style="margin-right: 0.8pt; font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">Allocation of net income (loss)</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">1,200,287</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">290,380</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">(223,973</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">)</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">(54,185</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">)</div> </td> </tr> <tr> <td style="vertical-align: bottom; width: 52%;" valign="bottom"> <div style="margin-right: 0.8pt; font-size: 10pt; font-style: normal; font-family: 'Times New Roman'; font-variant: normal; text-transform: none;">Denominator:</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: right; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: right; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: right; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: right; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 52%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> <div style="margin-right: 0.8pt; font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">Basic and diluted weighted average ordinary shares outstanding</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">15,449,000</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">3,737,500</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">15,449,000</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">3,737,500</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 52%; padding-bottom: 4px;" valign="bottom"> <div style="margin-right: 0.8pt; font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">Basic and diluted net income (loss) per ordinary share</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">0.08</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">0.08</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">(0.01</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">)</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">(0.01</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">)</div> </td> </tr> </table> <div><span style="font-style: normal; font-variant: normal; text-transform: none;"><br class="Apple-interchange-newline"/> </span></div> <div style="margin: 0px 0px 0px; font-family: 'Times New Roman'; font-size: 10pt; text-align: left;"> <span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"><br/> </span></div> <div style="text-align: justify; font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">Recent Accounting Pronouncements</div> <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; font-weight: bold; text-align: justify; text-transform: none;"> <span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company’s management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying unaudited condensed financial statements.</div>

<div style="text-align: justify; font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">Basis of Presentation</div> <div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div style="display:none;"><br/></div> <div style="font-family: 'Times New Roman',Times,serif; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify;">The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. Accordingly, certain disclosures included in the annual financial statements have been condensed or omitted from these unaudited condensed financial statements as they are not required for unaudited interim condensed financial statements. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the three months ended March 31, 2023 are not necessarily indicative of the results that may be expected through December 31, 2023 or any future periods.</div> <div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div style="display:none;"><br/></div> <div style="font-family: 'Times New Roman',Times,serif; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify;">The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form 10-K for the year ended December 31, 2022 and filed by the Company with the SEC on April 12, 2023.</div>

<div style="text-align: justify; font-style: italic; font-weight: bold; font-family: 'Times New Roman',Times,serif; font-size: 13.3333px; font-variant: normal; text-transform: none;"><span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; text-indent: 0px; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">Concentration of Cash Balances</span></div> <div style="display:none;"><br/></div> <div style="text-align: justify; text-indent: 24.5pt;"><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/> </span> </div> <div style="text-align: justify; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company has significant cash balances at financial institutions which throughout the year regularly exceed the federally insured limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.</div>

<div style="text-align: justify; font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">Use of Estimates</div> <div><span style="font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; font-style: normal;"> </span></div> <div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> <span style="font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; font-style: normal;"><br/> </span> </div> <div><span style="font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none; font-style: normal;"> </span></div> <div style="text-align: justify; color: rgb(0, 0, 0); font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <span style="display: inline; float: none; letter-spacing: normal; white-space: normal; word-spacing: 0px; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-weight: normal; text-indent: 0px; text-transform: none; font-variant: normal;">The preparation of <span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt;">unaudited </span></span><span style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; text-align: justify; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">condensed financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets liabilities and expenses and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements. Actual results could differ from those estimates.</span></div>

<div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-weight: bold; font-variant: normal; text-transform: none;">Investments Held in Trust Account</div> <div><span style="font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the condensed balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities are included <span style="font-family: 'Times New Roman',Times,serif; font-size: 13.3333px; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: 0px; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">in interest income and unrealized gain on investments held in Trust Account in the accompanying unaudited condensed statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.</span></div>

<div style="text-align: justify; font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">Financial Instruments</div> <div><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div style="text-align: justify; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC Topic 820, “Fair Value Measurements and Disclosures,” equals or approximates the carrying amounts represented in the condensed balance sheets.</div>

<div style="text-align: justify; font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">Fair Value Measurements</div> <div><span style="font-style: normal; font-variant: normal; text-transform: none;"> <span style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"> </span> </span></div> <div style="text-align: justify; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:</div> <div><span style="font-style: normal; font-variant: normal; text-transform: none;"> <span style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"> </span> </span></div> <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"> <tr> <td style="width: 18pt; vertical-align: top; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">•</td> <td style="width: auto; vertical-align: top;"> <div style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify;">Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;</div> </td> </tr> </table> <div><br/></div> <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"> <tr> <td style="width: 18pt; vertical-align: top; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">•</td> <td style="width: auto; vertical-align: top;"> <div style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify;">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and</div> </td> </tr> </table> <div><br/></div> <table cellpadding="0" cellspacing="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;"> <tr> <td style="width: 18pt; vertical-align: top; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">•</td> <td style="width: auto; vertical-align: top;"> <div style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify;">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</div> </td> </tr> </table> <div><span style="font-style: normal; font-variant: normal; text-transform: none;"> <span style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal;"> </span></span></div> <div><span style="font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="text-align: justify; font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.</div> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> <span style="font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-family: 'Times New Roman',Times,serif; font-size: 13.3333px; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: 0px; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">As of March 31, 2023 and December 31, 2022, the carrying values of cash, accounts payable, accrued expenses and due to related party approximate their fair values due to the short-term nature of the instruments. The Company’s investments held in Trust Account are comprised of investments in U.S. Treasury securities with an original maturity of 185 days or less and are recognized at fair value. The fair value of investments held in Trust Account is determined using quoted prices in active markets.</span></div>

<div style="text-align: justify; font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">Offering Costs Associated with the Initial Public Offering</div> <div style="display:none;"><br/></div> <div style="text-align: justify; text-indent: 23.55pt;"><span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/> </span> </div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">Offering costs consisted of legal, accounting, underwriting and other costs incurred that were directly related to the Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with the Class A ordinary shares issue</span><span style="font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">d were charged against the carrying value of the Class A ordinary shares subject to possible redemption upon<span style="font-size: 10pt;"> the completion of the Initial Public Offering. The Company classifies deferred underwriting commissions as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.</span></span></div>

<div><span style="font-family: 'Times New Roman'; font-style: italic; font-weight: bold; font-size: 10pt; font-variant: normal; text-transform: none;">Class A Ordinary Shares Subject to Possible Redemption</span> </div> <div style="font-family: 'Times New Roman';"><span style="font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-style: normal; font-variant: normal; text-transform: none;">The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholder<span style="font-family: 'Times New Roman',Times,serif; font-size: 13.3333px; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; text-align: justify; text-indent: 0px; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">s’ deficit. The Public Shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of March 31, 2023 and December 31, 2022,</span> 14,950,000 Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s condensed balance sheets.<br class="Apple-interchange-newline"/> </span> </div> <div style="font-family: 'Times New Roman';"><span style="font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the Class A ordinary shares subject to possible redemption to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit.</div>

14950000

<div style="text-align: justify; font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">Income Taxes</div> <div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> <span style="font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">FASB ASC Topic 740, “Income Taxes,” prescribes<span style="font-weight: normal; font-size: 10pt;"> a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits <span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; text-indent: 0px; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">as of March 31, 2023 and December 31, 2022.</span> The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. <span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: justify; text-indent: 0px; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">As of March 31, 2023 and December 31, 2022,</span> there were no unrecognized tax benefits and no amounts were accrued for the payment of interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. </span></div> <div><span style="font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; text-align: justify; text-transform: none;"> <span style="font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div><span style="font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">There is currently no taxation imposed on income by the government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s unaudited condensed financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.</div>

<div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify;"><span style="font-weight: bold; font-style: italic; font-variant: normal; text-transform: none;">Net Income (Loss) per Ordinary Share</span><span style="font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: justify; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: bold;"> <br/> </span></div> <div style="display:none;"><br/></div> <div style="font-family: 'Times New Roman',Times,serif; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify;">The Company has two classes of shares: Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per ordinary share is computed by dividing net income (loss) by the weighted-average number of ordinary shares outstanding during the periods. Accretion associated with the Class A ordinary shares subject to possible redemption is excluded from earnings per ordinary share as the redemption value approximates fair value.</div> <div style="display:none;"><br/></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"><span style="font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman', Times, serif; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"> <tr> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> <div style="margin-right: 0.8pt; font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;"> </div> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="14" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; font-weight: bold; font-style: normal; font-variant: normal; text-transform: none;">For the Three Months Ended</div> <div style="text-align: center; font-weight: bold; font-style: normal; font-variant: normal; text-transform: none;">March 31,</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; font-size: 10pt; font-weight: bold; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;"> 2023</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; font-size: 10pt; font-weight: bold; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">2022</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> <div style="margin-right: 0.8pt; font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;"> </div> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; font-size: 10pt; font-weight: bold; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">Class A</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; font-size: 10pt; font-weight: bold; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">Class B</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; font-size: 10pt; font-weight: bold; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">Class A</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; font-size: 10pt; font-weight: bold; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">Class B</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom;" valign="bottom"> <div style="margin-right: 0.8pt; font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">Basic and diluted net income (loss) per ordinary share:</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom;" valign="bottom"> <div style="margin-right: 0.8pt; font-size: 10pt; font-style: normal; font-family: 'Times New Roman'; font-variant: normal; text-transform: none;">Numerator:</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 52%; background-color: #CCEEFF;" valign="bottom"> <div style="margin-right: 0.8pt; font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">Allocation of net income (loss)</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">1,200,287</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">290,380</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">(223,973</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">)</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">(54,185</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">)</div> </td> </tr> <tr> <td style="vertical-align: bottom; width: 52%;" valign="bottom"> <div style="margin-right: 0.8pt; font-size: 10pt; font-style: normal; font-family: 'Times New Roman'; font-variant: normal; text-transform: none;">Denominator:</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: right; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: right; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: right; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: right; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 52%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> <div style="margin-right: 0.8pt; font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">Basic and diluted weighted average ordinary shares outstanding</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">15,449,000</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">3,737,500</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">15,449,000</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">3,737,500</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 52%; padding-bottom: 4px;" valign="bottom"> <div style="margin-right: 0.8pt; font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">Basic and diluted net income (loss) per ordinary share</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">0.08</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">0.08</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">(0.01</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">)</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">(0.01</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">)</div> </td> </tr> </table>

<div style="display:none;"><br/></div> <div style="font-family: 'Times New Roman',Times,serif; font-size: 13.3333px; font-style: normal; font-variant: normal; font-weight: 400; letter-spacing: normal; text-indent: 0px; text-transform: none; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; text-align: justify;">The Company has two classes of shares: Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per ordinary share is computed by dividing net income (loss) by the weighted-average number of ordinary shares outstanding during the periods. Accretion associated with the Class A ordinary shares subject to possible redemption is excluded from earnings per ordinary share as the redemption value approximates fair value.</div> <div style="display:none;"><br/></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial;"><span style="font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman', Times, serif; letter-spacing: normal; orphans: 2; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"> <tr> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> <div style="margin-right: 0.8pt; font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;"> </div> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="14" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; font-weight: bold; font-style: normal; font-variant: normal; text-transform: none;">For the Three Months Ended</div> <div style="text-align: center; font-weight: bold; font-style: normal; font-variant: normal; text-transform: none;">March 31,</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; font-size: 10pt; font-weight: bold; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;"> 2023</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="6" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; font-size: 10pt; font-weight: bold; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">2022</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> <div style="margin-right: 0.8pt; font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;"> </div> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; font-size: 10pt; font-weight: bold; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">Class A</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; font-size: 10pt; font-weight: bold; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">Class B</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; font-size: 10pt; font-weight: bold; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">Class A</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="text-align: center; font-size: 10pt; font-weight: bold; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">Class B</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom;" valign="bottom"> <div style="margin-right: 0.8pt; font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">Basic and diluted net income (loss) per ordinary share:</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom;" valign="bottom"> <div style="margin-right: 0.8pt; font-size: 10pt; font-style: normal; font-family: 'Times New Roman'; font-variant: normal; text-transform: none;">Numerator:</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 52%; background-color: #CCEEFF;" valign="bottom"> <div style="margin-right: 0.8pt; font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">Allocation of net income (loss)</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">1,200,287</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">290,380</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">(223,973</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">)</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">(54,185</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">)</div> </td> </tr> <tr> <td style="vertical-align: bottom; width: 52%;" valign="bottom"> <div style="margin-right: 0.8pt; font-size: 10pt; font-style: normal; font-family: 'Times New Roman'; font-variant: normal; text-transform: none;">Denominator:</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: right; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: right; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: right; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: right; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; vertical-align: bottom; text-align: right; width: 9%;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 52%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> <div style="margin-right: 0.8pt; font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">Basic and diluted weighted average ordinary shares outstanding</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">15,449,000</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">3,737,500</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">15,449,000</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">3,737,500</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 52%; padding-bottom: 4px;" valign="bottom"> <div style="margin-right: 0.8pt; font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">Basic and diluted net income (loss) per ordinary share</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">0.08</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">0.08</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">(0.01</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">)</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">(0.01</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> <div style="font-size: 10pt; font-family: 'Times New Roman'; font-style: normal; font-variant: normal; text-transform: none;">)</div> </td> </tr> </table>

1200287

290380

-223973

-54185

15449000

3737500

15449000

3737500

0.08

-0.01

<div style="text-align: justify; font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">Recent Accounting Pronouncements</div> <div style="color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; font-weight: bold; text-align: justify; text-transform: none;"> <span style="font-weight: normal; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company’s management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying unaudited condensed financial statements.</div>

<div><span style="font-style: italic;"> <span style="font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">Note 3 - Initial Public Offering</span> </span></div> <div><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; text-align: justify; font-weight: normal;">On July 15, 2021, the Company consummated its Initial Public Offering of 14,950,000 Public Shares, including the 1,950,000 Public Shares as a result of the underwriters’ full exercise of their over-allotment option, at an offering price of $10.00 per Public Share, generating gross proceeds of $149.5 million, and incurring offering costs of approximately $8.7 million, inclusive of approximately $5.2 million in deferred underwriting commissions. On August 8, 2022, the Company received a waiver from one of the underwriters of its Initial Public Offering pursuant to which such underwriter waived all rights to its 50% share of the deferred underwriting commissions payable upon completion of an initial Business Combination (see Note 1). </div>

14950000

1950000

149500000

8700000

5200000 0.50

<div><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <span style="font-weight: bold;">Note 4 - Related Party Transactions</span> </span></div> <div><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-weight: bold; background-color: rgb(255, 255, 255); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">Founder Shares</div> <div><span style="font-style: normal; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div> <div><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">On March 18, 2021, the Sponsor paid $25,000 to cover certain of the Company’s expenses in exchange for the issuance of 3,737,500 Class B ordinary shares, par value $0.0001 (the “Founder Shares”). In June 2021, the Sponsor transferred an aggregate of 120,000 Founder Shares to the Company’s independent directors. The Sponsor agreed to forfeit up to 487,500 Founder Shares to the extent that the over-allotment option was not exercised in full by the underwriters, so that the Founder Shares would represent 20.0% of the Company’s issued and outstanding ordinary shares (excluding the Private Placement Shares) after the Initial Public Offering. On July 15, 2021, the underwriters fully exercised the over-allotment option to purchase additional 1,950,000 Public Shares. As a result, the 487,500 Class B ordinary shares were no longer subject to forfeiture.</div> <div><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The initial shareholders agreed, subject to limited exceptions, not to transfer, assign or sell any of their Founder Shares until the earlier to occur of: (A) one year after the completion of the initial Business Combination and (B) subsequent to the initial Business Combination, (x) if the closing price of Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the Public Shareholders having the right to exchange their ordinary shares for cash, securities or other property.</div> <div><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-weight: bold; background-color: rgb(255, 255, 255); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">Private Placement Shares</div> <div><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement of 499,000 Private Placement Shares, at a price of $10.00 per Private Placement Share to the Sponsor, generating gross proceeds of approximately $5.0 million. Certain proceeds from the Private Placement Shares were added to the proceeds from the Initial Public Offering held in the Trust Account.</div> <div><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Private Placement Shares are not transferable or salable until 30 days after the completion of the initial Business Combination. Certain proceeds from the Private Placement Shares have been added to the proceeds from the Initial Public Offering held in the Trust Account. The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Shares until 30 days after the completion of the initial Business Combination. </div> <div><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-weight: bold; background-color: rgb(255, 255, 255); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">Related Party Loans</div> <div><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div><span style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">On March 31, 2021, a related party advanced approximately $1,400 to cover for certain expenses on behalf of the Company. The Company fully repaid the advance from related party of approximately $1,400 on April 5, 2021.</div> <div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/> </span></div> <div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">On March 18, 2021, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover for expenses related to the Initial Public Offering pursuant to a promissory note (the “Note”). This loan was non-interest bearing and payable upon the completion of the Initial Public Offering. The Company borrowed $150,000 under the Note and fully repaid the Note amount on July 15, 2021. Subsequent to the repayment, the loan facility was no longer available to the Company.</div> <div><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div style="text-align: justify;"><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company may repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans may be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of the proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon the consummation of a Business Combination, without interest, or, at the lender<span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">’</span>s discretion, up to $1.5 million of such Working Capital Loans may be convertible into shares of the post Business Combination entity at a price of $10.00 per share. The shares would be identical to the Private Placement Shares. As of March 31, 2023 and December 31, 2022, the Company had no outstanding borrowings under the Working Capital Loans. </span> </div> <div> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-weight: bold; background-color: rgb(255, 255, 255); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">Administrative Support Agreement</div> <div><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Commencing on the date that the Company’s registration statement relating to its Initial Public Offering was declared effective through the earlier of consummation of the initial Business Combination and the Company’s liquidation, the Company agreed to reimburse the Sponsor for office space, secretarial and administrative services provided to the Company in the amount of $<span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">10,000</span> per month. For the three months ended March 31, 2023 and 2022, the Company incurred expenses of approximately $30,000 (unaudited) and $30,000 (unaudited), respectively, under this agreement. As of March 31, 2023 and December 31, 2022, the Company had $120,000 (unaudited) and $90,000, respectively, in due to related party on the balance sheets.</div>

25000

3737500

0.0001

120000

487500 0.20

1950000

487500

P1Y

P20D P30D P150D

499000

5000000

P30D P30D

1400

300000

150000

1500000

10000

30000

120000

90000

<div><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <span style="font-weight: bold;"> Note 5 - Commitments and Contingencies</span> </span></div> <div><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"><br/> </span> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-weight: bold; background-color: rgb(255, 255, 255); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;">Registration Rights</div> <div><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"><br/> </span> </div> <div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">The holders of Founder Shares, Private Placement Shares, as well as the Private Placement Shares that may be issued upon conversion of Working Capital Loans, are entitled to registration rights pursuant to a registration and shareholder rights agreement signed upon the consummation of the Initial Public Offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the Company’s completion of its Business Combination. However, the registration and shareholder rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lock-up period, which occurs (i) in the case of the Founder Shares, in accordance with the letter agreement the Company’s initial shareholders entered into and (ii) in the case of the Private Placement Shares, 30 days after the completion of the Company’s Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.</div> <div><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"><br/> </span> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic; font-weight: bold; background-color: rgb(255, 255, 255); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;">Underwriting Agreement</div> <div><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"><br/> </span> </div> <div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">The Company granted the underwriters a 45-day option from the final prospectus relating to the Initial Public Offering to purchase up to 1,950,000 additional Public Shares to cover over-allotments at the Initial Public Offering price less the underwriting discounts and commissions. On July 15, 2021, the underwriters fully exercised the over-allotment option.</div> <div><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"><br/> </span> </div> <div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;">The underwriters were paid an underwriting discount of $0.20 per Public Share, or approximately $3.0 million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.35 per Public Share, or approximately $5.2 million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. </div> <div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none; font-weight: normal;"> <br/> </div> <div style="text-align: justify;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">On August 8, 2022, the Company received a waiver from one of the underwriters</span> of its Initial Public Offering<span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> pursuant to which such underwriter waived all rights to its 50% share of the deferred underwriting commissions payable upon completion of an initial Business Combination. In connection with this waiver, the underwriter also agreed that (i) this waiver is not intended to allocate its 50% portion of the deferred underwriting commissions to the other underwrite<span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">r that has not waived its right to receive its share of the deferred underwriting commissions</span> and (ii) the waived portion of the deferred underwriting commissions can, at the discretion of the Company, be paid to one or more parties or otherwise be used in connection with an initial Business Combination. During the year ended December 31, 2022, the Company derecognized approximately $2.6 million of the deferred underwriting commissions and recorded an adjustment to the carrying value of the shares of Class A ordinary shares subject to possible redemption.</span><br/> </div> <div style="text-align: justify;"><span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <br/> </span></div>

3 P45D 1950000 0.2 3000000 0.35 5200000 0.50 0.50 2600000 <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">Note </span><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: bold;">6 - Class A Ordinary Shares Subject to Possible Redemption</span></span></div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">The Public Shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of future events. As of March 31, 2023 and December 31, 2022, there were 14,950,000 Class A ordinary shares subject to possible redemption.</span></div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Public Shares issued in the Initial Public Offering and in connection with the exercise by the underwriters of the over-allotment option were recognized in Class A ordinary shares subject to possible redemption as follows:</div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"> <tr> <td style="vertical-align: middle; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Gross proceeds<br/> </div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">149,500,000</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle; width: 88%; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Less:</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Offering costs allocated to Class A ordinary shares subject to possible redemption</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt;">(8,709,154</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div> </td> </tr> <tr> <td style="vertical-align: middle; width: 88%; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Plus:</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td rowspan="1" style="vertical-align: middle; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt; margin-left: 9pt;">Waiver of deferred underwriting commission</div> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">2,616,250</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Accretion on Class A ordinary shares subject to possible redemption amount</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt;">8,094,625</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td rowspan="1" style="vertical-align: middle; font-weight: bold; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">Class A ordinary shares subject to possible redemption at December 31, 2022</td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-weight: bold; white-space: nowrap;" valign="bottom">151,501,721</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td rowspan="1" style="vertical-align: middle; font-weight: normal; width: 88%; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Plus:</div> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td rowspan="1" style="vertical-align: middle; width: 88%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="margin-left: 9pt;"> <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Accretion on<span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: -9.6px; text-transform: none; white-space: nowrap; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;"> Class A ordinary shares subject to possible redemption</span> amount</div> </div> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; white-space: nowrap; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">1,692,535</span></td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle; width: 88%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Class A ordinary shares subject t<span style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">o possible redemption <span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; text-indent: 0px; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">at March 31, 2023</span></span></div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">153,194,256</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> </tr> </table>

14950000

<div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Public Shares issued in the Initial Public Offering and in connection with the exercise by the underwriters of the over-allotment option were recognized in Class A ordinary shares subject to possible redemption as follows:</div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span></div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"> <tr> <td style="vertical-align: middle; width: 88%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Gross proceeds<br/> </div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">149,500,000</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: rgb(204, 238, 255); white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle; width: 88%; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Less:</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Offering costs allocated to Class A ordinary shares subject to possible redemption</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt;">(8,709,154</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt;">)</div> </td> </tr> <tr> <td style="vertical-align: middle; width: 88%; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Plus:</div> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-family: 'Times New Roman'; text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td rowspan="1" style="vertical-align: middle; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt; margin-left: 9pt;">Waiver of deferred underwriting commission</div> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">2,616,250</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle; width: 88%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Accretion on Class A ordinary shares subject to possible redemption amount</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt;">8,094,625</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td rowspan="1" style="vertical-align: middle; font-weight: bold; width: 88%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom">Class A ordinary shares subject to possible redemption at December 31, 2022</td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: rgb(204, 238, 255); font-weight: bold; white-space: nowrap;" valign="bottom">151,501,721</td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td rowspan="1" style="vertical-align: middle; font-weight: normal; width: 88%; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Plus:</div> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td rowspan="1" style="vertical-align: middle; width: 88%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> <div style="margin-left: 9pt;"> <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Accretion on<span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: -9.6px; text-transform: none; white-space: nowrap; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;"> Class A ordinary shares subject to possible redemption</span> amount</div> </div> </td> <td colspan="1" rowspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" rowspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-transform: none; white-space: nowrap; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; display: inline !important; float: none;">1,692,535</span></td> <td colspan="1" rowspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: middle; width: 88%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Class A ordinary shares subject t<span style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">o possible redemption <span style="font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; text-align: left; text-indent: 0px; white-space: normal; word-spacing: 0px; text-decoration-style: initial; text-decoration-color: initial; display: inline ! important; float: none;">at March 31, 2023</span></span></div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; white-space: nowrap;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">153,194,256</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; white-space: nowrap;" valign="bottom"> </td> </tr> </table>

149500000

8709154

2616250

8094625

151501721

1692535

153194256

<div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="font-weight: bold;">Note 7 - Shareholders’ Deficit</span> </span></div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><span style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-size: 10pt; font-variant: normal; text-transform: none;">Preference Shares</span> -<span style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> The Company is authorized to issue 1,000,000 preference shares with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of March 31, 2023 and December 31, 2022, there were no preference shares issued or outstanding.</span></div> <div><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div style="text-align: justify;"><span style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-size: 10pt; font-variant: normal; text-transform: none;">Class A Ordinary Shares</span><span style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> <span style="font-weight: bold;">- </span>The Company is authorized to issue 479,000,000 Class A ordinary shares with a par value of $0.0001 per share. <span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Holders of the Company’s Class A ordinary shares are entitled to one vote for each share. </span>As of March 31, 2023 and December 31, <span style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">2022</span>, there were 15,449,000 Class A ordinary shares issued and outstanding, of which 14,950,000 shares were subject to possible redemption and classified in temporary equity</span>, respectively<span style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> (see Note 6).</span> </div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold; background-color: rgb(255, 255, 255); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </div> <div><span style="font-style: normal; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div> <div><span style="font-style: normal; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div> <div><span style="font-style: normal; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div> <div><span style="font-style: normal; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-variant: normal; text-transform: none;"> </span></div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><span style="font-family: 'Times New Roman'; font-weight: bold; font-style: italic; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-size: 10pt; font-variant: normal; text-transform: none;">Class B Ordinary Shares </span><span style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">- The Company is authorized to issue 20,000,000 Class B ordinary shares with a par value of $0.0001 per share. As of March 31, 2023 and December 31, <span style="font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">2022</span>, there were 3,737,500 Class B ordinary shares issued and outstanding (see Note 4).</span></div> <div><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><br/> </span> </div> <div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"><span style="background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders. Holders of Class A ordinary shares and holders of Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the shareholders except as required by law.</span></div> <div><br/> </div> <div style="text-align: justify; color: rgb(0, 0, 0); background-color: rgb(255, 255, 255); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Class B ordinary shares will automatically convert into Class A ordinary shares on the first business day following the consummation of the initial Business Combination at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, 20% of the sum of (i) the total number of ordinary shares issued and outstanding (excluding the Private Placement Shares) upon the consummation of the Initial Public Offering, plus (ii) the sum of the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Shares issued to the Sponsor, members of the Company’s management team or any of their affiliates upon conversion of Working Capital Loans. In no event will the Class B ordinary shares convert into Class A ordinary shares at a rate of less than one-to-one.</div>

1000000

479000000

0.0001

1 15449000 15449000 15449000 15449000

14950000

20000000

0.0001

3737500

1 0.20 1

<div><span style="font-weight: bold; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </span> </div> <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">Note </span><span style="font-weight: bold;">8</span><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);"> - Fair Value Measurements</span></div> <div><br/> </div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">The following tables present information about the Company’s assets that are measured at fair value on a recurring basis as of March 31, 2023 and December </span><span style="font-family: 'Times New Roman';">31,<span style="font-size: 10pt; color: rgb(0, 0, 0);"> </span>2022<span style="font-size: 10pt; color: rgb(0, 0, 0);"> and indicate the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value.</span></span></div> <div><br/> </div> <div><span style="font-style: italic; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-size: 10pt; font-variant: normal; text-transform: none;">March 31, 2023</span></div> <div><span style="font-style: italic; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-size: 10pt; font-variant: normal; text-transform: none;"> <br/> </span></div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"> <tr> <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Description</div> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);"> Quoted Prices in<br/> </span></div> <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);"> Active Markets<br/> </span></div> <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">(Level<span style="font-weight: bold;"> </span></span><span style="font-weight: bold;">1)</span></div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);"> Significant Other<br/> </span></div> <div style="text-align: center;"><span style="font-weight: bold;">Observable Inputs</span></div> <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">(Level </span><span style="font-weight: bold;">2)</span></div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-weight: bold; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> Significant Other<br/> </span></div> <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> Unobservable Inputs<br/> </span></div> <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(Level </span>3)</div> </td> <td colspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Investments held in Trust Account</div> </td> <td colspan="1" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">U.S. Treasury Securities</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt;">153,293,384</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Cash equivalents - money market funds</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt;">872</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> </div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">153,294,256</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> </table> <div><span style="font-family: 'Times New Roman';"><br/> </span> </div> <div><span style="font-family: 'Times New Roman';"> </span></div> <div><span style="font-style: italic; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-size: 10pt; font-variant: normal; text-transform: none;">December 31, 2022</span><br/> </div> <div><br/> </div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"> <tr> <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Description</div> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">Quoted Prices in<br/> </span> <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);"> Active Markets</span></div> </div> <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">(Level </span><span style="font-weight: bold;">1)</span></div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">Significant Other<br/> </span> <div style="text-align: center;"><span style="font-weight: bold;">Observable Inputs</span></div> </div> <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">(Level </span><span style="font-weight: bold;">2)</span></div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">Significant Other<br/> </span> <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);"> Unobservable Inputs</span></div> </div> <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">(Level </span><span style="font-weight: bold;">3)</span></div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Investments held in Trust Account</div> </td> <td colspan="1" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">U.S. Treasury Securities</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt;">151,592,810</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Cash equivalents - money market funds</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt;">8,911</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> </div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">151,601,721</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> </table> <div><span style="font-family: 'Times New Roman';"><br/> </span> </div> <div><span style="font-family: 'Times New Roman';"> </span></div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Transfers to/from Levels 1, 2, and 3 are recognized at the end of the reporting period. There were <span style="font-family: 'Times New Roman';"><span style="font-size: 10pt; color: rgb(0, 0, 0);">no</span></span> transfers between levels of the hierarchy for the three months ended March 31, 2023 and the year ended December 31, 2022. Level 1 instruments include investments U.S. Treasury securities with an original maturity of <span style="font-family: 'Times New Roman';"><span style="font-size: 10pt; color: rgb(0, 0, 0);">185</span></span> days or less.</div>

<div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">The following tables present information about the Company’s assets that are measured at fair value on a recurring basis as of March 31, 2023 and December </span><span style="font-family: 'Times New Roman';">31,<span style="font-size: 10pt; color: rgb(0, 0, 0);"> </span>2022<span style="font-size: 10pt; color: rgb(0, 0, 0);"> and indicate the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value.</span></span></div> <div><br/> </div> <div><span style="font-style: italic; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-size: 10pt; font-variant: normal; text-transform: none;">March 31, 2023</span></div> <div><span style="font-style: italic; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-size: 10pt; font-variant: normal; text-transform: none;"> <br/> </span></div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"> <tr> <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Description</div> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);"> Quoted Prices in<br/> </span></div> <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);"> Active Markets<br/> </span></div> <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">(Level<span style="font-weight: bold;"> </span></span><span style="font-weight: bold;">1)</span></div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);"> Significant Other<br/> </span></div> <div style="text-align: center;"><span style="font-weight: bold;">Observable Inputs</span></div> <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">(Level </span><span style="font-weight: bold;">2)</span></div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="font-weight: bold; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; font-weight: bold; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> Significant Other<br/> </span></div> <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> Unobservable Inputs<br/> </span></div> <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">(Level </span>3)</div> </td> <td colspan="1" style="font-weight: bold; text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Investments held in Trust Account</div> </td> <td colspan="1" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">U.S. Treasury Securities</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt;">153,293,384</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Cash equivalents - money market funds</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt;">872</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> </div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">153,294,256</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> </table> <div><span style="font-family: 'Times New Roman';"><br/> </span> </div> <div><span style="font-family: 'Times New Roman';"> </span></div> <div><span style="font-style: italic; font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-size: 10pt; font-variant: normal; text-transform: none;">December 31, 2022</span><br/> </div> <div><br/> </div> <table cellpadding="0" cellspacing="0" class="cfttable" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: rgb(0, 0, 0); width: 100%;"> <tr> <td style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Description</div> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">Quoted Prices in<br/> </span> <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);"> Active Markets</span></div> </div> <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">(Level </span><span style="font-weight: bold;">1)</span></div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">Significant Other<br/> </span> <div style="text-align: center;"><span style="font-weight: bold;">Observable Inputs</span></div> </div> <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">(Level </span><span style="font-weight: bold;">2)</span></div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: #000000 solid 2px; white-space: nowrap;" valign="bottom"> <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">Significant Other<br/> </span> <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);"> Unobservable Inputs</span></div> </div> <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">(Level </span><span style="font-weight: bold;">3)</span></div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Investments held in Trust Account</div> </td> <td colspan="1" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="2" style="vertical-align: bottom;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 64%; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">U.S. Treasury Securities</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt;">151,592,810</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 64%; padding-bottom: 2px;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; margin-left: 9pt;">Cash equivalents - money market funds</div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt;">8,911</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 2px;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 solid 2px;" valign="bottom"> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 solid 2px;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 2px; white-space: nowrap;" valign="bottom"> </td> </tr> <tr> <td style="vertical-align: bottom; width: 64%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"> </div> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">151,601,721</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> <td colspan="1" style="text-align: right; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF;" valign="bottom"> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">$</div> </td> <td colspan="1" style="vertical-align: bottom; text-align: right; width: 9%; border-bottom: #000000 double 4px; background-color: #CCEEFF;" valign="bottom"> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">—</div> </td> <td colspan="1" style="text-align: left; vertical-align: bottom; width: 1%; padding-bottom: 4px; background-color: #CCEEFF; white-space: nowrap;" valign="bottom"> </td> </tr> </table>

153293384

872

153294256

151592810

8911

151601721

P185D

<div><span style="font-family: 'Times New Roman';"><span style="font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Note 9 - Subsequent Events</span> </span></div> <div><span style="font-family: 'Times New Roman';"> </span></div> <div><span style="font-family: 'Times New Roman';"> </span></div> <div><span style="font-family: 'Times New Roman';"> </span></div> <div><span style="font-family: 'Times New Roman';"> </span></div> <div><span style="font-family: 'Times New Roman';"> </span></div> <div><span style="font-family: 'Times New Roman';"> </span></div> <div><span style="font-family: 'Times New Roman';"> </span></div> <div><span style="font-family: 'Times New Roman';"> </span></div> <div><span style="font-family: 'Times New Roman';"> </span></div> <div><span style="font-weight: bold; font-family: 'Times New Roman';"> </span><span style="font-family: 'Times New Roman';"> </span></div> <div><span style="font-family: 'Times New Roman';"><br/> </span> </div> <div><span style="font-family: 'Times New Roman';"> </span></div> <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; background-color: rgb(255, 255, 255); font-weight: normal; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">The Company evaluated subsequent events and transactions that occurred up to the date the unaudited condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited condensed financial statements.<span style="font-family: 'Times New Roman';"> </span></div>

EXCEL 46 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 48 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 49 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 106 161 1 false 24 0 false 7 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://perceptivelife.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 010000 - Statement - CONDENSED BALANCE SHEETS Sheet http://perceptivelife.com/role/CondensedBalanceSheets CONDENSED BALANCE SHEETS Statements 2 false false R3.htm 010100 - Statement - CONDENSED BALANCE SHEETS (Parenthetical) Sheet http://perceptivelife.com/role/CondensedBalanceSheetsParenthetical CONDENSED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 020000 - Statement - UNAUDITED CONDENSED STATEMENTS OF OPERATIONS Sheet http://perceptivelife.com/role/UnauditedCondensedStatementsOfOperations UNAUDITED CONDENSED STATEMENTS OF OPERATIONS Statements 4 false false R5.htm 030000 - Statement - UNAUDITED CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT Sheet http://perceptivelife.com/role/UnauditedCondensedStatementsOfChangesInShareholdersDeficit UNAUDITED CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT Statements 5 false false R6.htm 040000 - Statement - UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS Sheet http://perceptivelife.com/role/UnauditedCondensedStatementsOfCashFlows UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS Statements 6 false false R7.htm 060100 - Disclosure - Description of Organization and Business Operations Sheet http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperations Description of Organization and Business Operations Notes 7 false false R8.htm 060200 - Disclosure - Summary of Significant Accounting Policies Sheet http://perceptivelife.com/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 060300 - Disclosure - Initial Public Offering Sheet http://perceptivelife.com/role/InitialPublicOffering Initial Public Offering Notes 9 false false R10.htm 060400 - Disclosure - Related Party Transactions Sheet http://perceptivelife.com/role/RelatedPartyTransactions Related Party Transactions Notes 10 false false R11.htm 060500 - Disclosure - Commitments and Contingencies Sheet http://perceptivelife.com/role/CommitmentsAndContingencies Commitments and Contingencies Notes 11 false false R12.htm 060600 - Disclosure - Class A Ordinary Shares Subject to Possible Redemption Sheet http://perceptivelife.com/role/ClassOrdinarySharesSubjectToPossibleRedemption Class A Ordinary Shares Subject to Possible Redemption Notes 12 false false R13.htm 060700 - Disclosure - Shareholders' Deficit Sheet http://perceptivelife.com/role/ShareholdersDeficit Shareholders' Deficit Notes 13 false false R14.htm 060800 - Disclosure - Fair Value Measurements Sheet http://perceptivelife.com/role/FairValueMeasurements Fair Value Measurements Notes 14 false false R15.htm 060900 - Disclosure - Subsequent Events Sheet http://perceptivelife.com/role/SubsequentEvents Subsequent Events Notes 15 false false R16.htm 070200 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://perceptivelife.com/role/SummaryOfSignificantAccountingPolicies 16 false false R17.htm 080200 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://perceptivelife.com/role/SummaryOfSignificantAccountingPolicies 17 false false R18.htm 080600 - Disclosure - Class A Ordinary Shares Subject to Possible Redemption (Tables) Sheet http://perceptivelife.com/role/ClassOrdinarySharesSubjectToPossibleRedemptionTables Class A Ordinary Shares Subject to Possible Redemption (Tables) Tables http://perceptivelife.com/role/ClassOrdinarySharesSubjectToPossibleRedemption 18 false false R19.htm 080800 - Disclosure - Fair Value Measurements (Tables) Sheet http://perceptivelife.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://perceptivelife.com/role/FairValueMeasurements 19 false false R20.htm 090100 - Disclosure - Description of Organization and Business Operations, Summary (Details) Sheet http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsSummaryDetails Description of Organization and Business Operations, Summary (Details) Details http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperations 20 false false R21.htm 090102 - Disclosure - Description of Organization and Business Operations, Going Concern (Details) Sheet http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsGoingConcernDetails Description of Organization and Business Operations, Going Concern (Details) Details 21 false false R22.htm 090200 - Disclosure - Summary of Significant Accounting Policies, Cash and Cash Equivalents (Details) Sheet http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesCashAndCashEquivalentsDetails Summary of Significant Accounting Policies, Cash and Cash Equivalents (Details) Details 22 false false R23.htm 090202 - Disclosure - Summary of Significant Accounting Policies, Class A Ordinary Shares Subject to Possible Redemption (Details) Sheet http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesClassOrdinarySharesSubjectToPossibleRedemptionDetails Summary of Significant Accounting Policies, Class A Ordinary Shares Subject to Possible Redemption (Details) Details 23 false false R24.htm 090204 - Disclosure - Summary of Significant Accounting Policies, Income Taxes (Details) Sheet http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesIncomeTaxesDetails Summary of Significant Accounting Policies, Income Taxes (Details) Details 24 false false R25.htm 090206 - Disclosure - Summary of Significant Accounting Policies, Net Income (Loss) Per Ordinary Shares (Details) Sheet http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerOrdinarySharesDetails Summary of Significant Accounting Policies, Net Income (Loss) Per Ordinary Shares (Details) Details 25 false false R26.htm 090300 - Disclosure - Initial Public Offering (Details) Sheet http://perceptivelife.com/role/InitialPublicOfferingDetails Initial Public Offering (Details) Details http://perceptivelife.com/role/InitialPublicOffering 26 false false R27.htm 090400 - Disclosure - Related Party Transactions, Founder Shares (Details) Sheet http://perceptivelife.com/role/RelatedPartyTransactionsFounderSharesDetails Related Party Transactions, Founder Shares (Details) Details 27 false false R28.htm 090402 - Disclosure - Related Party Transactions, Founder Shares, Private Placement Shares (Details) Sheet http://perceptivelife.com/role/RelatedPartyTransactionsFounderSharesPrivatePlacementSharesDetails Related Party Transactions, Founder Shares, Private Placement Shares (Details) Details 28 false false R29.htm 090404 - Disclosure - Related Party Transactions, Related Party Loans and Administrative Support Agreement (Details) Sheet http://perceptivelife.com/role/RelatedPartyTransactionsRelatedPartyLoansAndAdministrativeSupportAgreementDetails Related Party Transactions, Related Party Loans and Administrative Support Agreement (Details) Details 29 false false R30.htm 090500 - Disclosure - Commitments and Contingencies, Registration Rights (Details) Sheet http://perceptivelife.com/role/CommitmentsAndContingenciesRegistrationRightsDetails Commitments and Contingencies, Registration Rights (Details) Details 30 false false R31.htm 090502 - Disclosure - Commitments and Contingencies, Underwriting Agreement (Details) Sheet http://perceptivelife.com/role/CommitmentsAndContingenciesUnderwritingAgreementDetails Commitments and Contingencies, Underwriting Agreement (Details) Details 31 false false R32.htm 090600 - Disclosure - Class A Ordinary Shares Subject to Possible Redemption (Details) Sheet http://perceptivelife.com/role/ClassOrdinarySharesSubjectToPossibleRedemptionDetails Class A Ordinary Shares Subject to Possible Redemption (Details) Details http://perceptivelife.com/role/ClassOrdinarySharesSubjectToPossibleRedemptionTables 32 false false R33.htm 090700 - Disclosure - Shareholders' Deficit (Details) Sheet http://perceptivelife.com/role/ShareholdersDeficitDetails Shareholders' Deficit (Details) Details http://perceptivelife.com/role/ShareholdersDeficit 33 false false R34.htm 090800 - Disclosure - Fair Value Measurements (Details) Sheet http://perceptivelife.com/role/FairValueMeasurementsDetails Fair Value Measurements (Details) Details http://perceptivelife.com/role/FairValueMeasurementsTables 34 false false All Reports Book All Reports [dq-0542-Deprecated-Concept] Concept DueToRelatedPartiesCurrent in us-gaap/2022 used in 4 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. brhc20052681_10q.htm 1115, 1123, 5126 [dq-0542-Deprecated-Concept] Concept NotesPayableRelatedPartiesClassifiedCurrent in us-gaap/2022 used in 2 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. brhc20052681_10q.htm 3712 [dq-0542-Deprecated-Concept] Concept NotesPayableRelatedPartiesCurrentAndNoncurrent in us-gaap/2022 used in 2 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. brhc20052681_10q.htm 4978 [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 2 fact(s) appearing in ix:hidden were eligible for transformation: arye:PeriodToCeaseOperationsIfBusinessCombinationIsNotCompletedWithinCombinationPeriod, dei:SecurityExchangeName - brhc20052681_10q.htm 11 brhc20052681_10q.htm arye-20230331.xsd arye-20230331_cal.xml arye-20230331_def.xml arye-20230331_lab.xml arye-20230331_pre.xml brhc20052681_ex31-1.htm brhc20052681_ex31-2.htm brhc20052681_ex32-1.htm brhc20052681_ex32-2.htm http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 52 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "brhc20052681_10q.htm": { "axisCustom": 0, "axisStandard": 10, "baseTaxonomies": { "http://fasb.org/us-gaap/2022": 290, "http://xbrl.sec.gov/dei/2022": 31 }, "contextCount": 106, "dts": { "calculationLink": { "local": [ "arye-20230331_cal.xml" ] }, "definitionLink": { "local": [ "arye-20230331_def.xml" ] }, "inline": { "local": [ "brhc20052681_10q.htm" ] }, "labelLink": { "local": [ "arye-20230331_lab.xml" ] }, "presentationLink": { "local": [ "arye-20230331_pre.xml" ] }, "schema": { "local": [ "arye-20230331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2004/ref-2004-08-10.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/currency/2022/currency-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/exch/2022/exch-2022.xsd", "https://xbrl.sec.gov/naics/2022/naics-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd", "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" ] } }, "elementCount": 265, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 2, "http://perceptivelife.com/20230331": 1, "http://xbrl.sec.gov/dei/2022": 6, "total": 9 }, "keyCustom": 40, "keyStandard": 121, "memberCustom": 8, "memberStandard": 16, "nsprefix": "arye", "nsuri": "http://perceptivelife.com/20230331", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230101to20230331", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000100 - Document - Document and Entity Information", "menuCat": "Cover", "order": "1", "role": "http://perceptivelife.com/role/DocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230101to20230331", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230101to20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "060400 - Disclosure - Related Party Transactions", "menuCat": "Notes", "order": "10", "role": "http://perceptivelife.com/role/RelatedPartyTransactions", "shortName": "Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230101to20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230101to20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "060500 - Disclosure - Commitments and Contingencies", "menuCat": "Notes", "order": "11", "role": "http://perceptivelife.com/role/CommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230101to20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230101to20230331", "decimals": null, "first": true, "lang": "en-US", "name": "arye:ClassAOrdinarySharesSubjectToPossibleRedemptionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "060600 - Disclosure - Class A Ordinary Shares Subject to Possible Redemption", "menuCat": "Notes", "order": "12", "role": "http://perceptivelife.com/role/ClassOrdinarySharesSubjectToPossibleRedemption", "shortName": "Class A Ordinary Shares Subject to Possible Redemption", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230101to20230331", "decimals": null, "first": true, "lang": "en-US", "name": "arye:ClassAOrdinarySharesSubjectToPossibleRedemptionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230101to20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "060700 - Disclosure - Shareholders' Deficit", "menuCat": "Notes", "order": "13", "role": "http://perceptivelife.com/role/ShareholdersDeficit", "shortName": "Shareholders' Deficit", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230101to20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230101to20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "060800 - Disclosure - Fair Value Measurements", "menuCat": "Notes", "order": "14", "role": "http://perceptivelife.com/role/FairValueMeasurements", "shortName": "Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230101to20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230101to20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "060900 - Disclosure - Subsequent Events", "menuCat": "Notes", "order": "15", "role": "http://perceptivelife.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230101to20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230101to20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "070200 - Disclosure - Summary of Significant Accounting Policies (Policies)", "menuCat": "Policies", "order": "16", "role": "http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "Summary of Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230101to20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230101to20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "080200 - Disclosure - Summary of Significant Accounting Policies (Tables)", "menuCat": "Tables", "order": "17", "role": "http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesTables", "shortName": "Summary of Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230101to20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230101to20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:TemporaryEquityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "080600 - Disclosure - Class A Ordinary Shares Subject to Possible Redemption (Tables)", "menuCat": "Tables", "order": "18", "role": "http://perceptivelife.com/role/ClassOrdinarySharesSubjectToPossibleRedemptionTables", "shortName": "Class A Ordinary Shares Subject to Possible Redemption (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230101to20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:TemporaryEquityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230101to20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "080800 - Disclosure - Fair Value Measurements (Tables)", "menuCat": "Tables", "order": "19", "role": "http://perceptivelife.com/role/FairValueMeasurementsTables", "shortName": "Fair Value Measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230101to20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230331", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "010000 - Statement - CONDENSED BALANCE SHEETS", "menuCat": "Statements", "order": "2", "role": "http://perceptivelife.com/role/CondensedBalanceSheets", "shortName": "CONDENSED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230331", "decimals": "0", "lang": null, "name": "us-gaap:PrepaidExpenseCurrent", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20210715", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DeferredOfferingCosts", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090100 - Disclosure - Description of Organization and Business Operations, Summary (Details)", "menuCat": "Details", "order": "20", "role": "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsSummaryDetails", "shortName": "Description of Organization and Business Operations, Summary (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20210715to20210715", "decimals": "-5", "lang": null, "name": "us-gaap:PaymentsToAcquireMarketableSecurities", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230331", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090102 - Disclosure - Description of Organization and Business Operations, Going Concern (Details)", "menuCat": "Details", "order": "21", "role": "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsGoingConcernDetails", "shortName": "Description of Organization and Business Operations, Going Concern (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230331", "decimals": "-5", "lang": null, "name": "arye:WorkingCapital", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "us-gaap:CashEquivalentsAtCarryingValue", "div", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230331", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090200 - Disclosure - Summary of Significant Accounting Policies, Cash and Cash Equivalents (Details)", "menuCat": "Details", "order": "22", "role": "http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesCashAndCashEquivalentsDetails", "shortName": "Summary of Significant Accounting Policies, Cash and Cash Equivalents (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:CashEquivalentsAtCarryingValue", "div", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230331", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "us-gaap:TemporaryEquitySharesOutstanding", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230331_StatementClassOfStockAxis_CommonClassAMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:TemporaryEquitySharesOutstanding", "reportCount": 1, "unitRef": "U001", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090202 - Disclosure - Summary of Significant Accounting Policies, Class A Ordinary Shares Subject to Possible Redemption (Details)", "menuCat": "Details", "order": "23", "role": "http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesClassOrdinarySharesSubjectToPossibleRedemptionDetails", "shortName": "Summary of Significant Accounting Policies, Class A Ordinary Shares Subject to Possible Redemption (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R24": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230331", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:UnrecognizedTaxBenefits", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090204 - Disclosure - Summary of Significant Accounting Policies, Income Taxes (Details)", "menuCat": "Details", "order": "24", "role": "http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesIncomeTaxesDetails", "shortName": "Summary of Significant Accounting Policies, Income Taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230331", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:UnrecognizedTaxBenefits", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230101to20230331_StatementClassOfStockAxis_CommonClassAMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:UndistributedEarnings", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090206 - Disclosure - Summary of Significant Accounting Policies, Net Income (Loss) Per Ordinary Shares (Details)", "menuCat": "Details", "order": "25", "role": "http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerOrdinarySharesDetails", "shortName": "Summary of Significant Accounting Policies, Net Income (Loss) Per Ordinary Shares (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "ix:continuation", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230101to20230331_StatementClassOfStockAxis_CommonClassAMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:UndistributedEarnings", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20210715", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DeferredOfferingCosts", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090300 - Disclosure - Initial Public Offering (Details)", "menuCat": "Details", "order": "26", "role": "http://perceptivelife.com/role/InitialPublicOfferingDetails", "shortName": "Initial Public Offering (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R27": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230331", "decimals": "2", "first": true, "lang": null, "name": "arye:PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOffering", "reportCount": 1, "unitRef": "U004", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090400 - Disclosure - Related Party Transactions, Founder Shares (Details)", "menuCat": "Details", "order": "27", "role": "http://perceptivelife.com/role/RelatedPartyTransactionsFounderSharesDetails", "shortName": "Related Party Transactions, Founder Shares (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20210715to20210715_ClassOfWarrantOrRightAxis_PublicSharesMember_SubsidiarySaleOfStockAxis_OverAllotmentOptionMember", "decimals": "0", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesIssuedForServices", "reportCount": 1, "unique": true, "unitRef": "U001", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20210715to20210715_ClassOfWarrantOrRightAxis_PrivatePlacementSharesMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues", "reportCount": 1, "unitRef": "U001", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090402 - Disclosure - Related Party Transactions, Founder Shares, Private Placement Shares (Details)", "menuCat": "Details", "order": "28", "role": "http://perceptivelife.com/role/RelatedPartyTransactionsFounderSharesPrivatePlacementSharesDetails", "shortName": "Related Party Transactions, Founder Shares, Private Placement Shares (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230101to20230331_ClassOfWarrantOrRightAxis_PrivatePlacementSharesMember", "decimals": null, "lang": "en-US", "name": "arye:PrivatePlacementSharesHoldingPeriod", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230101to20230331", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RepaymentsOfRelatedPartyDebt", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090404 - Disclosure - Related Party Transactions, Related Party Loans and Administrative Support Agreement (Details)", "menuCat": "Details", "order": "29", "role": "http://perceptivelife.com/role/RelatedPartyTransactionsRelatedPartyLoansAndAdministrativeSupportAgreementDetails", "shortName": "Related Party Transactions, Related Party Loans and Administrative Support Agreement (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230101to20230331", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RepaymentsOfRelatedPartyDebt", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230331", "decimals": "4", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "U003", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "010100 - Statement - CONDENSED BALANCE SHEETS (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://perceptivelife.com/role/CondensedBalanceSheetsParenthetical", "shortName": "CONDENSED BALANCE SHEETS (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "us-gaap:PreferredStockParOrStatedValuePerShare", "span", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230331", "decimals": "4", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "U003", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20210715", "decimals": "INF", "first": true, "lang": null, "name": "arye:NumberOfDemandsEligibleSecurityHolderCanMake", "reportCount": 1, "unique": true, "unitRef": "U006", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090500 - Disclosure - Commitments and Contingencies, Registration Rights (Details)", "menuCat": "Details", "order": "30", "role": "http://perceptivelife.com/role/CommitmentsAndContingenciesRegistrationRightsDetails", "shortName": "Commitments and Contingencies, Registration Rights (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20210715", "decimals": "INF", "first": true, "lang": null, "name": "arye:NumberOfDemandsEligibleSecurityHolderCanMake", "reportCount": 1, "unique": true, "unitRef": "U006", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20210715to20210715", "decimals": null, "first": true, "lang": "en-US", "name": "arye:OptionForUnderwritersToPurchaseAdditionalUnitsTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090502 - Disclosure - Commitments and Contingencies, Underwriting Agreement (Details)", "menuCat": "Details", "order": "31", "role": "http://perceptivelife.com/role/CommitmentsAndContingenciesUnderwritingAgreementDetails", "shortName": "Commitments and Contingencies, Underwriting Agreement (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "ix:continuation", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20210715to20210715", "decimals": null, "first": true, "lang": "en-US", "name": "arye:OptionForUnderwritersToPurchaseAdditionalUnitsTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20210715", "decimals": "-5", "first": true, "lang": null, "name": "us-gaap:DeferredOfferingCosts", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090600 - Disclosure - Class A Ordinary Shares Subject to Possible Redemption (Details)", "menuCat": "Details", "order": "32", "role": "http://perceptivelife.com/role/ClassOrdinarySharesSubjectToPossibleRedemptionDetails", "shortName": "Class A Ordinary Shares Subject to Possible Redemption (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230331_StatementClassOfStockAxis_CommonClassAMember_SubsidiarySaleOfStockAxis_IPOMember", "decimals": "0", "lang": null, "name": "us-gaap:TemporaryEquitySharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "U001", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "us-gaap:PreferredStockSharesAuthorized", "span", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230331", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unitRef": "U001", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090700 - Disclosure - Shareholders' Deficit (Details)", "menuCat": "Details", "order": "33", "role": "http://perceptivelife.com/role/ShareholdersDeficitDetails", "shortName": "Shareholders' Deficit (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230101to20230331", "decimals": "INF", "lang": null, "name": "arye:CommonStockVotingRightsNumberOfVotes", "reportCount": 1, "unique": true, "unitRef": "U007", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3", "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3", "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3", "span", "span", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230101to20230331", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "090800 - Disclosure - Fair Value Measurements (Details)", "menuCat": "Details", "order": "34", "role": "http://perceptivelife.com/role/FairValueMeasurementsDetails", "shortName": "Fair Value Measurements (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3", "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3", "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3", "span", "span", "div", "ix:continuation", "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230101to20230331", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230101to20230331", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:GeneralAndAdministrativeExpense", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "020000 - Statement - UNAUDITED CONDENSED STATEMENTS OF OPERATIONS", "menuCat": "Statements", "order": "4", "role": "http://perceptivelife.com/role/UnauditedCondensedStatementsOfOperations", "shortName": "UNAUDITED CONDENSED STATEMENTS OF OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230101to20230331", "decimals": "0", "lang": null, "name": "us-gaap:OperatingIncomeLoss", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "030000 - Statement - UNAUDITED CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT", "menuCat": "Statements", "order": "5", "role": "http://perceptivelife.com/role/UnauditedCondensedStatementsOfChangesInShareholdersDeficit", "shortName": "UNAUDITED CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20211231_StatementClassOfStockAxis_CommonClassAMember_StatementEquityComponentsAxis_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230101to20230331", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "U002", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "040000 - Statement - UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS", "menuCat": "Statements", "order": "6", "role": "http://perceptivelife.com/role/UnauditedCondensedStatementsOfCashFlows", "shortName": "UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230101to20230331", "decimals": "0", "lang": null, "name": "us-gaap:IncreaseDecreaseInPrepaidExpensesOther", "reportCount": 1, "unique": true, "unitRef": "U002", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230101to20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "060100 - Disclosure - Description of Organization and Business Operations", "menuCat": "Notes", "order": "7", "role": "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperations", "shortName": "Description of Organization and Business Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230101to20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230101to20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "060200 - Disclosure - Summary of Significant Accounting Policies", "menuCat": "Notes", "order": "8", "role": "http://perceptivelife.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230101to20230331", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230101to20230331", "decimals": null, "first": true, "lang": "en-US", "name": "arye:InitialPublicOfferingTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "060300 - Disclosure - Initial Public Offering", "menuCat": "Notes", "order": "9", "role": "http://perceptivelife.com/role/InitialPublicOffering", "shortName": "Initial Public Offering", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "brhc20052681_10q.htm", "contextRef": "c20230101to20230331", "decimals": null, "first": true, "lang": "en-US", "name": "arye:InitialPublicOfferingTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 24, "tag": { "arye_AdditionalUnitsThatCanBePurchasedToCoverOverAllotments": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of additional shares that can be purchased by the underwriters to cover over-allotments.", "label": "Additional Units That Can be Purchased to Cover Over Allotments", "terseLabel": "Additional shares that can be purchased to cover over-allotments (in shares)" } } }, "localname": "AdditionalUnitsThatCanBePurchasedToCoverOverAllotments", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/CommitmentsAndContingenciesUnderwritingAgreementDetails" ], "xbrltype": "sharesItemType" }, "arye_AdministrativeSupportAgreementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Administrative Support Agreement [Abstract]", "terseLabel": "Administrative Support Agreement [Abstract]" } } }, "localname": "AdministrativeSupportAgreementAbstract", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/RelatedPartyTransactionsRelatedPartyLoansAndAdministrativeSupportAgreementDetails" ], "xbrltype": "stringItemType" }, "arye_AdministrativeSupportAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "An agreement whereby, on the effective date of the registration statement on Form S-1 related to the Initial Public Offering through the earlier of consummation of the initial Business Combination and the Company's liquidation, the Company will pay a monthly fee for office space, utilities and secretarial and administrative support.", "label": "Administrative Support Agreement [Member]" } } }, "localname": "AdministrativeSupportAgreementMember", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/RelatedPartyTransactionsRelatedPartyLoansAndAdministrativeSupportAgreementDetails" ], "xbrltype": "domainItemType" }, "arye_AdvanceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Advance made to the Company.", "label": "Advance [Member]" } } }, "localname": "AdvanceMember", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/RelatedPartyTransactionsRelatedPartyLoansAndAdministrativeSupportAgreementDetails" ], "xbrltype": "domainItemType" }, "arye_CashDepositedInTrustAccountPerUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per-share amount of net proceeds deposited in the Trust Account upon closing of the Initial Public Offerings and Private Placement.", "label": "Cash Deposited in Trust Account Per Unit", "terseLabel": "Unit price, Initial Public Offering and Private Placement (in dollars per unit)" } } }, "localname": "CashDepositedInTrustAccountPerUnit", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsSummaryDetails" ], "xbrltype": "perShareItemType" }, "arye_ClassAOrdinarySharesSubjectToPossibleRedemptionTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for Class A ordinary shares subject to possible redemption reflected on the condensed balance sheet.", "label": "Class A Ordinary Shares Subject to Possible Redemption [Text Block]", "terseLabel": "Class A Ordinary Shares Subject to Possible Redemption" } } }, "localname": "ClassAOrdinarySharesSubjectToPossibleRedemptionTextBlock", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/ClassOrdinarySharesSubjectToPossibleRedemption" ], "xbrltype": "textBlockItemType" }, "arye_CommonStockPermanentAndTemporaryEquitySharesIssued": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of permanent and temporary equity common stock issued. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Permanent and Temporary Equity, Shares Issued", "terseLabel": "Ordinary shares, shares issued (in shares)" } } }, "localname": "CommonStockPermanentAndTemporaryEquitySharesIssued", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/ShareholdersDeficitDetails" ], "xbrltype": "sharesItemType" }, "arye_CommonStockPermanentAndTemporaryEquitySharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of permanent and temporary equity common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Permanent and Temporary Equity, Shares Outstanding", "terseLabel": "Ordinary shares, shares outstanding (in shares)" } } }, "localname": "CommonStockPermanentAndTemporaryEquitySharesOutstanding", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/ShareholdersDeficitDetails" ], "xbrltype": "sharesItemType" }, "arye_CommonStockSharesSubjectToForfeiture": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of common stock shares subject to forfeiture in the event of the over-allotment option was not exercised by the underwriters.", "label": "Common Stock, Shares, Subject to Forfeiture", "terseLabel": "Shares subject to forfeiture (in shares)" } } }, "localname": "CommonStockSharesSubjectToForfeiture", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/RelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "sharesItemType" }, "arye_CommonStockSubjectToPossibleRedemptionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock Subject To Possible Redemption [Abstract]" } } }, "localname": "CommonStockSubjectToPossibleRedemptionAbstract", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/ClassOrdinarySharesSubjectToPossibleRedemptionDetails" ], "xbrltype": "stringItemType" }, "arye_CommonStockVotingRightsNumberOfVotes": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of votes each eligible share holder is entitled to for each common share held.", "label": "Common Stock, Voting Rights, Number of Votes", "terseLabel": "Voting rights per share" } } }, "localname": "CommonStockVotingRightsNumberOfVotes", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/ShareholdersDeficitDetails" ], "xbrltype": "integerItemType" }, "arye_DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of deferred offering costs paid by sponsor in exchange for ordinary shares in noncash financing activities.", "label": "Deferred Offering Costs Paid by Sponsor in Exchange for Issuance of Ordinary Shares", "verboseLabel": "Offering costs paid by sponsor in exchange for issuance of founder shares" } } }, "localname": "DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsGoingConcernDetails" ], "xbrltype": "monetaryItemType" }, "arye_DeferredUnderwritingCommissions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of outstanding underwriting commissions payable initially due after one year or beyond the operating cycle if longer, excluding current portion.", "label": "Deferred Underwriting Commissions", "terseLabel": "Deferred underwriting commissions" } } }, "localname": "DeferredUnderwritingCommissions", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/CommitmentsAndContingenciesUnderwritingAgreementDetails", "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsSummaryDetails", "http://perceptivelife.com/role/InitialPublicOfferingDetails" ], "xbrltype": "monetaryItemType" }, "arye_DeferredUnderwritingCommissionsNonCurrent": { "auth_ref": [], "calculation": { "http://perceptivelife.com/role/CondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of outstanding underwriting commissions initially due after one year or beyond the operating cycle if longer, excluding current portion.", "label": "Deferred Underwriting Commissions Non Current", "terseLabel": "Deferred underwriting commissions" } } }, "localname": "DeferredUnderwritingCommissionsNonCurrent", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "arye_DeferredUnderwritingCommissionsPerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Deferred underwriting commissions per share payable to underwriters if the Company completes a Business Combination, subject to terms of the underwriting agreement.", "label": "Deferred Underwriting Commissions Per Share", "terseLabel": "Deferred underwriting commissions (in dollars per share)" } } }, "localname": "DeferredUnderwritingCommissionsPerShare", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/CommitmentsAndContingenciesUnderwritingAgreementDetails" ], "xbrltype": "perShareItemType" }, "arye_ExtinguishmentOfDeferredUnderwritingCommissions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of gain from the extinguishment of deferred underwriting commissions.", "label": "Extinguishment of deferred underwriting commissions", "terseLabel": "Waiver of deferred underwriting commission" } } }, "localname": "ExtinguishmentOfDeferredUnderwritingCommissions", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/ClassOrdinarySharesSubjectToPossibleRedemptionDetails" ], "xbrltype": "monetaryItemType" }, "arye_FairMarketValueAsPercentageOfNetAssetsHeldInTrustAccountIncludedInInitialBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fair market value as a percentage of the net assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on the income earned on the Trust Account) at the time of the agreement to enter into the initial Business Combination.", "label": "Fair Market Value as Percentage of Net Assets Held in Trust Account Included in Initial Business Combination", "terseLabel": "Fair market value as percentage of net assets held in Trust Account included in initial Business Combination" } } }, "localname": "FairMarketValueAsPercentageOfNetAssetsHeldInTrustAccountIncludedInInitialBusinessCombination", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsSummaryDetails" ], "xbrltype": "percentItemType" }, "arye_FounderSharesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Founder Shares [Abstract]", "terseLabel": "Founder Shares [Abstract]" } } }, "localname": "FounderSharesAbstract", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/RelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "stringItemType" }, "arye_GainLossFromSettlementOfDeferredUnderwritingCommissions": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of gain (loss) from settlement of deferred underwriting commissions.", "label": "Gain (Loss) from Settlement of Deferred Underwriting Commissions", "terseLabel": "Gain from settlement of deferred underwriting commissions" } } }, "localname": "GainLossFromSettlementOfDeferredUnderwritingCommissions", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/CommitmentsAndContingenciesUnderwritingAgreementDetails" ], "xbrltype": "monetaryItemType" }, "arye_GoingConcernAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Going Concern [Abstract]", "verboseLabel": "Going Concern [Abstract]" } } }, "localname": "GoingConcernAbstract", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsGoingConcernDetails" ], "xbrltype": "stringItemType" }, "arye_IndependentDirectorNomineesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Independent directors nominated for serving the entity.", "label": "Independent Director Nominees [Member]", "terseLabel": "Independent Director Nominees [Member]" } } }, "localname": "IndependentDirectorNomineesMember", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/RelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "domainItemType" }, "arye_InitialPublicOfferingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Initial Public Offering [Abstract]" } } }, "localname": "InitialPublicOfferingAbstract", "nsuri": "http://perceptivelife.com/20230331", "xbrltype": "stringItemType" }, "arye_InitialPublicOfferingOfUnitsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Initial Public Offering of Units [Abstract]", "terseLabel": "Initial Public Offering [Abstract]" } } }, "localname": "InitialPublicOfferingOfUnitsAbstract", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/InitialPublicOfferingDetails" ], "xbrltype": "stringItemType" }, "arye_InitialPublicOfferingTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the initial public offering of the Company's common stock.", "label": "Initial Public Offering [Text Block]", "terseLabel": "Initial Public Offering" } } }, "localname": "InitialPublicOfferingTextBlock", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/InitialPublicOffering" ], "xbrltype": "textBlockItemType" }, "arye_InterestOnTrustAccountToBeHeldToPayDissolutionExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Interest received on the Trust Account that can be used to pay dissolution expenses if a Business Combination is not completed with the Combination Period.", "label": "Interest on Trust Account to be held to pay dissolution expenses", "terseLabel": "Interest from Trust Account that can be held to pay dissolution expenses" } } }, "localname": "InterestOnTrustAccountToBeHeldToPayDissolutionExpenses", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsSummaryDetails" ], "xbrltype": "monetaryItemType" }, "arye_NetTangibleAssetThresholdForRedeemingPublicShares": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Net tangible asset threshold for redeeming Public Shares.", "label": "Net Tangible Asset Threshold for Redeeming Public Shares", "terseLabel": "Net tangible asset threshold for redeeming Public Shares" } } }, "localname": "NetTangibleAssetThresholdForRedeemingPublicShares", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsSummaryDetails" ], "xbrltype": "monetaryItemType" }, "arye_NumberOfDemandsEligibleSecurityHolderCanMake": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Represents the number of demands eligible security holder can make.", "label": "Number Of Demands Eligible Security Holder Can Make", "terseLabel": "Number of demands eligible security holder can make" } } }, "localname": "NumberOfDemandsEligibleSecurityHolderCanMake", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/CommitmentsAndContingenciesRegistrationRightsDetails" ], "xbrltype": "integerItemType" }, "arye_NumberOfOperatingBusinessesIncludedInInitialBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of operating businesses that must be included in initial Business Combination.", "label": "Number of Operating Businesses Included in Initial Business Combination", "terseLabel": "Number of operating businesses included in initial Business Combination" } } }, "localname": "NumberOfOperatingBusinessesIncludedInInitialBusinessCombination", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsSummaryDetails" ], "xbrltype": "integerItemType" }, "arye_NumberOfTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of trading days for common stock price to exceed threshold, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Number of Trading Days", "terseLabel": "Number of trading days" } } }, "localname": "NumberOfTradingDays", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/RelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "durationItemType" }, "arye_OptionForUnderwritersToPurchaseAdditionalUnitsTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time from the date of the final prospectus relating to the Initial Public Offering for underwriters to purchase additional Units to cover over-allotments, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Option for Underwriters to Purchase Additional Units Term", "terseLabel": "Term of option for underwriters to purchase additional Units to cover over-allotments" } } }, "localname": "OptionForUnderwritersToPurchaseAdditionalUnitsTerm", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/CommitmentsAndContingenciesUnderwritingAgreementDetails" ], "xbrltype": "durationItemType" }, "arye_OrganizationAndBusinessOperationsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Organization and Business Operations [Line Items]" } } }, "localname": "OrganizationAndBusinessOperationsLineItems", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsGoingConcernDetails", "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsSummaryDetails" ], "xbrltype": "stringItemType" }, "arye_OrganizationAndBusinessOperationsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the Company's organization and business operations.", "label": "Organization and Business Operations [Table]" } } }, "localname": "OrganizationAndBusinessOperationsTable", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsGoingConcernDetails", "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsSummaryDetails" ], "xbrltype": "stringItemType" }, "arye_PercentageOfDeferredUnderwritingCommissionsPayableIncludedInInitialBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of deferred underwriting commissions payable at the time of the agreement to enter into the initial Business Combination.", "label": "Percentage of Deferred Underwriting Commissions Payable Included in Initial Business Combination", "terseLabel": "Percentage of deferred underwriting commissions payable included in initial business combination" } } }, "localname": "PercentageOfDeferredUnderwritingCommissionsPayableIncludedInInitialBusinessCombination", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/CommitmentsAndContingenciesUnderwritingAgreementDetails", "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsSummaryDetails", "http://perceptivelife.com/role/InitialPublicOfferingDetails" ], "xbrltype": "percentItemType" }, "arye_PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOffering": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Founder shares as a percentage of the Company's issued and outstanding shares after the Initial Public Offering.", "label": "Percentage of Issued and Outstanding Shares After Initial Public Offering", "terseLabel": "Founder shares as a percentage of issued and outstanding shares after initial public offering" } } }, "localname": "PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOffering", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/RelatedPartyTransactionsFounderSharesDetails", "http://perceptivelife.com/role/ShareholdersDeficitDetails" ], "xbrltype": "percentItemType" }, "arye_PercentageOfPublicSharesThatCanBeRedeemedWithoutPriorConsent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of Public Shares that can be redeemed without the prior consent of the Company.", "label": "Percentage of Public Shares That can be Redeemed Without Prior Consent", "terseLabel": "Percentage of Public Shares that can be redeemed without prior consent" } } }, "localname": "PercentageOfPublicSharesThatCanBeRedeemedWithoutPriorConsent", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsSummaryDetails" ], "xbrltype": "percentItemType" }, "arye_PercentageOfPublicSharesThatWouldNotBeRedeemedIfBusinessCombinationIsNotCompletedWithinInitialCombinationPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of Public Shares that would not be redeemed if a Business Combination is not completed within the Initial Combination Period.", "label": "Percentage of Public Shares That Would not be Redeemed if Business Combination is not Completed Within Initial Combination Period", "terseLabel": "Percentage of Public Shares that would not be redeemed if Business Combination is not completed within Initial Combination Period" } } }, "localname": "PercentageOfPublicSharesThatWouldNotBeRedeemedIfBusinessCombinationIsNotCompletedWithinInitialCombinationPeriod", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsSummaryDetails" ], "xbrltype": "percentItemType" }, "arye_PeriodOfRestrictionForFounderSharesForInitialShareholders": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The period of time after the completion of initial business combination that initial shareholders are not permitted to transfer, assign or sell any of their held Founder Shares, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Period of Restriction for Founder Shares for Initial Shareholders", "terseLabel": "Period to not transfer, assign or sell Founder Shares" } } }, "localname": "PeriodOfRestrictionForFounderSharesForInitialShareholders", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/RelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "durationItemType" }, "arye_PeriodToCeaseOperationsIfBusinessCombinationIsNotCompletedWithinCombinationPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time to cease operations if a Business Combination is not completed within Combination Period in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Period to Cease Operations if Business Combination is not Completed within Combination Period", "terseLabel": "Period to cease operations if Business Combination is not completed within Combination Period" } } }, "localname": "PeriodToCeaseOperationsIfBusinessCombinationIsNotCompletedWithinCombinationPeriod", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsSummaryDetails" ], "xbrltype": "durationItemType" }, "arye_PeriodToRedeemPublicSharesIfBusinessCombinationIsNotCompletedWithinInitialCombinationPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time to redeem Public Shares if Business Combination is not completed within the Initial Combination Period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Period to Redeem Public Shares if Business Combination is not Completed Within Initial Combination Period", "terseLabel": "Period to redeem Public Shares if Business Combination is not completed within Initial Combination Period" } } }, "localname": "PeriodToRedeemPublicSharesIfBusinessCombinationIsNotCompletedWithinInitialCombinationPeriod", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsSummaryDetails" ], "xbrltype": "durationItemType" }, "arye_PostTransactionOwnershipPercentageOfTheTargetBusiness": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Post-transaction ownership percentage of the outstanding voting securities of the target business sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940.", "label": "Post Transaction Ownership Percentage of The Target Business", "terseLabel": "Post-transaction ownership percentage of the target business" } } }, "localname": "PostTransactionOwnershipPercentageOfTheTargetBusiness", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsSummaryDetails" ], "xbrltype": "percentItemType" }, "arye_PrivatePlacementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Private Placement [Abstract]" } } }, "localname": "PrivatePlacementAbstract", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/RelatedPartyTransactionsFounderSharesPrivatePlacementSharesDetails" ], "xbrltype": "stringItemType" }, "arye_PrivatePlacementSharesHoldingPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time after the completion of the initial Business Combination in which the Sponsor and the Company's officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Shares, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Private Placement Shares Holding Period", "terseLabel": "Number of days shares are transferrable after completion of initial business combination" } } }, "localname": "PrivatePlacementSharesHoldingPeriod", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/RelatedPartyTransactionsFounderSharesPrivatePlacementSharesDetails" ], "xbrltype": "durationItemType" }, "arye_PrivatePlacementSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Securities sold in a private placement that consist of Class A common stock.", "label": "Private Placement Shares [Member]", "terseLabel": "Private Placement Shares [Member]" } } }, "localname": "PrivatePlacementSharesMember", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsGoingConcernDetails", "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsSummaryDetails", "http://perceptivelife.com/role/RelatedPartyTransactionsFounderSharesPrivatePlacementSharesDetails" ], "xbrltype": "domainItemType" }, "arye_ProceedsFromIssuanceOfPrivatePlacementHeldOutsideOfTrustAccount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement that was not deposited in the Trust Account.", "label": "Proceeds from Issuance of Private Placement, Held Outside of Trust Account", "terseLabel": "Proceeds from private placement not held in Trust Account" } } }, "localname": "ProceedsFromIssuanceOfPrivatePlacementHeldOutsideOfTrustAccount", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsGoingConcernDetails" ], "xbrltype": "monetaryItemType" }, "arye_PromissoryNoteToCoverExpensesRelatedToInitialPublicOfferingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Loan of up to $300,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (Note). The Note was non-interest bearing and payable on the earlier of June 30, 2018 or the completion of the Initial Public Offering.", "label": "Promissory Note to Cover Expenses Related to Initial Public Offering [Member]", "terseLabel": "Promissory Note [Member]" } } }, "localname": "PromissoryNoteToCoverExpensesRelatedToInitialPublicOfferingMember", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsGoingConcernDetails", "http://perceptivelife.com/role/RelatedPartyTransactionsRelatedPartyLoansAndAdministrativeSupportAgreementDetails" ], "xbrltype": "domainItemType" }, "arye_PublicSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Securities sold in a public offering that consist of Class A common stock.", "label": "Public Shares [Member]", "terseLabel": "Public Shares [Member]" } } }, "localname": "PublicSharesMember", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsSummaryDetails", "http://perceptivelife.com/role/InitialPublicOfferingDetails", "http://perceptivelife.com/role/RelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "domainItemType" }, "arye_RedeemableOrdinarySharesAccretionToRedemptionValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of accretion of redeemable ordinary shares to their redemption value during the period.", "label": "Redeemable Ordinary Shares Accretion To Redemption Value", "terseLabel": "Accretion on Class A ordinary shares subject to possible redemption amount", "verboseLabel": "Increase in redemption value of Class A ordinary shares subject to possible redemption" } } }, "localname": "RedeemableOrdinarySharesAccretionToRedemptionValue", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/ClassOrdinarySharesSubjectToPossibleRedemptionDetails", "http://perceptivelife.com/role/UnauditedCondensedStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "monetaryItemType" }, "arye_RegistrationRightsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Registration Rights [Abstract]", "terseLabel": "Registration Rights [Abstract]" } } }, "localname": "RegistrationRightsAbstract", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/CommitmentsAndContingenciesRegistrationRightsDetails" ], "xbrltype": "stringItemType" }, "arye_RelatedPartyTransactionPeriodicPaymentAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of the periodic payment due to related party during the financial reporting period.", "label": "Related Party Transaction, Periodic Payment Amount", "terseLabel": "Monthly fee" } } }, "localname": "RelatedPartyTransactionPeriodicPaymentAmount", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/RelatedPartyTransactionsRelatedPartyLoansAndAdministrativeSupportAgreementDetails" ], "xbrltype": "monetaryItemType" }, "arye_SharesSubjectToPossibleRedemptionPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for shares subject to possible redemption.", "label": "Shares Subject to Possible Redemption [Policy Text Block]", "terseLabel": "Class A Ordinary Shares Subject to Possible Redemption" } } }, "localname": "SharesSubjectToPossibleRedemptionPolicyTextBlock", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "arye_SponsorAffiliateOfSponsorOrCertainCompanyOfficersAndDirectorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ARYA Sciences Holdings II (Sponsor), an affiliate of the Sponsor, or certain of the Company's officers and directors.", "label": "Sponsor Affiliate of Sponsor or Certain Company Officers and Directors [Member]", "terseLabel": "Sponsor Affiliate of Sponsor or Certain Company Officers and Directors [Member]" } } }, "localname": "SponsorAffiliateOfSponsorOrCertainCompanyOfficersAndDirectorsMember", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/RelatedPartyTransactionsRelatedPartyLoansAndAdministrativeSupportAgreementDetails" ], "xbrltype": "domainItemType" }, "arye_StockConversionRatio": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ratio applied to the conversion of stock, for example but not limited to, one share converted to two or two shares converted to one.", "label": "Stock Conversion Ratio", "terseLabel": "Stock conversion basis at time of business combination" } } }, "localname": "StockConversionRatio", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/ShareholdersDeficitDetails" ], "xbrltype": "pureItemType" }, "arye_ThresholdPeriodAfterInitialBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold period after the initial Business Combination for the common stock price to exceed the threshold price per share, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Threshold Period after Initial Business Combination", "terseLabel": "Threshold period after initial Business Combination" } } }, "localname": "ThresholdPeriodAfterInitialBusinessCombination", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/RelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "durationItemType" }, "arye_TradingDaysThreshold": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold period of specified trading days that common stock price exceeds threshold price per share, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Trading Days Threshold", "terseLabel": "Trading day threshold period" } } }, "localname": "TradingDaysThreshold", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/RelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "durationItemType" }, "arye_UnderwritingAgreementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Underwriting Agreement [Abstract]", "terseLabel": "Underwriting Agreement [Abstract]" } } }, "localname": "UnderwritingAgreementAbstract", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/CommitmentsAndContingenciesUnderwritingAgreementDetails" ], "xbrltype": "stringItemType" }, "arye_UnderwritingDiscount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate underwriting discount fee paid to the underwriters upon the closing of the Initial Public Offering.", "label": "Underwriting Discount", "terseLabel": "Underwriting discount" } } }, "localname": "UnderwritingDiscount", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/CommitmentsAndContingenciesUnderwritingAgreementDetails" ], "xbrltype": "monetaryItemType" }, "arye_UnderwritingDiscountFee": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Underwriting discount fee per unit paid to underwriters.", "label": "Underwriting Discount Fee", "terseLabel": "Underwriting discount (in dollars per share)" } } }, "localname": "UnderwritingDiscountFee", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/CommitmentsAndContingenciesUnderwritingAgreementDetails" ], "xbrltype": "perShareItemType" }, "arye_WorkingCapital": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of difference between current assets and liabilities.", "label": "Working Capital", "terseLabel": "Working capital" } } }, "localname": "WorkingCapital", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsGoingConcernDetails" ], "xbrltype": "monetaryItemType" }, "arye_WorkingCapitalLoansMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Working capital loans to finance transaction costs in connection with a Business Combination.", "label": "Working Capital Loans [Member]" } } }, "localname": "WorkingCapitalLoansMember", "nsuri": "http://perceptivelife.com/20230331", "presentation": [ "http://perceptivelife.com/role/RelatedPartyTransactionsRelatedPartyLoansAndAdministrativeSupportAgreementDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r291" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r292" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r289" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r289" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r294" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r289" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r293" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityListingsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Listings [Line Items]" } } }, "localname": "EntityListingsLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_EntityListingsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container for exchange listing information for an entity", "label": "Entity Listings [Table]" } } }, "localname": "EntityListingsTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r289" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r289" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r289" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r289" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r288" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r290" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://perceptivelife.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "srt_MaximumMember": { "auth_ref": [ "r150", "r151", "r152", "r153", "r192", "r246", "r262", "r271", "r272", "r281", "r285", "r287", "r313", "r323", "r324", "r325", "r326", "r327", "r328" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsSummaryDetails", "http://perceptivelife.com/role/FairValueMeasurementsDetails", "http://perceptivelife.com/role/RelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r150", "r151", "r152", "r153", "r192", "r246", "r262", "r271", "r272", "r281", "r285", "r287", "r313", "r323", "r324", "r325", "r326", "r327", "r328" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsSummaryDetails", "http://perceptivelife.com/role/RelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r150", "r151", "r152", "r153", "r184", "r192", "r193", "r194", "r195", "r245", "r246", "r262", "r271", "r272", "r281", "r285", "r287", "r309", "r313", "r324", "r325", "r326", "r327", "r328" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsSummaryDetails", "http://perceptivelife.com/role/FairValueMeasurementsDetails", "http://perceptivelife.com/role/RelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r150", "r151", "r152", "r153", "r184", "r192", "r193", "r194", "r195", "r245", "r246", "r262", "r271", "r272", "r281", "r285", "r287", "r309", "r313", "r324", "r325", "r326", "r327", "r328" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsSummaryDetails", "http://perceptivelife.com/role/FairValueMeasurementsDetails", "http://perceptivelife.com/role/RelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r11", "r286" ], "calculation": { "http://perceptivelife.com/role/CondensedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r13" ], "calculation": { "http://perceptivelife.com/role/CondensedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "verboseLabel": "Accrued expenses" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r5", "r286" ], "calculation": { "http://perceptivelife.com/role/CondensedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r196", "r197", "r198", "r302", "r303", "r304", "r315" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/UnauditedCondensedStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net income (loss) to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_Assets": { "auth_ref": [ "r73", "r78", "r90", "r104", "r137", "r139", "r141", "r144", "r154", "r155", "r157", "r158", "r159", "r160", "r161", "r163", "r164", "r210", "r212", "r226", "r286", "r311", "r312", "r321" ], "calculation": { "http://perceptivelife.com/role/CondensedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/CondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r87", "r95", "r104", "r144", "r154", "r155", "r157", "r158", "r159", "r160", "r161", "r163", "r164", "r210", "r212", "r226", "r286", "r311", "r312", "r321" ], "calculation": { "http://perceptivelife.com/role/CondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/CondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsHeldInTrustNoncurrent": { "auth_ref": [ "r298" ], "calculation": { "http://perceptivelife.com/role/CondensedBalanceSheets": { "order": 0.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.", "label": "Investments held in Trust Account" } } }, "localname": "AssetsHeldInTrustNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r34" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.", "label": "Summary of Significant Accounting Policies" } } }, "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Cash": { "auth_ref": [ "r268", "r269", "r286", "r297" ], "calculation": { "http://perceptivelife.com/role/CondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash at bank", "terseLabel": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/CondensedBalanceSheets", "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsGoingConcernDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents [Abstract]" } } }, "localname": "CashAndCashEquivalentsAtCarryingValueAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesCashAndCashEquivalentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r29" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r24", "r28", "r33" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Cash - end of the period", "periodStartLabel": "Cash - beginning of the period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r24", "r69" ], "calculation": { "http://perceptivelife.com/role/UnauditedCondensedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "totalLabel": "Net change in cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashEquivalentsAtCarryingValue": { "auth_ref": [ "r297" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash Equivalents, at Carrying Value", "terseLabel": "Cash equivalents" } } }, "localname": "CashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesCashAndCashEquivalentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r91", "r92", "r93", "r104", "r120", "r121", "r124", "r127", "r130", "r131", "r144", "r154", "r157", "r158", "r159", "r163", "r164", "r167", "r168", "r171", "r175", "r182", "r226", "r273", "r296", "r299", "r305" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/ClassOrdinarySharesSubjectToPossibleRedemptionDetails", "http://perceptivelife.com/role/CondensedBalanceSheets", "http://perceptivelife.com/role/CondensedBalanceSheetsParenthetical", "http://perceptivelife.com/role/DocumentAndEntityInformation", "http://perceptivelife.com/role/RelatedPartyTransactionsFounderSharesDetails", "http://perceptivelife.com/role/ShareholdersDeficitDetails", "http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesClassOrdinarySharesSubjectToPossibleRedemptionDetails", "http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerOrdinarySharesDetails", "http://perceptivelife.com/role/UnauditedCondensedStatementsOfChangesInShareholdersDeficit", "http://perceptivelife.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/ShareholdersDeficitDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r59", "r61" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class of Warrant or Right [Axis]" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsGoingConcernDetails", "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsSummaryDetails", "http://perceptivelife.com/role/InitialPublicOfferingDetails", "http://perceptivelife.com/role/RelatedPartyTransactionsFounderSharesDetails", "http://perceptivelife.com/role/RelatedPartyTransactionsFounderSharesPrivatePlacementSharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.", "label": "Class of Warrant or Right [Domain]" } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsGoingConcernDetails", "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsSummaryDetails", "http://perceptivelife.com/role/InitialPublicOfferingDetails", "http://perceptivelife.com/role/RelatedPartyTransactionsFounderSharesDetails", "http://perceptivelife.com/role/RelatedPartyTransactionsFounderSharesPrivatePlacementSharesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r15", "r75", "r81" ], "calculation": { "http://perceptivelife.com/role/CondensedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r45", "r148", "r149", "r270", "r310" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonClassAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock representing ownership interest in a corporation.", "label": "Class A Ordinary Shares [Member]", "terseLabel": "Class A [Member]" } } }, "localname": "CommonClassAMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/ClassOrdinarySharesSubjectToPossibleRedemptionDetails", "http://perceptivelife.com/role/CondensedBalanceSheets", "http://perceptivelife.com/role/CondensedBalanceSheetsParenthetical", "http://perceptivelife.com/role/DocumentAndEntityInformation", "http://perceptivelife.com/role/RelatedPartyTransactionsFounderSharesDetails", "http://perceptivelife.com/role/ShareholdersDeficitDetails", "http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesClassOrdinarySharesSubjectToPossibleRedemptionDetails", "http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerOrdinarySharesDetails", "http://perceptivelife.com/role/UnauditedCondensedStatementsOfChangesInShareholdersDeficit", "http://perceptivelife.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "us-gaap_CommonClassBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.", "label": "Class B Ordinary Shares [Member]", "terseLabel": "Class B [Member]" } } }, "localname": "CommonClassBMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/CondensedBalanceSheets", "http://perceptivelife.com/role/CondensedBalanceSheetsParenthetical", "http://perceptivelife.com/role/DocumentAndEntityInformation", "http://perceptivelife.com/role/RelatedPartyTransactionsFounderSharesDetails", "http://perceptivelife.com/role/ShareholdersDeficitDetails", "http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerOrdinarySharesDetails", "http://perceptivelife.com/role/UnauditedCondensedStatementsOfChangesInShareholdersDeficit", "http://perceptivelife.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r302", "r303", "r315" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Ordinary Shares [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/UnauditedCondensedStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Ordinary shares, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/CondensedBalanceSheetsParenthetical", "http://perceptivelife.com/role/RelatedPartyTransactionsFounderSharesDetails", "http://perceptivelife.com/role/ShareholdersDeficitDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Ordinary shares, shares authorized (in shares)" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/CondensedBalanceSheetsParenthetical", "http://perceptivelife.com/role/ShareholdersDeficitDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Ordinary shares, shares issued (in shares)" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/CondensedBalanceSheetsParenthetical", "http://perceptivelife.com/role/ShareholdersDeficitDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r4", "r51" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Ordinary shares, shares outstanding (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/CondensedBalanceSheetsParenthetical", "http://perceptivelife.com/role/ShareholdersDeficitDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r4", "r286" ], "calculation": { "http://perceptivelife.com/role/CondensedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r77", "r134" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration of Cash Balances" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConversionOfStockAmountConverted1": { "auth_ref": [ "r30", "r31", "r32" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Conversion value" } } }, "localname": "ConversionOfStockAmountConverted1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/RelatedPartyTransactionsRelatedPartyLoansAndAdministrativeSupportAgreementDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r46", "r165" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Conversion price (in dollars per share)" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/RelatedPartyTransactionsRelatedPartyLoansAndAdministrativeSupportAgreementDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtSecuritiesAvailableForSaleTerm": { "auth_ref": [ "r316" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and maturity of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Investment maturity period" } } }, "localname": "DebtSecuritiesAvailableForSaleTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/FairValueMeasurementsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DeferredChargesPolicyTextBlock": { "auth_ref": [ "r89" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for deferral and amortization of significant deferred charges.", "label": "Deferred Charges, Policy [Policy Text Block]", "terseLabel": "Offering Costs Associated with the Initial Public Offering" } } }, "localname": "DeferredChargesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DeferredOfferingCosts": { "auth_ref": [ "r308" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.", "label": "Deferred offering costs associated with initial public offering", "negatedLabel": "Offering costs allocated to Class A ordinary shares subject to possible redemption" } } }, "localname": "DeferredOfferingCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/ClassOrdinarySharesSubjectToPossibleRedemptionDetails", "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsSummaryDetails", "http://perceptivelife.com/role/InitialPublicOfferingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueToRelatedPartiesCurrent": { "auth_ref": [ "r11", "r156", "r157", "r158", "r162", "r163", "r164", "r237", "r301" ], "calculation": { "http://perceptivelife.com/role/CondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).", "label": "Due to Related Parties, Current", "terseLabel": "Due to related party" } } }, "localname": "DueToRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/CondensedBalanceSheets", "http://perceptivelife.com/role/RelatedPartyTransactionsRelatedPartyLoansAndAdministrativeSupportAgreementDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r102", "r110", "r111", "r112", "r113", "r114", "r118", "r120", "r124", "r126", "r127", "r128", "r216", "r217", "r260", "r261", "r276" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Basic net income (loss) per ordinary share (in dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerOrdinarySharesDetails", "http://perceptivelife.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]" } } }, "localname": "EarningsPerShareBasicLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerOrdinarySharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasicTwoClassMethodAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Basic and Diluted Net Income (Loss) Per Common Share [Abstract]" } } }, "localname": "EarningsPerShareBasicTwoClassMethodAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerOrdinarySharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r102", "r110", "r111", "r112", "r113", "r114", "r120", "r124", "r126", "r127", "r128", "r216", "r217", "r260", "r261", "r276" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted net income (loss) per ordinary share (in dollars per share)" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerOrdinarySharesDetails", "http://perceptivelife.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r36", "r37" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Net Income (Loss) per Ordinary Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shareholders' Deficit [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r51", "r85", "r99", "r100", "r101", "r105", "r106", "r107", "r109", "r115", "r117", "r129", "r145", "r183", "r196", "r197", "r198", "r208", "r209", "r215", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r263", "r264", "r265" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/UnauditedCondensedStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r218", "r219", "r224" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": { "auth_ref": [ "r63", "r64" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Assets Measured on Recurring Basis" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": { "auth_ref": [ "r65" ], "lang": { "en-us": { "role": { "documentation": "Class of asset.", "label": "Asset Class [Domain]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueByAssetClassAxis": { "auth_ref": [ "r63", "r66" ], "lang": { "en-us": { "role": { "documentation": "Information by class of asset.", "label": "Asset Class [Axis]" } } }, "localname": "FairValueByAssetClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r166", "r185", "r186", "r187", "r188", "r189", "r190", "r219", "r242", "r243", "r244", "r279", "r280", "r282", "r283", "r284" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r218", "r219", "r220", "r221", "r225" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Measurements [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r223" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Measurements" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/FairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r166", "r185", "r190", "r219", "r242", "r282", "r283", "r284" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Quoted Prices in Active Markets (Level 1) [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r166", "r185", "r190", "r219", "r243", "r279", "r280", "r282", "r283", "r284" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Significant Other Observable Inputs (Level 2) [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r166", "r185", "r186", "r187", "r188", "r189", "r190", "r219", "r244", "r279", "r280", "r282", "r283", "r284" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Significant Other Unobservable Inputs (Level 3) [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value Measurement, Policy [Policy Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3": { "auth_ref": [ "r222" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transfer of financial instrument classified as an asset into level 3 of the fair value hierarchy.", "label": "Transfers in into Level 3" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/FairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3": { "auth_ref": [ "r222" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transfers of financial instrument classified as an asset out of level 3 of the fair value hierarchy.", "label": "Transfers out of Level 3" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/FairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r166", "r185", "r186", "r187", "r188", "r189", "r190", "r242", "r243", "r244", "r279", "r280", "r282", "r283", "r284" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r223", "r225" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Recurring [Member]" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r67", "r68" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GainLossOnInvestments": { "auth_ref": [ "r19", "r44", "r295" ], "calculation": { "http://perceptivelife.com/role/UnauditedCondensedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://perceptivelife.com/role/UnauditedCondensedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized and unrealized gain (loss) on investment.", "label": "Unrealized gain (loss) on investments held in Trust Account", "negatedLabel": "Unrealized (gain) loss on investments held in Trust Account" } } }, "localname": "GainLossOnInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/UnauditedCondensedStatementsOfCashFlows", "http://perceptivelife.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r18" ], "calculation": { "http://perceptivelife.com/role/UnauditedCondensedStatementsOfOperations": { "order": 0.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and administrative expenses", "terseLabel": "Related party expense" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/RelatedPartyTransactionsRelatedPartyLoansAndAdministrativeSupportAgreementDetails", "http://perceptivelife.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IPOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First sale of stock by a private company to the public.", "label": "IPO [Member]", "terseLabel": "Initial Public Offering [Member]" } } }, "localname": "IPOMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/ClassOrdinarySharesSubjectToPossibleRedemptionDetails", "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsSummaryDetails", "http://perceptivelife.com/role/InitialPublicOfferingDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNAUDITED CONDENSED STATEMENTS OF OPERATIONS [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]", "terseLabel": "Income Taxes [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesIncomeTaxesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r98", "r200", "r201", "r204", "r205", "r206", "r207" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties": { "auth_ref": [ "r26" ], "calculation": { "http://perceptivelife.com/role/UnauditedCondensedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the obligations due for goods and services provided by the following types of related parties: a parent company and its subsidiaries, subsidiaries of a common parent, an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management, an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.", "label": "Due to related party" } } }, "localname": "IncreaseDecreaseInAccountsPayableRelatedParties", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableTrade": { "auth_ref": [ "r26" ], "calculation": { "http://perceptivelife.com/role/UnauditedCondensedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.", "label": "Increase (Decrease) in Accounts Payable, Trade", "terseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayableTrade", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r26" ], "calculation": { "http://perceptivelife.com/role/UnauditedCondensedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Accrued expenses" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpensesOther": { "auth_ref": [ "r26" ], "calculation": { "http://perceptivelife.com/role/UnauditedCondensedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of consideration paid in advance for other costs that provide economic benefits in future periods.", "label": "Increase (Decrease) in Prepaid Expenses, Other", "negatedLabel": "Prepaid expenses" } } }, "localname": "IncreaseDecreaseInPrepaidExpensesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/UnauditedCondensedStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentPolicyTextBlock": { "auth_ref": [ "r143", "r330" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for investment in financial asset.", "label": "Investment, Policy [Policy Text Block]", "terseLabel": "Investments Held in Trust Account" } } }, "localname": "InvestmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InvestmentsFairValueDisclosure": { "auth_ref": [ "r218" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.", "label": "Investments, Fair Value Disclosure", "terseLabel": "Investments held in Trust Account" } } }, "localname": "InvestmentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/FairValueMeasurementsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investments, Fair Value Disclosure [Abstract]", "terseLabel": "Investments held in Trust Account [Abstract]" } } }, "localname": "InvestmentsFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/FairValueMeasurementsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InvestorMember": { "auth_ref": [ "r318", "r319" ], "lang": { "en-us": { "role": { "documentation": "Business entity or individual that puts money, by purchase or expenditure, in something offering potential profitable returns, such as interest income or appreciation in value.", "label": "Sponsor [Member]", "terseLabel": "Sponsor [Member]" } } }, "localname": "InvestorMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsGoingConcernDetails", "http://perceptivelife.com/role/RelatedPartyTransactionsFounderSharesDetails", "http://perceptivelife.com/role/RelatedPartyTransactionsFounderSharesPrivatePlacementSharesDetails", "http://perceptivelife.com/role/RelatedPartyTransactionsRelatedPartyLoansAndAdministrativeSupportAgreementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r12", "r104", "r144", "r154", "r155", "r157", "r158", "r159", "r160", "r161", "r163", "r164", "r211", "r212", "r213", "r226", "r277", "r311", "r321", "r322" ], "calculation": { "http://perceptivelife.com/role/CondensedBalanceSheets": { "order": 0.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total Liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r9", "r74", "r80", "r286", "r300", "r307", "r317" ], "calculation": { "http://perceptivelife.com/role/CondensedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total Liabilities and Shareholders' Deficit" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "Liabilities and Shareholders' Deficit" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/CondensedBalanceSheets", "http://perceptivelife.com/role/CondensedBalanceSheetsParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r14", "r88", "r104", "r144", "r154", "r155", "r157", "r158", "r159", "r160", "r161", "r163", "r164", "r211", "r212", "r213", "r226", "r286", "r311", "r321", "r322" ], "calculation": { "http://perceptivelife.com/role/CondensedBalanceSheets": { "order": 0.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/CondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_MoneyMarketFundsMember": { "auth_ref": [ "r314" ], "lang": { "en-us": { "role": { "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.", "label": "Money Market Funds [Member]", "terseLabel": "Cash Equivalents - Money Market Funds [Member]" } } }, "localname": "MoneyMarketFundsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r24", "r25", "r27" ], "calculation": { "http://perceptivelife.com/role/UnauditedCondensedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash Flows from Operating Activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/UnauditedCondensedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r17", "r27", "r76", "r83", "r86", "r96", "r97", "r101", "r104", "r108", "r110", "r111", "r112", "r113", "r116", "r117", "r122", "r137", "r138", "r140", "r142", "r144", "r154", "r155", "r157", "r158", "r159", "r160", "r161", "r163", "r164", "r217", "r226", "r278", "r311" ], "calculation": { "http://perceptivelife.com/role/UnauditedCondensedStatementsOfCashFlows": { "order": 0.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://perceptivelife.com/role/UnauditedCondensedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net income (loss)", "totalLabel": "Net income (loss)" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/UnauditedCondensedStatementsOfCashFlows", "http://perceptivelife.com/role/UnauditedCondensedStatementsOfChangesInShareholdersDeficit", "http://perceptivelife.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Numerator: [Abstract]" } } }, "localname": "NetIncomeLossAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerOrdinarySharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r20" ], "calculation": { "http://perceptivelife.com/role/UnauditedCondensedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total other income (expense)" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nonoperating Income (Expense) [Abstract]", "terseLabel": "Other income (expense)" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_NotesPayableRelatedPartiesClassifiedCurrent": { "auth_ref": [ "r10", "r71", "r301" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Working capital loan outstanding amount" } } }, "localname": "NotesPayableRelatedPartiesClassifiedCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsGoingConcernDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableRelatedPartiesCurrentAndNoncurrent": { "auth_ref": [ "r70", "r82", "r301" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount for notes payable (written promise to pay), due to related parties.", "label": "Borrowings outstanding" } } }, "localname": "NotesPayableRelatedPartiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/RelatedPartyTransactionsRelatedPartyLoansAndAdministrativeSupportAgreementDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r137", "r138", "r140", "r142", "r278" ], "calculation": { "http://perceptivelife.com/role/UnauditedCondensedStatementsOfOperations": { "order": 0.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Description of Organization and Business Operations [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r0", "r62" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "Description of Organization and Business Operations" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperations" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherLiabilitiesAndSharesSubjectToMandatoryRedemptionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Liabilities and Financial Instruments Subject to Mandatory Redemption [Abstract]", "terseLabel": "Common stock subject to possible redemption [Abstract]" } } }, "localname": "OtherLiabilitiesAndSharesSubjectToMandatoryRedemptionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesClassOrdinarySharesSubjectToPossibleRedemptionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OverAllotmentOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Right given to the underwriter to sell additional shares over the initial allotment.", "label": "Over-Allotment Option [Member]" } } }, "localname": "OverAllotmentOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsSummaryDetails", "http://perceptivelife.com/role/InitialPublicOfferingDetails", "http://perceptivelife.com/role/RelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsToAcquireMarketableSecurities": { "auth_ref": [ "r43" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for purchase of marketable security.", "label": "Payments to Acquire Marketable Securities", "terseLabel": "Net proceeds from Initial Public Offering and Private Placement deposited in Trust Account" } } }, "localname": "PaymentsToAcquireMarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsSummaryDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r3", "r167" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preference shares, par value (in dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/CondensedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preference shares, shares authorized (in shares)" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/CondensedBalanceSheetsParenthetical", "http://perceptivelife.com/role/ShareholdersDeficitDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r3", "r167" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preference shares, shares issued (in shares)" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/CondensedBalanceSheetsParenthetical", "http://perceptivelife.com/role/ShareholdersDeficitDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preference shares, shares outstanding (in shares)" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/CondensedBalanceSheetsParenthetical", "http://perceptivelife.com/role/ShareholdersDeficitDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r3", "r286" ], "calculation": { "http://perceptivelife.com/role/CondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding at March 31, 2023 and December 31, 2022" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r94", "r146", "r147", "r274" ], "calculation": { "http://perceptivelife.com/role/CondensedBalanceSheets": { "order": 0.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "auth_ref": [ "r21" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.", "label": "Gross proceeds", "terseLabel": "Gross proceeds from initial public offering" } } }, "localname": "ProceedsFromIssuanceInitialPublicOffering", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/ClassOrdinarySharesSubjectToPossibleRedemptionDetails", "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsSummaryDetails", "http://perceptivelife.com/role/InitialPublicOfferingDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r21" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from issuance of common stock" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/RelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": { "auth_ref": [ "r21" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.", "label": "Proceeds from Issuance of Private Placement", "terseLabel": "Gross proceeds from private placement" } } }, "localname": "ProceedsFromIssuanceOfPrivatePlacement", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsSummaryDetails", "http://perceptivelife.com/role/RelatedPartyTransactionsFounderSharesPrivatePlacementSharesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOrSaleOfEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Proceeds from Issuance or Sale of Equity [Abstract]", "terseLabel": "Initial Public Offering and Private Placement [Abstract]" } } }, "localname": "ProceedsFromIssuanceOrSaleOfEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsSummaryDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ProceedsFromRelatedPartyDebt": { "auth_ref": [ "r22" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.", "label": "Loan proceeds" } } }, "localname": "ProceedsFromRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsGoingConcernDetails", "http://perceptivelife.com/role/RelatedPartyTransactionsRelatedPartyLoansAndAdministrativeSupportAgreementDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r191", "r236", "r237" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsGoingConcernDetails", "http://perceptivelife.com/role/RelatedPartyTransactionsFounderSharesDetails", "http://perceptivelife.com/role/RelatedPartyTransactionsFounderSharesPrivatePlacementSharesDetails", "http://perceptivelife.com/role/RelatedPartyTransactionsRelatedPartyLoansAndAdministrativeSupportAgreementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAmountsOfTransaction": { "auth_ref": [ "r72", "r236" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transactions with related party during the financial reporting period.", "label": "Related party transaction" } } }, "localname": "RelatedPartyTransactionAmountsOfTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/RelatedPartyTransactionsRelatedPartyLoansAndAdministrativeSupportAgreementDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r84", "r236", "r237", "r320" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsGoingConcernDetails", "http://perceptivelife.com/role/RelatedPartyTransactionsRelatedPartyLoansAndAdministrativeSupportAgreementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r84" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsGoingConcernDetails", "http://perceptivelife.com/role/RelatedPartyTransactionsRelatedPartyLoansAndAdministrativeSupportAgreementDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionDueFromToRelatedPartyAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Loans [Abstract]" } } }, "localname": "RelatedPartyTransactionDueFromToRelatedPartyAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/RelatedPartyTransactionsRelatedPartyLoansAndAdministrativeSupportAgreementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/RelatedPartyTransactionsFounderSharesDetails", "http://perceptivelife.com/role/RelatedPartyTransactionsFounderSharesPrivatePlacementSharesDetails", "http://perceptivelife.com/role/RelatedPartyTransactionsRelatedPartyLoansAndAdministrativeSupportAgreementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r191", "r236", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r320" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsGoingConcernDetails", "http://perceptivelife.com/role/RelatedPartyTransactionsFounderSharesDetails", "http://perceptivelife.com/role/RelatedPartyTransactionsFounderSharesPrivatePlacementSharesDetails", "http://perceptivelife.com/role/RelatedPartyTransactionsRelatedPartyLoansAndAdministrativeSupportAgreementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r234", "r235", "r237", "r238", "r239" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfRelatedPartyDebt": { "auth_ref": [ "r23" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.", "label": "Repayment to related party" } } }, "localname": "RepaymentsOfRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/RelatedPartyTransactionsRelatedPartyLoansAndAdministrativeSupportAgreementDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r6", "r58", "r79", "r266", "r267", "r286" ], "calculation": { "http://perceptivelife.com/role/CondensedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r85", "r105", "r106", "r107", "r109", "r115", "r117", "r145", "r196", "r197", "r198", "r208", "r209", "r215", "r263", "r265" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated Deficit [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/UnauditedCondensedStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/ClassOrdinarySharesSubjectToPossibleRedemptionDetails", "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsSummaryDetails", "http://perceptivelife.com/role/InitialPublicOfferingDetails", "http://perceptivelife.com/role/RelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r306" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Basic and Diluted Net Income (Loss) Per Common Share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable": { "auth_ref": [ "r35", "r38", "r120", "r121", "r124" ], "lang": { "en-us": { "role": { "documentation": "The table contains disclosure pertaining to an entity's basic earnings per share.", "label": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]" } } }, "localname": "ScheduleOfEarningsPerShareBasicByCommonClassTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerOrdinarySharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r71", "r72" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/RelatedPartyTransactionsFounderSharesDetails", "http://perceptivelife.com/role/RelatedPartyTransactionsFounderSharesPrivatePlacementSharesDetails", "http://perceptivelife.com/role/RelatedPartyTransactionsRelatedPartyLoansAndAdministrativeSupportAgreementDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r47", "r49", "r50", "r52", "r53", "r54", "r55", "r56", "r57", "r58", "r91", "r92", "r93", "r130", "r167", "r168", "r169", "r171", "r175", "r180", "r182", "r281", "r296", "r299" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/ShareholdersDeficitDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share price (in dollars per share)" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/RelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Shares Issued, Price Per Share", "terseLabel": "Share price (in dollars per share)" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsSummaryDetails", "http://perceptivelife.com/role/InitialPublicOfferingDetails", "http://perceptivelife.com/role/RelatedPartyTransactionsFounderSharesPrivatePlacementSharesDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Number of shares no longer subject to forfeiture (in shares)", "periodEndLabel": "Ending balance (in shares)", "periodStartLabel": "Beginning balance (in shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/RelatedPartyTransactionsFounderSharesDetails", "http://perceptivelife.com/role/UnauditedCondensedStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r91", "r92", "r93", "r104", "r120", "r121", "r124", "r127", "r130", "r131", "r144", "r154", "r157", "r158", "r159", "r163", "r164", "r167", "r168", "r171", "r175", "r182", "r226", "r273", "r296", "r299", "r305" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/ClassOrdinarySharesSubjectToPossibleRedemptionDetails", "http://perceptivelife.com/role/CondensedBalanceSheets", "http://perceptivelife.com/role/CondensedBalanceSheetsParenthetical", "http://perceptivelife.com/role/DocumentAndEntityInformation", "http://perceptivelife.com/role/RelatedPartyTransactionsFounderSharesDetails", "http://perceptivelife.com/role/ShareholdersDeficitDetails", "http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesClassOrdinarySharesSubjectToPossibleRedemptionDetails", "http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerOrdinarySharesDetails", "http://perceptivelife.com/role/UnauditedCondensedStatementsOfChangesInShareholdersDeficit", "http://perceptivelife.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r16", "r51", "r85", "r99", "r100", "r101", "r105", "r106", "r107", "r109", "r115", "r117", "r129", "r145", "r183", "r196", "r197", "r198", "r208", "r209", "r215", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r263", "r264", "r265" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/UnauditedCondensedStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/CondensedBalanceSheets", "http://perceptivelife.com/role/CondensedBalanceSheetsParenthetical", "http://perceptivelife.com/role/UnauditedCondensedStatementsOfChangesInShareholdersDeficit", "http://perceptivelife.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNAUDITED STATEMENTS OF CASH FLOWS [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "CONDENSED BALANCE SHEETS [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNAUDITED CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r105", "r106", "r107", "r129", "r247" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/CondensedBalanceSheets", "http://perceptivelife.com/role/CondensedBalanceSheetsParenthetical", "http://perceptivelife.com/role/UnauditedCondensedStatementsOfChangesInShareholdersDeficit", "http://perceptivelife.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Stock Issued During Period, Shares, Issued for Services", "terseLabel": "Shares issued (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/RelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r3", "r4", "r51", "r58" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Shares issued (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsSummaryDetails", "http://perceptivelife.com/role/InitialPublicOfferingDetails", "http://perceptivelife.com/role/RelatedPartyTransactionsFounderSharesPrivatePlacementSharesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r4", "r7", "r8", "r42", "r286", "r300", "r307", "r317" ], "calculation": { "http://perceptivelife.com/role/CondensedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "totalLabel": "Total shareholders' deficit" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/CondensedBalanceSheets", "http://perceptivelife.com/role/UnauditedCondensedStatementsOfChangesInShareholdersDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Shareholders' Deficit:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/CondensedBalanceSheets", "http://perceptivelife.com/role/CondensedBalanceSheetsParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Deficit [Abstract]" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/ShareholdersDeficitDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r60", "r103", "r168", "r170", "r171", "r172", "r173", "r174", "r175", "r176", "r177", "r178", "r179", "r181", "r183", "r214" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Shareholders' Deficit" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/ShareholdersDeficit" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r240", "r241" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Different names of stock transactions and the different attributes of each transaction.", "label": "Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table]" } } }, "localname": "SubsidiaryOrEquityMethodInvesteeSaleOfStockBySubsidiaryOrEquityInvesteeTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/InitialPublicOfferingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/ClassOrdinarySharesSubjectToPossibleRedemptionDetails", "http://perceptivelife.com/role/DescriptionOfOrganizationAndBusinessOperationsSummaryDetails", "http://perceptivelife.com/role/InitialPublicOfferingDetails", "http://perceptivelife.com/role/RelatedPartyTransactionsFounderSharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsidiarySaleOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Subsidiary, Sale of Stock [Line Items]" } } }, "localname": "SubsidiarySaleOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/InitialPublicOfferingDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityAccretionToRedemptionValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of accretion of temporary equity to its redemption value during the period.", "label": "Accretion on Class A ordinary shares subject to possible redemption amount" } } }, "localname": "TemporaryEquityAccretionToRedemptionValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/ClassOrdinarySharesSubjectToPossibleRedemptionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityByClassOfStockTable": { "auth_ref": [ "r1", "r48" ], "lang": { "en-us": { "role": { "documentation": "Table of capital stock that is classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. This table may include a description by series, value, shares authorized, shares issued and outstanding, redemption price per share and subscription receivable.", "label": "Temporary Equity, by Class of Stock [Table]" } } }, "localname": "TemporaryEquityByClassOfStockTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/ClassOrdinarySharesSubjectToPossibleRedemptionDetails", "http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesClassOrdinarySharesSubjectToPossibleRedemptionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": { "auth_ref": [ "r154", "r157", "r158", "r159", "r163", "r164" ], "calculation": { "http://perceptivelife.com/role/CondensedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.", "label": "Class A ordinary shares subject to possible redemption; 14,950,000 shares at redemption value of approximately $10.25 and $10.13 per share at March 31, 2023 and December 31, 2022, respectively", "verboseLabel": "Class A ordinary shares subject to possible redemption" } } }, "localname": "TemporaryEquityCarryingAmountAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/ClassOrdinarySharesSubjectToPossibleRedemptionDetails", "http://perceptivelife.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class A Ordinary Shares Subject to Possible Redemption [Abstract]" } } }, "localname": "TemporaryEquityDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Temporary Equity [Line Items]" } } }, "localname": "TemporaryEquityLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/ClassOrdinarySharesSubjectToPossibleRedemptionDetails", "http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesClassOrdinarySharesSubjectToPossibleRedemptionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityParOrStatedValuePerShare": { "auth_ref": [ "r1", "r48" ], "lang": { "en-us": { "role": { "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.", "label": "Temporary Equity, Par or Stated Value Per Share", "terseLabel": "Ordinary shares, par value (in dollars per share)" } } }, "localname": "TemporaryEquityParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/CondensedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_TemporaryEquitySharesOutstanding": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Shares Outstanding", "terseLabel": "Ordinary shares subject to possible redemption (in shares)", "verboseLabel": "Ordinary shares subject to possible redemption (in shares)" } } }, "localname": "TemporaryEquitySharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/ClassOrdinarySharesSubjectToPossibleRedemptionDetails", "http://perceptivelife.com/role/CondensedBalanceSheetsParenthetical", "http://perceptivelife.com/role/ShareholdersDeficitDetails", "http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesClassOrdinarySharesSubjectToPossibleRedemptionDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_TemporaryEquityTableTextBlock": { "auth_ref": [ "r1", "r48" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Class A Ordinary Shares Subject to Possible Redemption" } } }, "localname": "TemporaryEquityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/ClassOrdinarySharesSubjectToPossibleRedemptionTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_USTreasurySecuritiesMember": { "auth_ref": [ "r275", "r282", "r284", "r329" ], "lang": { "en-us": { "role": { "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).", "label": "US Treasury Securities [Member]" } } }, "localname": "USTreasurySecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/FairValueMeasurementsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UndistributedEarnings": { "auth_ref": [ "r123", "r125" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The earnings that is allocated to common stock and participating securities to the extent that each security may share in earnings as if all of the earnings for the period had been distributed.", "label": "Allocation of net income (loss)" } } }, "localname": "UndistributedEarnings", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerOrdinarySharesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r199", "r203" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits", "terseLabel": "Unrecognized tax benefits" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": { "auth_ref": [ "r202" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued", "terseLabel": "Accrued interest and penalties" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesIncomeTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r39", "r40", "r41", "r132", "r133", "r135", "r136" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r119", "r127" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted average ordinary shares outstanding, diluted (in shares)", "terseLabel": "Diluted weighted average ordinary shares outstanding (in shares)" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerOrdinarySharesDetails", "http://perceptivelife.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Denominator: [Abstract]" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerOrdinarySharesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r118", "r127" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted average ordinary shares outstanding, basic (in shares)", "terseLabel": "Basic weighted average ordinary shares outstanding (in shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://perceptivelife.com/role/SummaryOfSignificantAccountingPoliciesNetIncomeLossPerOrdinarySharesDetails", "http://perceptivelife.com/role/UnauditedCondensedStatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 7 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(27)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a)(5))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "66", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2814-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(c),9(a))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r288": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r289": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r291": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r292": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r293": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r294": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(b))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.A)", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=122040515&loc=d3e105025-122735", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(b)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126980459&loc=d3e62557-112803", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(3)(b))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r34": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27405-111563", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r45": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r62": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.17)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" } }, "version": "2.2" } ZIP 53 0001140361-23-024396-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001140361-23-024396-xbrl.zip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
C.PQZBYVKU'U M?F*F6&N5>%: Q ^=BD -L]V8L(&;+K%Y&8R9?05HT.],!'&9J6,M&()TPW/! M$)IJ7D(JDRY+L8AIXBI<9J(Q#)J3F'WX<$/*0_K,F$L.8JM6 RT<\@Z-AHD3 M\\@UTE6:Y$^=D_)5^Q)M+$ [!RN44/('>=6(-(WLR@UE^UB M4$,9SV AJ8M^X5[4L1*J]%-$UFO\L"$Y+5=]<$.2YT]I=G?X0+99V5T'<$VJ M50!2>!FL7U?2 /W 0.CMT3?:/>+\AIC')(>6P139AMFL3P,ZI$%HE68L&M7' MA78."=V0HD@9^G.\HD[8>5'3!J;AH"- .!!#C+>I;AP96(XI6 VP#K8.S@! M]H7?WNZ]??NVT4C*C@!Z3-9;WN8GFTU.OJ0/28G73^A?]M_^ M_1N?P_16/VNNL4-+ZL;0.NG!WO43;&A94L? MJ<77RD7-$//X9)QH2%HJZV[IBV9LVEE>W32KY&-\#9$?#U9E'B-'8:"/* M11-1ZHU<5[N(8SOF=47;1OFR[S? ;TK/6J9XO#()Y.P\"-&0S<224Z7"YSS&+= M-=G%O;^Q/,G,$;N>FC0F/5@6Z3U%I)75J0?/++86[7O47/KIG3*CA*=1LV*I M [+TM'6K="./]28,Q+;YG0'3:79\D?.C>5:\8)J;+#RUU"S7:\%R7.<'?,F: MGU\/DALM+2Y$-N^A39+7O=@Y7H_ABQT]CUTJULABG0$#A\T^QP-NK#$=FT\@ MU.[W4$]ME^-3:I4*JB*IC.YD6,JSD&=G'1$7R;T-(>B M0$-OHJM2I:(=/74O;5*M\W174.XG#-:XI/L]RB#)$/6SN<3HTE M5)OZRBH%--8-7L"C4O*V)OZ]2RYZ<$[ M[Y;*@2XQ6Y@Q6H^ EL$6]5\"7/Q"L"->I@J=!;ZX/2U*OK>E%S&5+YM *;T, MA;M@#K23K[)LA'9?84&?L?Y\^W1B'*LKAKA\3@FT@IR 586%21!Z=9WCI-CF M3U=XNASHFOK4A$4*K(Y##8GD*HOR&T[O[$J\.'W&>W.&/6U:=;IS8H/8&F98.<3P@*ACL>8:$&Z8X^X!@@9@]'-AK MWBD6J,TX1 *3_[&Q#KLN"2 (IC.J8HY:=E$_ MFLEPIKH>B.7SB0@6Q!@\-;JCX2[-]+A3O6MP)[X+P5W7$ACN%$:UN.O)+NI' M<\&=LAZ(Y?-)N.N*M;CKZXZ%NT^T)K#B]H+>\_IG=)X'8*VU H4SV: .8Z+< M@NWH3HLR729K]('/3. '=C+>'.X:Z-< ,7P\$66M2(,P26=4="ECFN)-%V$ M\:QC!Q1E3K%,EM0C[80$&DV!ZRIXYKF,RKP)L:TGEXHY@J\_.&.//ZXPFD% M.?K'#FWT'W\_)C2EU/3$E._J'R&]&XBY7@D@4*Q_;I.\Q/GZZ1/>D%P.$*.27&!3DPE'>LQL%YWX$;TF6]'M8K@?FA756?2KQK/KT) M\1T5->9[-L=#?>7Z-%O13$8W)J>4D= NR0 @7; (C7*5<1O"^SH[=->P/F77 M<-&W\T"VNMZ(XV=6(UH0E]&LL#56-_$3OF-G_R19^3%YD&%E$A&ZA;)(<'=0 M- C;#53:-G?_%"I-MV_W"K%W<^CM:2J,N'U@5>].E!9[=2I+8Z'WF)(G3]9G MV0I_^1_X20E?C8R WYY,,( EB[ (5ALW0UBETV"X?H?X2T3?S@'%NGHCCI]9 MA6-)7 2RTM982'Z?KNLUBDH0]U\+^.V^#H;NSA@L:GMVS8"5Q!NLLL>H>CX' ME"HJAM@_I@J;.TD1EK*%L1!YG7PY6U%*I+=I=62B 9X660&K6ME@X&HLPZ+8 M[,0,:9-N@V]V'HLH-".TV^J9>%:'B@<:-9$41MOC3;$L2V'+,+ MV/*G8[)2I]).&M*$BU$#8-[%8!]Z^L7NRC8+8[.PFXSI2.Y55Q6Q.XMJ><04 MYD H-T"0036FGJ8Q*,NS-58_(ZRUJ^:(=D. MV;YVB9Y);=',SW5'TN)H7=JJ%-62@32[8\SK MC:F[B(H=7(UH>#]7:1BXNVOR8>GUZE7;SF]-A58&54)S:!XL-4S\:D+9(U9J M21UC@^6Q:'%UC]?K8_*P23+U,(]*0*" *! ,_*XY6+@K+)M!WE-HH,U?H/K- M'/"LK"3B\EE5V.W*BHCM6QES'"<_IJW&'HB,#7VAP9 M^R CG$TT7^65.'M.L!S@74176>Z)0@)<,1T&]VH<3]%6J M/?RWDZ.-V(Q(H*MC%1,,=6&@@Z2EY(32\LC$N"1%F:S_=[K1+BXP":I((0E" M44(P&X40*@].=.@K]LA0B2 J,YLU L9Z51%!6P,&&@@Z2A(HK(XP_\_\YSA1 M@%[UJOZ!XJN0N?V.(;#Y_+Y-[1R^++K@N0I[- -T*BN F#^5:;-[7I?HVG0 MFS?H=_YNXN/(3)5%G+ZNJND6A,4V6V%G;-"R49*S$C^HIQ2U4DKP=J3 -S: MC -BV;P;D$6M/IC9>\0%9H7H?BTJ4:W\Y"9DMPIJ=$OVXB.\OD_N:?_@YIH5 M6P*9[G7]$_NO \ L&X-"L<:N#KY*\07_DUW)N7_PWS0KA*^\-YH'7W]L]65;AVPRT:_&Y(.*2>ZB211WA.>2\3C@@0VI*E0F; M=*55^E8O ZB5Y$^8L>?=VW?O]CF#V)._GV5IF2;KR^W-.EU>W-[BG#JYN/V5 M/BXT)Z/[J-0?PDUE()&Z#'Y*J!X,"(4#Z+'^VO\I3RB M5OYPB?0]85.,[PB#TZFU[9LCK>K#NOA^:&[\."1J+Z[O,:(E2'.,5FFQ M7!-VOPNZ)3DJZ9NTIM:FHA;IA'OVNEZ<_&V!EE665;!4X8<9TJV/%2/1E#7J MP+!6S\PMR7Q<0$9,-'I^ J!H2"Y^9X*(2\XQE(=@RR>3& *N&-F#X"!VWM!S M%@ Q?:[PPE#EDQ0,057\1,"GQ^?3U8O8QQNI.IHV.!E>IO21K^LUX6LJ")M]9-2&!!#FSQ=TDS@RQ+C%7O?FN+/J4%4 ML.FU/91FZ#+[S^Q#=G*=_4+_<_4MRR<>DG*/YQ7X2_*P65.Y;R_W__/?/NR_ M._D6Y7A#S=$/4?!T(^]3 M*HHS7NR),Q0C#HDC;I2+6P3IEHQZ4S& #9-@F*Q[0WI_MYJ)O4/MRV>, TUR M, @(@2F SBQ@JV]RX0V'@QT<:#3HQJ@9'%(1! I-NST(%*"M<[7]X^*VXTQ" MDD&B_C%*B1#<*@R"M\QZ'UK8ZE06]=X:-B'5;8-9:ZEH@FG]5JWP#N"ON=$U MX8NX 4(DE4*XY9364 2XPK2W!N.^0-WO(K7;[CY; &C:V@$("&QI-58!&UJ# M!U\<'.@BUK/%@:9Y'8 #T,:U.DOJXO83+DH:^EE3])[D[\F6]K_S:C$C_7<] MIL__S1H#"@,)8L%VZL\28">$'(/=@C?ZH271,BW,,%\ L^O2E^D#1LEMB:OU M+S2%H$T_/ZR-OFQ6P]PT9U?2US=LV)^]Y[W^1J+HN*&8QR@C)?/RD)8L3:!$ M*-FI9[>89@A)4:1W&>+3!NLU8N@Y8\M+)8(ZAM]T0F?26,/K6>F#"@:7IOA]'5 M]N8?>%E>$UJ 6YR6V[QW2).'2G-XDY-*2!AP\0">4GLXU;+;V4:GWRH,K!55 MRU=4:@QBMZTB2U7Y&IA'-E]<+QHGCSA_DZS7I.37=9,-;TP_)P6/#_@+SI=I M05/3FRNM_)V"+D2:Y!S0(0? M:%L@4^OSRA"N6P@V%L)!\TIAL$ZS6](H4W\$C4P(%94FX9H3HWDMIPQ:"VD2 M9RZ;'\W51YR_M@AWI7R+:I.U*)@ C,)&'_[ .'BIP-#$P8' (UJ5QN2%20_ MO+U-URF[(.6V?G*1'^.\3-*L/G+D@DHL*1H.LU6SET:]+Q;08G/&)(3%$"X! M% "\!PY7)BU1H5PL#C_]YR&Z6J:8$JQ O] F/&4'89^=H>]JB]^SKBY-H&I/ MSNBPR\?F(?V_VES#073196!K)D\L M%3U\H#T2><1CB&K]P2!/T]=:!7$=U%':0XT:JO50I?B*L*S).4L.,%T>!'?!S"H#0@Z\(M4ZO14/HB$V#]A"I=]SW=?^4KR==KL#,J*[<-#TNR8MZY_K5:4=N?/ MUNF?VW255!VDSBOT.5VOV4@!2JKUJ%7^R9>X5G-NJ-@D2[R'MF6ZIBYQ-=Y8 MX&6.RR1G16#_3L1 551?>.+Q R\.N84DVPR;B[9C-(*:(W/U,D8>YSC+Y6[$ MH866(Q&@QU,M+:Z& :X_1WB:@'$)682C($@ MHPF[@9@!#;"'JT=&;TT/0_&N[4H([\+2CXZI")V#OG5#6B$++^I'Z"%9X28[ MKU/CR9-75?40VU>54X".6*>M[RF#UC!4)JDPZUZW^[O*G4?4\:Q0;5+G5*.@ M4>0R3Q]I]_5R33N"C(W5-J>=>R YGV?[]/E?7=MKF) 0;T@MQH[6>UU=]6OTX>4C7VP;;?\ M5))BKSJSR/6XOOH3H/8;=,_L>Z5[='T(1H8Q0#H>R:Z\.PC)U=$(? 8Z1,_= M62B3V<%X&L WJ^KK%0XO%H&Z(^W@(1AZ3)V;%\@#Z=P]A@)1.%29'_]>'TK% M3EYM(G>>W*R;QL;]6-<7BUS=V7+PR(4]UEGRJ5FL8!/3I'(P"Q)T5N,%>>=% M!V9%13B?RZRMM4)U\'=8.Z!3T0(]VJ6?_&RB8Y(]TLA*@\\G%H(DA)E$F@V* M2I&@#1,*B_!;"/5.]'L:=#H+_B=*-IMUNIO-7+:2_/JNZHRW3OY-FX"29_Q- M3Z D>SS/YNU)K=[,CGXFK!/ _E.W-L)KJC7UGC\34HACS4H[#Q32NZT$6E,Q MH >T$+:ZQ@\;DE.)TS^W M:?E49; 7V[(HDXQEL1(. ZWT3R/VLP)T3*:/4_!6/JP<+J=I>IOM=![KEIS^ MM6FL5 -JC1V$N2'QO#ZR,_A#?21E_:8=PZM./OZ<48S?IQO:Y:2!"!?LPA"4 M4&,YLSZ#*>I0@"N.]1R*-NU!GSX&56=_^A=H(MZ!'Z \I Q&-<[9OE2(%MK M E4VFF.84)_83FL7D"=XZSK^2<(_D?,-G=.)THTQ0( L\"07E8-Q?/,+$%!#Y!/@H ^5A;Y-\*.TOF4WMV7 M17,Y,WV&Y^FFUT,KY']A#A9'F/\#J]2]F: MEFIRLKJACW(6T7*SDJ[JBX(JZ28#K&3Q>NH3D[R@I&"O4U5KZ:K55A'4XFH, M[()G7E9OP:CM95>5-*K$]] .TUSE!:/1GC+!P1$N+3*ZB9,(65T&@Y(F.S4, M//GKW X0]VL1^F,*6-\!V^N*V2()HB=0;6ZL/H.S=O5,<4-*<4 MR(L"@#S07>.QWD'7X'"4R!3-=0A]MO;W1H%@C3_V,QH+;"RC$DPBHZUUJ'62Y>[ZZ9$T8[Z%;FX!* +DSA>@XD1EW8%+6^C2 M^C6[9S85$\E7)EHA-F,F@N;O3>_@!#_0$A2G]8#5%5YN\[1\^H6/6!TGV8?D M#YG70U3KS^JG&A)W?#R!Y]L#G&L#BK>MQ2=QB,3M9&F@'*99*A M!VIGXM1X$,!(8,6+Q/>QTI+ MJR%:S0YINV![+XY>,.SZ!)U=N(;$[L-P*X)9==$5J">U9K-;VJ%RB5\UR%<> MZ)0Z%QQ8[,;##NA%&S9' P%T\$H I+TS(Q! H$'S5S8,\ID&9]H)/DF+);MT MXSV6D6>1JG^@5BH$[QJCX'U*LQ\MU$UJB^Y+M*K?\I.[V=SK-DM+M$E2OEAE MVXCBR2_,M54V<:\9$?D:A1;V1H.1, 33V%H<#$'/O@2?YC5Z/_7%0P#XT+2M M 0 );%4-E@&;5(N7(3 YT$49MG)U1=;K).^L])AX$2L &(65@XMRT/,+JYIOI2TUZO?45/HNS4U M]CUB]$)%:Z^: [)$B(ESK%",$CC B*%BH,$V= 05:"+JP.1L@06(01J:T_W, M>7*^X\F5P!-KRO?J::))!"?D26"B&. 9,'$,+$4,MAS4;!G2G+QZFF@RSPEI M IJ97O#K4MZ3O'5(T7U-+BG)[I,"'ZY6*1-(UK]F:5E[DDCVRE$_V?-\EZ34KV$:LK>+X-N(/GN=Z_ M$\ L H)U,>+YVVJ#W=!BC$]SF(QYN&]@@M,\N5+D//E5XF*CC YE+C+]5PI^ M35H\.OH#D^%A3@'SX.$% .8 S7YY=;# O^-">+OT2OFAR8='YT?T=60.B\@< M5I#!+^P89>W8D(5C549Y>'>7XSN6/@I=2G']6+UL3)@I9D3<;B@]^7TO:U(P MM3H%G>!Q%E>%G=MV:"%9:959<\8!AYKR:PXB+"*;(0E M9(/6CYD6CSUC-'BL#[.B ;2!E!OA^Z0\3K(CW#32JVMRS/*C"_K_AVV*)*$L MS$A[;?PP(V&WCP_Q"=Y0!Q7#<*OY8*N=O6F=M+D^9*"DAOB.M!O<9M.3;V8?8ZUSC/KPXTW ()A$)\Q^!/329Z8^[,,X<5YQI M+;"JXS80,X(.9](#G9P>FM1I,GX$IE_#'0,F:&&%B,"2 X$EQJ9%UXS,YQCL MR2FCR2\GHTRT09S#9LFY9A.UDZQB6$0O"?Y)[RBWFDQJO':ZO@R":N#]9O#POSU@PZ@\74' M?VS8P!+HSZ(99'!!U5!9ZZ&$*=)\K-;D4VMYH]L,UU?:4Q\;-AAO! ("TO$T MOJ9V9]0,*\3HT H;Q01UT37 NH_J5'_*D&O.VAL7-2''CDV MQ"?DN6-#_<-B_V!XQ'^5V-<=2#8N]J.&&*^,V5$&C/HIK53#>T] M;(N2C>VEM56V K@YK5IU#L'4J240HN4S$ %@I3X5<:#AWD&)006Z/5[^EY3W9EI=Y2O)CDK$]3Q*5(4PIKD[S M-P5U58RO9_!$&Z P3G?$#+(M76E3WI6K49 M78HV&,>J>V%"\*2_$L;7JO(ZF&%%FY)H\!>@#2U%-(KU+CX3.7;=X5AC"=6F M$+>%:F-?^=2'S0P)!7C+V1#WD6XX&UJ4:+0Z"&BZA&;K*ZWZV)DAK:#SY92P ME68X*7"=Q%-79[>*9/VL^$C*X_IP4UZZ-.N\KDSUD^@X]G>9-;3]P)@%6YP8 M.7B4$IK"6P2'\A$<;!4K<]",'K!#8]);S0&\*"U01LKVH-XJ'J:9(%,["#Q% M@W4#GNM)&O&X2\:@2R]TP[KJQO,8/V)V80BLAQ*G:.,&H/TV K%M)CSR7 B1 MQQ1WCNUQYROS0Q#ZK*D?WFV"+Q-L7RI.^<8- ?= *!*/0(3CZ\!( 2FSSH M1.G@59W*;G_3N9#U](UK5R^B)ZG3%\431.R-4+!H'<%X9;4&Y%BN%9W#:N1+ M&AKSC=+=,W7Z$3OXQ,67T%>,27ZYZ8C,,G4;$L%IKS6)]L-F'-M@>Y<1"SE5 M5!-ZG)\&A+-=K[-R9@AE7V,)-*I?7# !ZJ5&*EV$_FK$DDX54H0^+$B&]#6D MC ?M%Q=20/N]QTEQ?T*3Z2(MV1+$ZWQ;E(=+?LP;]%=%$)" MI-T^>)_0V:4V8CE:8''G376IYNX.IPRS!0EDB?&J0*O&"*H[7MP4JFU51YZZ M'7=:\,[299X^LN-5+]?)<@ZW:GK C0P"A!@>[+HMRUW=Q,Z(FRI-#^S[(5B3Y/N@H,O,/ETNZEGA/>\6( M,B#V+LG<4NV)C_Z*AE1-%@6.U-$V-_Q&MNL5S;=VR\*5?] *V5C%L:^I_92%O9":Y M+_V-4!"GU<+1/L SBWWQ]\Y$+/BR]E?N2UA;T!6[Q>6-@#'9LXRVB8P45Y M(8R$7),C_ M>KZ[)9?)TDA8%66]9(4Z_;'!6]$ZW#3-25^10(R%-P#"?X/WV MH&)H(W* U46C2T/F$J>/-!(2U71.=Y/JMKZ58),\L9$6R M9'XN/F<4YO?IIINT7]_CZR2_PV63F&N(2?D HHA7ZD M8;#1!5-]4^YT$6F4V.4*C70B7W MTAYYB(KM[6VZ3-F\/-LZDI8\LZU:[AS_N4US7"_;O$L+2A*4L'5.*,T>*5WX M=/ZR.GVLNC2RGF5J7Q[7+P^K72;[?_G7MU//- 7Q@T#!51H-&&)NUZ[9AW3BHB-B5=-"MW4P#2L"!VF'^H7+3-]R_+(9L,QHEGG#7XB?*,Q[IS* MO7Q:,M5;M";9'<[W: ^8'?3,7VWISZ'9)=O#G$Y^P80K,(D_>D3.6Q1;=CLY MB(Q_F!S/T5$(\FG>UD@)-SFBCMR+PY !,%UR]!8"LX,.S'3Q M\L7!3).[ ,(,-!]YGZ3YAR3_ Y=_8VW@8=%-AS[BDE_P5; 107$=_H!KML9P M57_TN*Y"2!ZS9. YV B%U<:7Z+X7S -ZX"YV"6"BZ)JQS9/\DL&BFJE0[IK\ M;I>JL9Y145R/P(WCJ4B;M5=0T MEF VN$\MT3\KD[.]JFR4J$!&9I\8^V-Z;1N.^#]MSF$/)O4>HY23!;S].N)5 M/M#?FH@G#M.RFU4K3^B7.M:)<>YY7,WVHJ**IN?R(L)*8)\I=O$ .UQC%'6R MX'*@2:?$9$J12(G!Y7E<1?>B@HNFO_HB@@OL0I7.RO$/F%W-)Z]"T0HT2TP4 M D&S;CU[\(M#="[T$V9JC<75;EE&02KNT[Y6M1F$-(,U M#1?HD/>;*&Z*DBS_F'HMA;Z6B5.]2'-:/=G=A)7&##QD@!8G:&U[@H4M*Q!V M"?U>O?L_S[3F=5/]OE4?.DFO- HY Z]UX F @Q<& -U\MB\ HIUX8AEUOJP& MJ :,^<9UHCB_!-()U,95N#)%/8T$O)A.^U"!O4J[3>W#L,W@Z\L948W,.=6^ MTC@(U^\>A?.GW"0*_7/F&4C@C_: +]\$(:1W4(=UJ02J/3R3L=%G'Q\<3M5X M5@$"\(P,V()%.@H#OI 3A(G>P1;NJ89JE+/=G++\&B:@T?M"P@1L[Z\ZHK0] MH=0TKND@VO3$C*)!0FCS@V7!\'0A,!C58Y7088[(0V@@!.S&2IM RE(3![SY*^^^H>SL['#C^.4 M&_&]:MUG;8WOW.\R[2O1=#":+=.",];@$H FM2"EBD*(O+)%T=/5UM2%:0_"P[_;*D^=(=?D__T1;Y(E^E M&351=2XD'@-;E8X;"+8*L6DVL!#1CB^ *9=U%RZ$&Y[N[ZX,;.R !4H#&XW#W@H;V9CMM#ES5]KW;T M/>W2M]LY: S7 WM?F>J*MV=#5: C*P!*XM5'>,3Y#7$XW *H7&-0EO8:+OP: MVK3#U%M2'459?"6J%]B>#5&A)PG8&@22/WTD);XFQX02JCGA]Q->LQ'>:U*O M1JB6HC<_0;-" ,C>;J(@U%[@B$>8^QB3!2 E,@U[ #A8G),D8^%HNV$<^)=W M;]_NO7W[EOV]9 9W]TSDE4E4KZ;67::[V>:,$E5_G5U@7A>2#:!@]!TKZ_<_ M\*-%V9_U9$'V)FW.';_!27LIKW3*!GVS3MF9;+?H_]]F&+U[NX<.WN[_-W8V M&WM?7W3!CVTTWH$^_=P#$/=(#/CWAFW"3'<';B *.7F8 )N%@"E*W !1S40T M'.:4I?7)3:'V?/I/N]"@"PMS66 P2^;I)R3F1+WP28GP,L!.2\"4)RX!#_H$ M_,HE%X3,FDN@?8/?2/X'ZZI4JS4D[JE?UA]'?AG";]$6>#ZM-*^EGD):'BM/ M6:5@UAF_P>5GC+/VO-[ZO!.6@:[3Y"9=SV'46U./Q/KU11Z(JP8(#) MFM1V/6! \YGZ(:J?/K-JU>0*SO4:V(KW#0(VR6KC'K5[L*O=Y;.L74WKY5R[ MH.W*SX0/@-%?EV>'-T69)TMYM:E)I/X):I$0#*HLPH48DW4M%/5*"_X*U>_0 M[\W;B;,W8\41UP\MHE0EWF+58"L&%D#G)DQ.O"%Q\"(AH0E<@R !&L0N\KLD M2__)\\K#;-5LU+NH+G @67%._WU6X@=Y!8Z_8OW3?11#H._N!SP9]W:M98FG MI07[)TK9OU&.-_3SL(2]7J1"6\8:WH6P83=!)1M&YJ/.!=[))/GN>N556BS7 M- 8PJR0OZTV_MR1_J/:*RNOH5^0AH:8?>(^N8"MOTJSRQFX,(>Q8Q>P)\;.B MZP'SJ@S34GP IDD0VL1HX&ZCC1&^;L\3B$HT,^DJ\-YN>_#%3@?] MSAG'U29NGT8#KR:]B8[>?BH4L]V[9O'(M\T3E%S;NUHI*C6YC_';N:[;X<3< M65F<5.W0-N=K1(06Z(9LJP.OZMM*ORUH.R,QN#V3@K3&Y][DB)!R9FROPCW) MRO7=B=IQ-PZ.1VI>!'\ "'9N5KC&W%N44&P.;4F&@A.T!3G]P@X_V:;%/8N1 MUJ-1)+@/U*X_E+=V""D]G8&W,L/\:\DZQ)PT.7+'^C9\(Q1?=R,8=#HX:>)& M9RCX2#@B1*9[&FHI/Z@ (W, IH4:Z!@2_;3-.O6'^*M#N*8Q&Q'B@6/% SP" M3FX-] X)=#8]EJ2/U1)*&\!?';XU0]@CXAMTX/N8'SIVQ_ ,ORVMR M2:@SFBM^PBO\L.'YI'I>;YAR_>%\E4,X[><+KMD:YE=+YB'F%I42XEJH5D/7 M!#6*:*#S83Q/B!7L&[;8$%T<>"$+N\(\?..H#G8(Q30#Q)<6:@19W M42>H2%.1#:BA#2Q!%)JQQK=FD[3ANFV'2TT[S.P@;FCJEG@.A-&USE,R)K"7 M&>(:L+L96HPHO#D8RINO5-%U3R>E"FB'U>KZDJS3Y9,NJ1VJ7G].?_60(.'K M#3QY'5@ ;5089$^:[4ZJ$[KX+F(NS=-6IRQUXN1S,/8( ![$>.!KJ8T#PXHP M-@E@DLJAGD'A3Y-(QYRQ4D:S21TG@;LF51P5[X&IX1"7@"GA4/>@J'^F*> D MD->D?*-"/LI9F9HYD(\D.Z[V8$KL\=:3SKMTT(,X4\OJ)MJ9E:Z>K<=BN1E: M'"=Y_L02M4=V"SQ*BN;$%6%($*W8&;KT#=F619ED*Z:AO6NKOE=K_816S.0M MN[R3+:9_P@D[HA+=X">2K;B7>G4C,_"T9"OU;]&:9'M MYY\^1?2'L'R(EA>ZU*=D64WTSL%R=#H:>V#/AW1V"<.;[AF/VILIJ0JJ=5X% M8BTG,$:"+- IBDZ^ %,X;[\PP#WH '>>ZZ%& JOE%,)(8 7-P5BVAQ_8BF%Q MS.]PNM/#U?;%-._."5=9WVK+C_9B"1G-QU*RFCC%"@ F 8&*&!3\;;71 M86@QQF<)3#XVW#
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
=^@^@J<,SL!F48PB1-AZULSSE>:B8(RF MNH8YUF03$!8P)UC BVGZW'69Q7D( B5F)DN6%I,PSY,(K0X92 P1_#H
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�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end